
<html lang="en"     class="pb-page"  data-request-id="c466d9b1-a17f-45d9-a2ad-bafcc2ce02c4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.7b00282;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors" /></meta><meta name="dc.Creator" content="Teng-Kuang  Yeh" /></meta><meta name="dc.Creator" content="Ching-Chuan  Kuo" /></meta><meta name="dc.Creator" content="Yue-Zhi  Lee" /></meta><meta name="dc.Creator" content="Yi-Yu  Ke" /></meta><meta name="dc.Creator" content="Kuang-Feng  Chu" /></meta><meta name="dc.Creator" content="Hsing-Yu  Hsu" /></meta><meta name="dc.Creator" content="Hsin-Yu  Chang" /></meta><meta name="dc.Creator" content="Yu-Wei  Liu" /></meta><meta name="dc.Creator" content="Jen-Shin  Song" /></meta><meta name="dc.Creator" content="Cheng-Wei  Yang" /></meta><meta name="dc.Creator" content="Li-Mei  Lin" /></meta><meta name="dc.Creator" content="Manwu  Sun" /></meta><meta name="dc.Creator" content="Szu-Huei  Wu" /></meta><meta name="dc.Creator" content="Po-Chu  Kuo" /></meta><meta name="dc.Creator" content="Chuan  Shih" /></meta><meta name="dc.Creator" content="Chiung-Tong  Chen" /></meta><meta name="dc.Creator" content="Lun Kelvin  Tsou" /></meta><meta name="dc.Creator" content="Shiow-Ju  Lee" /></meta><meta name="dc.Description" content="Humans have two glutaminase genes, GLS (GLS1) and GLS2, each of which has two alternative transcripts: the kidney isoform (KGA) and glutaminase C (GAC) for GLS, and the liver isoform (LGA) and glut..." /></meta><meta name="Description" content="Humans have two glutaminase genes, GLS (GLS1) and GLS2, each of which has two alternative transcripts: the kidney isoform (KGA) and glutaminase C (GAC) for GLS, and the liver isoform (LGA) and glut..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 29, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00282" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00282" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00282" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00282" /></link>
        
    
    

<title>Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00282" /></meta><meta property="og:title" content="Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0010.jpeg" /></meta><meta property="og:description" content="Humans have two glutaminase genes, GLS (GLS1) and GLS2, each of which has two alternative transcripts: the kidney isoform (KGA) and glutaminase C (GAC) for GLS, and the liver isoform (LGA) and glutaminase B (GAB) for GLS2. Initial hit compound (Z)-5-((1-(4-bromophenyl)-2,5-dimethyl-1H-pyrrol-3-yl)methylene)thiazolidine-2,4-dione (2), a thiazolidine-2,4-dione, was obtained from a high throughput screening of 40 000 compounds against KGA. Subsequently, a series of thiazolidine-2,4-dione derivatives was synthesized. Most of these were found to inhibit KGA and GAC with comparable activities, were less potent inhibitors of GAB, and were moderately selective for GLS1 over GLS2. The relationships between chemical structure, activity, and selectivity were investigated. The lead compounds obtained were found to (1) offer in vitro cellular activities for inhibiting cell growth, clonogenicity, and cellular glutamate production, (2) exhibit high concentrations of exposure in plasma by a pharmacokinetic study, and (3) reduce the tumor size of xenografted human pancreatic AsPC-1 carcinoma cells in mice." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00282"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00282">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00282&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00282&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00282&amp;href=/doi/10.1021/acs.jmedchem.7b00282" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5599-5612</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00273" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00316" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Teng-Kuang++Yeh">Teng-Kuang Yeh</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ching-Chuan++Kuo">Ching-Chuan Kuo</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yue-Zhi++Lee">Yue-Zhi Lee</a></span><span class="author-xref-symbol "><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-8640-9525" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi-Yu++Ke">Yi-Yu Ke</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kuang-Feng++Chu">Kuang-Feng Chu</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hsing-Yu++Hsu">Hsing-Yu Hsu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hsin-Yu++Chang">Hsin-Yu Chang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yu-Wei++Liu">Yu-Wei Liu</a></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-8495-4941" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jen-Shin++Song">Jen-Shin Song</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng-Wei++Yang">Cheng-Wei Yang</a></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-3994-475X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li-Mei++Lin">Li-Mei Lin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manwu++Sun">Manwu Sun</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Szu-Huei++Wu">Szu-Huei Wu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Po-Chu++Kuo">Po-Chu Kuo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chuan++Shih">Chuan Shih</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chiung-Tong++Chen">Chiung-Tong Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lun+Kelvin++Tsou">Lun Kelvin Tsou</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-1593-5226" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shiow-Ju++Lee">Shiow-Ju Lee</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-4012-0149" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div><div class="corresp-info"><strong>*</strong>L.K.T.: telephone, +886-37-246-166, extension 35769; fax, +886-37-586-456; e-mail, <a href="/cdn-cgi/l/email-protection#6d0608011b0403191e02182d03051f0443021f0a43191a"><span class="__cf_email__" data-cfemail="1279777e647b7c66617d67527c7a607b3c7d60753c6665">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>S.-J.L.: telephone, +886-37-246-166, extension 35715; fax, +886-37-586-456; e-mail, <a href="/cdn-cgi/l/email-protection#ff8c939a9abf91978d96d1908d98d18b88"><span class="__cf_email__" data-cfemail="87f4ebe2e2c7e9eff5eea9e8f5e0a9f3f0">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00282&amp;href=/doi/10.1021%2Facs.jmedchem.7b00282" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5599–5612</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 13, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 February 2017</li><li><span class="item_label"><b>Published</b> online</span>29 June 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 July 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00282" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00282</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5599%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTeng-Kuang%2BYeh%252C%2BChing-Chuan%2BKuo%252C%2BYue-Zhi%2BLee%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D13%26contentID%3Dacs.jmedchem.7b00282%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BThiazolidine-2%252C4-dione%2BDerivatives%2Bas%2Ba%2BNovel%2BClass%2Bof%2BGlutaminase%2BInhibitors%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5612%26publicationDate%3DJuly%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00282"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2050</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00282" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Teng-Kuang&quot;,&quot;last_name&quot;:&quot;Yeh&quot;},{&quot;first_name&quot;:&quot;Ching-Chuan&quot;,&quot;last_name&quot;:&quot;Kuo&quot;},{&quot;first_name&quot;:&quot;Yue-Zhi&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Yi-Yu&quot;,&quot;last_name&quot;:&quot;Ke&quot;},{&quot;first_name&quot;:&quot;Kuang-Feng&quot;,&quot;last_name&quot;:&quot;Chu&quot;},{&quot;first_name&quot;:&quot;Hsing-Yu&quot;,&quot;last_name&quot;:&quot;Hsu&quot;},{&quot;first_name&quot;:&quot;Hsin-Yu&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Yu-Wei&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Jen-Shin&quot;,&quot;last_name&quot;:&quot;Song&quot;},{&quot;first_name&quot;:&quot;Cheng-Wei&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Li-Mei&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Manwu&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Szu-Huei&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Po-Chu&quot;,&quot;last_name&quot;:&quot;Kuo&quot;},{&quot;first_name&quot;:&quot;Chuan&quot;,&quot;last_name&quot;:&quot;Shih&quot;},{&quot;first_name&quot;:&quot;Chiung-Tong&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Lun&quot;,&quot;last_name&quot;:&quot;Kelvin Tsou&quot;},{&quot;first_name&quot;:&quot;Shiow-Ju&quot;,&quot;last_name&quot;:&quot;Lee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;5599-5612&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00282&quot;},&quot;abstract&quot;:&quot;Humans have two glutaminase genes, GLS (GLS1) and GLS2, each of which has two alternative transcripts: the kidney isoform (KGA) and glutaminase C (GAC) for GLS, and the liver isoform (LGA) and glutaminase B (GAB) for GLS2. Initial hit compound (Z)-5-((1-(4-bromophenyl)-2,5-dimethyl-1H-pyrrol-3-yl)methylene)thiazolidine-2,4-dione (2), a thiazolidine-2,4-dione, was obtained from a high throughput screening of 40 000 compounds against KGA. Subsequently, a series of thiazolidine-2,4-dione derivatives was synthesized. Most of these were found to inhibit KGA and GAC with comparable activities, were less potent inhibitors of GAB, and were moderately selective for GLS1 over GLS2. The relationships between chemical structure, activity, and selectivity were investigated. The lead compounds obtained were found to (1) offer in vitro cellular activities for inhibiting cell growth, clonogenicity, and cellular glutamate production, (2) exhibit high concentrations of exposure in plasma by a pharmacokinetic study, and (3) red&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00282&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00282" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00282&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00282" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00282&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00282" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00282&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00282&amp;href=/doi/10.1021/acs.jmedchem.7b00282" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00282" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00282" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00282%26sid%3Dliteratum%253Aachs%26pmid%3D28609101%26genre%3Darticle%26aulast%3DYeh%26date%3D2017%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BThiazolidine-2%252C4-dione%2BDerivatives%2Bas%2Ba%2BNovel%2BClass%2Bof%2BGlutaminase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D13%26spage%3D5599%26epage%3D5612%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/jmcmar.2017.60.issue-13/20170713/jmcmar.2017.60.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Humans have two glutaminase genes, <i>GLS</i> (<i>GLS1</i>) and <i>GLS2</i>, each of which has two alternative transcripts: the kidney isoform (KGA) and glutaminase C (GAC) for <i>GLS</i>, and the liver isoform (LGA) and glutaminase B (GAB) for <i>GLS2</i>. Initial hit compound (<i>Z</i>)-5-((1-(4-bromophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methylene)thiazolidine-2,4-dione (<b>2</b>), a thiazolidine-2,4-dione, was obtained from a high throughput screening of 40 000 compounds against KGA. Subsequently, a series of thiazolidine-2,4-dione derivatives was synthesized. Most of these were found to inhibit KGA and GAC with comparable activities, were less potent inhibitors of GAB, and were moderately selective for GLS1 over GLS2. The relationships between chemical structure, activity, and selectivity were investigated. The lead compounds obtained were found to (1) offer in vitro cellular activities for inhibiting cell growth, clonogenicity, and cellular glutamate production, (2) exhibit high concentrations of exposure in plasma by a pharmacokinetic study, and (3) reduce the tumor size of xenografted human pancreatic AsPC-1 carcinoma cells in mice.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer cells produce most of their energy by glycolysis and glutaminolysis rather than pyruvate oxidation. Warburg effect is the observation that cancer cells reprogram the cellular metabolism for cell growth mainly by the elevating glycolysis and glutaminolysis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Glutaminolysis occurs through deamido hydrolysis of glutamine by glutaminase (GA) to give glutamate, which is further oxidatively deaminated by glutamate dehydrogenase into α-ketoglutarate. This α-ketoglutarate enters the tricarboxylic acid cycle to replenish cellular nutrients.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Mammalian cells contain two <i>GLS</i> genes, <i>GLS1</i> (or <i>GLS</i>) and <i>GLS2</i>, each of which encodes two alternatively spliced mRNAs that are translated into isozymes: kidney GA (KGA) and GA isoform C for <i>GLS1</i>; liver GA (LGA) and GA isoform B for <i>GLS2</i>.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">GLS1 plays a vital role in up-regulating cell metabolism for tumor cell growth in vitro and in vivo.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8">(4-8)</a> Proteins or microRNAs that have been demonstrated to impact glutaminase expression or activity levels are involved in a number of diverse pathways and mechanisms, e.g., cMyc, miRNA23, EGFR.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Treatments with GLS1 inhibitors for Burkitt lymphoma P493 or breast carcinoma xenografted murine tumor models have validated GLS1 as a therapeutic target and demonstrated in vivo efficacy, significantly reducing tumor progression.<a onclick="showRef(event, 'ref4 ref8'); return false;" href="javascript:void(0);" class="ref ref4 ref8">(4, 8)</a> Elevated GLS2 enzymatic activity has also been correlated with tumor cell growth in vitro<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and in vivo.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> N-Myc activates GLS2 to promote conversion of glutamine to glutamate in MYCN-amplified neuroblastoma cells. Abrogation of GLS2 function profoundly inhibits glutaminolysis and dramatically decreases cell proliferation and survival in vitro<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> and in vivo.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> However, there is controversy over the role of GLS2 as a tumor suppressor. Enzymatic activity independent of GLS2 is up-regulated via p53 or p63 and plays a role of tumor suppressor.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11-14)</a> The p53 elevated GLS2 interacts with rac1 through its C-terminal domain to interrupt the interaction of rac1 with its partner, the small GTP binding protein exchanger, thereby inhibiting the rac1 functions of tumorigenesis. Expression levels and enzymatic activity of GLS1 and GLS2 in different types of tumor are varied;<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a> therefore the existing GLS1 or GLS2 could both be targeted for antitumor cell growth.</div><div class="NLM_p">Glutamine analogous antagonists 6-diazo-5-oxo-<span class="smallcaps smallerCapital">l</span>-norleucin<a onclick="showRef(event, 'ref5 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref5 ref19 ref20 ref21">(5, 19-21)</a> and acivicin<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> exert antitumoral efficacy in different animal models and were tested as chemotherapeutic agents in different clinical studies but were never approved as therapeutic agents for toxicity reasons.<a onclick="showRef(event, 'ref21 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref23">(21, 23)</a> Naturally occurring ardisianones allosterically binding to the C-terminal end of each GAB monomer<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and physapubescin inhabiting in the substrate binding pocket<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> were also reported to inhibit GAB or KGA with IC<sub>50</sub> values ranging from sub-μM to several μM. The most recent progress in the development of potent GA inhibitors has focused on allosteric small molecules, such as <u class="uu">b</u>is-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl <u class="uu">s</u>ulfide (BPTES)<a onclick="showRef(event, 'ref5 ref7 ref25 ref33'); return false;" href="javascript:void(0);" class="ref ref5 ref7 ref25 ref33">(5, 7, 25, 33)</a> and 2-(pyridin-2-yl)-<i>N</i>-(5-(4-(6-(2-(3-(trifluoromethoxy)phenyl)acetamido)pyridazin-3-yl)butyl)-1,3,4-thiadiazol-2-yl)acetamide (CB-839)<a onclick="showRef(event, 'ref8 ref26'); return false;" href="javascript:void(0);" class="ref ref8 ref26">(8, 26)</a>(<b>1</b>) (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). BPTES and <b>1</b> bind to the gating loop, which affects substrate binding and is located at the dimer–dimer interface that participates in the formation of active tetrameric GA. Their binding causes a conformational change that deactivates the active tetrameric GA.<a onclick="showRef(event, 'ref5 ref7 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref5 ref7 ref25 ref26">(5, 7, 25, 26)</a> In addition, 5-(3-bromo-4-(dimethylamino)phenyl)-2,2-dimethyl-2,3,5,6-tetrahydrobenzo[<i>a</i>]phenanthridin-4(1<i>H</i>)-one (bromobenzophenanthridinone 968)<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> binds between the N and C termini of two GAC monomers at the monomer–monomer interface and also exerts inhibition through modulating the conformation into inactive forms.<a onclick="showRef(event, 'ref5 ref27'); return false;" href="javascript:void(0);" class="ref ref5 ref27">(5, 27)</a> These inhibitors all exhibit high selectivity for GLS1 over GLS2 and thus target GLS1 elevated cancer types.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Exploration of GA inhibitors with different inhibitory mechanisms should result in more options for developing GA inhibitors into therapeutic agents. Herein, we report a novel class of thiazolidine-2,4-dione derived glutaminase inhibitors that preferentially inhibit the enzymatic activity of GLS1 over GLS2 and show in vivo efficacy in the AsPC-1 xenograft tumor model.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76374" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76374" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Analysis of Structure–Activity Relations</h3><div class="NLM_p">Compound (<i>Z</i>)-5-((1-(4-bromophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methylene)thiazolidine-2,4-dione (<b>2</b>) was identified by a high throughput screening of 40 000 compounds against KGA at the National Health Research Institutes (NHRI) HTS core facility. Replacement of the −CH<sub>3</sub> group with a thiophene (<b>3</b>) or phenyl (<b>4</b>) group increased the enzymatic inhibitory potency (IC<sub>50</sub>) from 3097 nM of <b>2</b> to 754 nM of <b>3</b> or moderately decreased to 4896 nM of <b>4</b> for KGA respectively (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of a Series of Thiazolidine-2,4-dione Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TsOH<sub>(cat.)</sub>, toluene, reflux; (b) POCl<sub>3</sub>, DMF, rt; (c) thiazolidine-2,4-dione, piperidine<sub>(cat.)</sub>, AcOH<sub>(cat.)</sub>, toluene, reflux; (d) (4-formylphenyl)boronic acid or (3-ethyl-4-formylphenyl)boronic acid or (3-chloro-4-formylphenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4 (cat.)</sub>, Na<sub>2</sub>CO<sub>3(aq)</sub>, DME, EtOH, reflux; (e) BBr<sub>3</sub>, DCM, 0 °C. The percentage (%) following each set of R groups is the percent yield for that reaction.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Thiazolidine-2,4-dione Derivatives That Inhibit the Enzymatic Activity of Human Glutaminase Isoforms KGA, GAC, and GAB<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last">Chemical core structures are shown. Measurement of the IC<sub>50</sub> values is described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Values shown are the mean ± SD from at least three independent experiments, each in duplicate.</p></div></div><div></div></div><div class="NLM_p">Hit compound <b>2</b> was further modified through an alternative route that started from intermediate <b>D</b><sub><b>1</b></sub> shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> to give a symmetric structured compound <b>5</b>. This modification improved potency further, and compound <b>5</b> had an IC<sub>50</sub> of 102 nM. Compounds <b>3</b> and <b>4</b> were similarly modified to give compounds <b>6</b> and <b>7</b>, respectively, and also exhibited improved potency (50 nM and 45 nM) by a ∼16- to 98-fold increase (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Substitutions at R1 (with –OCH<sub>3</sub>, –CN, or –OH) or at R2 (with –CH<sub>2</sub>CH<sub>3</sub> or –Cl) of compounds <b>5</b>–<b>7</b> gave compounds <b>8</b>–<b>17</b>. All of <b>8</b>–<b>17</b> retained the potency of <b>5</b>–<b>7</b>, and each possessed an improved selectivity for KGA/GAC over GAB from selectivity index of 2–12 to 8–74 (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p last">In general, most of compounds in this series inhibited KGA/GAC but exerted less potency for GAB. Thus, these compounds are moderately selective for GLS1 over GLS2.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> In Vitro Activities of Inhibiting Cellular Glutamate Production, Cell Growth, and Clonogenicity</h3><div class="NLM_p">This series of compounds was also found to (1) inhibit carcinoma cell growth, including cell lines of triple negative breast cancer MDA-MB-231 and pancreatic cancer AsPC-1 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>); (2) inhibit colony formation (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A); and (3) diminish cellular glutamate production (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). Of the compounds tested, compound <b>17</b> was the most potent, with the highest selectivity for KGA/GAC over GAB (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). However, <b>17</b> was found to exert the least inhibitory potency for cell growth and colony formation (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), suggesting it to have poor properties, e.g., cell permeability, and therefore disqualifying it from further in vivo efficacy testing. Accordingly, other compounds with good inhibitory potency for KGA/GAC enzymatic activity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), cell growth, and colony formation (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) were instead pursued.</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effects of glutaminase inhibitors, thiazolidine-2,4-dione derivatives, in inhibiting AsPC-1 cellular glutamate production and clonogenicity. Thiazolidine-2,4-dione derivatives inhibited colony formation of AsPC-1 (A) and diminished the cellular glutamate levels in both of AsPC-1<sup>WT</sup> (B, C) and AsPC-1<sup><i>GLS</i>–/–</sup> cells (C). The highly selective compound BPTES, which completely lost glutaminase inhibition in AsPC-1<sup><i>GLS</i>–/–</sup> cells, was used as reference compound control. The cells treated with thiazolidine-2,4-dione derivatives or the reference compound BPTES were subjected to assays for glutamates levels or clonogenicity as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Shown are the mean ± SD from three independent experiments, each in duplicate for (B) and (C): (∗∗) <i>P</i> < 0.01, (∗∗∗) <i>P</i> < 0.001 versus vehicle treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Growth Inhibition and Anticlonogenic Activity of Glutaminase Inhibitors, Thiazolidine-2,4-dione Derivatives, against Pancreatic Carcinoma Cells<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">clonogenicity inhibition (%)</th><th class="rowsep1 colsep0" colspan="2" align="center">growth inhibition</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">AsPC-1</th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">2 μM</th><th class="colsep0 rowsep0" align="center">10 μM</th><th class="colsep0 rowsep0" align="center">AsPC-1</th><th class="colsep0 rowsep0" align="center">MDA-MB-231</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BPTES</td><td class="colsep0 rowsep0" align="left">41 ± 6</td><td class="colsep0 rowsep0" align="left">98 ± 1</td><td class="colsep0 rowsep0" align="left">10.2 ± 1.3</td><td class="colsep0 rowsep0" align="left">6.8 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">13 ± 11</td><td class="colsep0 rowsep0" align="left">59 ± 8</td><td class="colsep0 rowsep0" align="left">34.5 ± 1.4</td><td class="colsep0 rowsep0" align="left">42 ± 1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">64 ± 11</td><td class="colsep0 rowsep0" align="left">87 ± 3</td><td class="colsep0 rowsep0" align="left">14.8 ± 2.0</td><td class="colsep0 rowsep0" align="left">28.7 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">79 ± 8</td><td class="colsep0 rowsep0" align="left">94 ± 3</td><td class="colsep0 rowsep0" align="left">10 ± 1.5</td><td class="colsep0 rowsep0" align="left">13.4 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">89 ± 0</td><td class="colsep0 rowsep0" align="left">95 ± 2</td><td class="colsep0 rowsep0" align="left">11.9 ± 1.1</td><td class="colsep0 rowsep0" align="left">10.6 ± 5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">90 ± 2</td><td class="colsep0 rowsep0" align="left">95 ± 2</td><td class="colsep0 rowsep0" align="left">12 ± 1.3</td><td class="colsep0 rowsep0" align="left">8.9 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">28 ± 9</td><td class="colsep0 rowsep0" align="left">59 ± 11</td><td class="colsep0 rowsep0" align="left">12.5 ± 2.4</td><td class="colsep0 rowsep0" align="left">15.3 ± 3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">44 ± 4</td><td class="colsep0 rowsep0" align="left">89 ± 5</td><td class="colsep0 rowsep0" align="left">24.8 ± 3.9</td><td class="colsep0 rowsep0" align="left">26.3 ± 2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">51 ± 2</td><td class="colsep0 rowsep0" align="left">91 ± 6</td><td class="colsep0 rowsep0" align="left">8.8 ± 1.7</td><td class="colsep0 rowsep0" align="left">8.2 ± 2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">18 ± 12</td><td class="colsep0 rowsep0" align="left">51 ± 25</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Shown are the mean ± SD from at least three independent experiments, each in duplicate. The clonogenicity inhibition treated with indicated compounds was presented as percentage relative to the vehicle treatment.</p></div></div></div><div class="NLM_p last">In order to confirm the selectivity of these potent compounds for glutaminase isoforms, their inhibition of cellular glutamate production was examined with AsPC-1<sup><i>GLS</i>–/–</sup> cells, in which the <i>GLS1</i> gene was knocked out and only GLS2 activity remained (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf" class="ext-link">Supporting Information Figure S1</a>). Compounds <b>6</b> and <b>7</b> inhibited the glutamate production in a dose dependent manner in both AsPC-1<sup>WT</sup> and AsPC-1<sup><i>GLS</i>–/–</sup> cells. However, BPTES treatments were only able to inhibit the glutamate production in AsPC-1<sup>WT</sup> by ∼60–70% and did not inhibit glutamate production in AsPC-1<sup><i>GLS–</i>/–</sup> cells at all. The results clearly demonstrated that only the highly GLS1 selective compound BPTES could not inhibit GLS2 activity in AsPC-1<sup><i>GLS</i>–/–</sup> cells (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C). Since the thiazolidine-2,4-dione derived glutaminase inhibitors <b>6</b> and <b>7</b> reported herein possessed a selectivity index of ∼2 and ∼6 for GLS1 over GLS2, respectively (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), the results obtained are consistent in that both <b>6</b> and <b>7</b> inhibit cellular glutamate production in either AsPC-1<sup>WT</sup> or AsPC-1<sup><i>GLS</i>–/–</sup> cells (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B and <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Pharmacokinetics and in Vivo Efficacy Tests</h3><div class="NLM_p">Pharmacokinetic studies entailed intravenous administration of the compounds to rats at 2 mg for BPTES and <b>6</b> or 0.1 mg for <b>5</b> and oral administration at 10 mg for BPTES and <b>6</b> or 1 mg for <b>5</b> per kg of body weight. Blood samples were taken, and the plasma was analyzed. BPTES, <b>5</b>, and <b>6</b> all exhibited very little bioavailability. However, <b>5</b> and <b>6</b> were well exposed in blood, and their area under the concentration–time curve (AUC) values (via intravenous route) of 43 580 and 3414 (ng/mL)·h, respectively, were obtained, much higher than that of BPTES (636 (ng/mL)·h; <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Properties of Glutaminase Inhibitors, BPTES, and Thiazolidine-2,4-dione Derivatives <b>5</b> and <b>6</b> in Rats<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">iv</th><th class="rowsep1 colsep0" colspan="6" align="center">po</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center">AUC<sub>(0–inf)</sub> ((ng/mL)·h)</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center">AUC<sub>(0–inf)</sub> ((ng/mL)·h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BPTES</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">5.3 ± 1.4</td><td class="colsep0 rowsep0" align="left">53 ± 7.6</td><td class="colsep0 rowsep0" align="left">8.8 ± 1.6</td><td class="colsep0 rowsep0" align="left">636 ± 90</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.1</td><td class="colsep0 rowsep0" align="left">40 ± 8.2</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.3</td><td class="colsep0 rowsep0" align="left">73 ± 2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">NA<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">3414 ± 1184</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">NA<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">16.6 ± 4.6</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">222 ± 89</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">5.0 ± 1.4</td><td class="colsep0 rowsep0" align="left">0.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.1 ± 0</td><td class="colsep0 rowsep0" align="left">43580 ± 8136</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NA<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">iv, intravenous administration; po, oral administration; <i>T</i><sub>1/2</sub>, terminal half-life; CL, total body clearance; <i>V</i><sub>ss</sub>, volume of distribution at steady state; AUC, area under the concentration time curve; <i>C</i><sub>max</sub>, the highest peak concentration; <i>T</i><sub>max</sub>, time to reach the highest peak concentration; <i>F</i>, % oral bioavailability.</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last">ND: not determined.</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last">NA: not available.</p></div></div></div><div class="NLM_p">Due to the poor bioavailability and high blood exposure of compounds <b>5</b> and <b>6</b>, in vivo efficacy tests were carried out by intraperitoneal injection of the tested compounds in a human pancreatic AsPC-1 xenograft tumor model. Nude mice bearing established AsPC-1 tumors were treated with BPTES (positive control) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A), <b>5</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A), and <b>6</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B), respectively. In vivo antitumor efficacy was expressed as tumor growth inhibition, a treatment outcome indicator. BPTES and compounds <b>5</b> and <b>6</b> significantly and effectively reduced tumor growth at a dose of 25 mg/kg (BPTES and <b>5</b>) or 50 mg/kg (<b>5</b> and <b>6</b>), resulting in 50–60% tumor growth inhibition by the end of the test (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, left panels). No overt signs of adverse effects or a body weight loss of >10% were observed during the experimental period (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, right panels). These results clearly demonstrate that <b>5</b> and <b>6</b> effectively inhibit tumor growth in a preclinical mouse model.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. In vivo antitumoral efficacy of GA inhibitors in AsPC-1 xenograft tumor model. (A) BPTES and compound <b>5</b>: AsPC-1 bearing mice were sorted into four groups. Group 1 mice received vehicle (2% DMSO/PBS), group 2 mice received BPTES at 25 mg/kg, groups 3 and 4 mice received compound <b>5</b> at 25 and 50 mg/kg through intraperitoneal (ip) injection, respectively, once daily on 5 on/2 off (5 days on and then 2 days off) schedule for the entire period of observation. (B) Compound <b>6</b>: AsPC-1 bearing mice were sorted into 3 groups. Group 1 mice received vehicle (2% DMSO/PBS), and groups 2 and 3 received compound <b>6</b> at 25 and 50 mg/kg through ip injection, respectively, once daily on 5 on/2 off schedule for the entire period of observation. % TGI was determined for antitumor effects which are expressed as [1 – ((<i>T<sub>t</sub></i> – <i>T</i><sub>0</sub>)/(<i>C<sub>t</sub></i> – <i>C</i><sub>0</sub>))] × 100 where <i>T<sub>t</sub></i> = median tumor volume of treated at time <i>t</i>, <i>T</i><sub>0</sub> = median tumor volume of treated at time 0, <i>C<sub>t</sub></i> = median tumor volume of control at time <i>t</i>, and <i>C</i><sub>0</sub> = median tumor volume of control at time 0. “<i>t</i>” is indicated as day 43 for (A) and day 68 for (B) in this study. Statistical significance was established at <i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Molecular Modeling, Site-Directed Mutagenesis Studies, and Binding Site Analysis</h3><div class="NLM_p">On the basis of the structure–activity relationships analyzed above, we sought to determine the possible binding site(s) of thiazolidine-2,4-dione derived lead compounds in KGA. Molecular modeling and docking studies were conducted using the human GLS1 crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>) and BIOVIA software (BIOVIA, Inc., San Diego, CA). Two different binding sites of glutaminase inhibitors were simulated through Biovia based on molecular docking on the human GLS1 crystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>). The first was for the allosteric inhibitors BPTES and <b>1</b> (data not shown), which are known to bind KGA/GAC at the dimer–dimer interface.<a onclick="showRef(event, 'ref7 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref7 ref25 ref26">(7, 25, 26)</a> The second was for thiazolidine-2,4-dione derived glutaminase inhibitors in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, compound <b>5</b> was predicted to bind to the substrate binding pocket of KGA (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). R387 of KGA was predicted to interact with thiazolidine-2,4-dione derived glutaminase inhibitors based on simulated docking results (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). Therefore, R387 was mutated into Ala to give KGA R387A, against which compounds <b>5</b>, <b>7</b>, and <b>17</b> were also tested; a ∼190- to >490-fold decrease in IC<sub>50</sub> values compared to wild type KGA was observed (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). These results suggested R387 interacts with compounds <b>5</b>, <b>7</b>, and <b>17</b> through hydrophobic bonding interactions.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Assignment of the KGA binding site of thiazolidine-2,4-dione derived glutaminase inhibitors. (A) Docking simulation of the compound <b>5</b> binding site in KGA. Shown were the alkyl to alkyl and alkyl to π hydrophobic bonding interactions (in blue dashed lines) of compound <b>5</b> (highlighted in cyan) with the residue Arg 387, which is located in the substrate binding pocket and highlighted in orange, of KGA in the best docked pose. The best docked pose was determined based on the results from site-directed mutagenesis (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) and the molecular modeling and docking studies, which were conducted using the human GLS1 crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>) and the BIOVIA/LigandFit program (BIOVIA, Inc., San Diego, CA) with the CHARMM force field.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The residues (Ser 286, Glu 381, Asn 335, and Tyr 414) involved in substrate glutamine binding site of KGA<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> were highlighted in yellow. Those residues, Ser 384 and Lys 507, which did not show interaction with the thiazolidine-2,4-dione derived glutaminase inhibitors as demonstrated by site-directed mutagenesis (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), were highlighted in magenta and green, respectively. (B) Close look of the hydrophobic interactions between the side chain CH<sub>2</sub> of compound <b>5</b> and Arg 387. (C) Overview of the proposed association of compound <b>5</b> in a GA tetramer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Activities (IC<sub>50</sub>) of Thiazolidine-2,4-dione Derivatives and BPTES against Human KGA Mutants<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center">compound</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">BPTES</th><th class="rowsep1 colsep0" colspan="2" align="center"><b>5</b></th><th class="rowsep1 colsep0" colspan="2" align="center"><b>7</b></th><th class="rowsep1 colsep0" colspan="2" align="center"><b>17</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">KGA</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>V.S</i>. KGA (fold)</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>V.S</i>. KGA (fold)</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>V.S</i>. KGA (fold)</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>V.S</i>. KGA (fold)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">WT</td><td class="colsep0 rowsep0" align="left">81 ± 15</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">102 ± 20</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">45 ± 4</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">57 ± 15</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S384A</td><td class="colsep0 rowsep0" align="left">65 ± 11</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">361 ± 3</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">78 ± 17</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">87 ± 24</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R387A</td><td class="colsep0 rowsep0" align="left">63 ± 10</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>490</td><td class="colsep0 rowsep0" align="left">8883 ± 136</td><td class="colsep0 rowsep0" align="left">197</td><td class="colsep0 rowsep0" align="left">10901 ± 759</td><td class="colsep0 rowsep0" align="left">191</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R387L</td><td class="colsep0 rowsep0" align="left">345 ± 36</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">1270 ± 40</td><td class="colsep0 rowsep0" align="left">12.5</td><td class="colsep0 rowsep0" align="left">603 ± 32</td><td class="colsep0 rowsep0" align="left">13.4</td><td class="colsep0 rowsep0" align="left">770 ± 57</td><td class="colsep0 rowsep0" align="left">13.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">K507A</td><td class="colsep0 rowsep0" align="left">66 ± 5</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">1045 ± 94</td><td class="colsep0 rowsep0" align="left">10.2</td><td class="colsep0 rowsep0" align="left">187 ± 46</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">269 ± 79</td><td class="colsep0 rowsep0" align="left">4.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Shown are the mean ± SD from three independent experiments, each in duplicate.</p></div></div></div><div class="NLM_p last">Those residues, S384 and K507 of KGA, which did not show interaction in above simulated docking model with the thiazolidine-2,4-dione derived glutaminase inhibitors (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A), were also mutated into Ala to give KGA S384A and K507A, against which compounds <b>5</b>, <b>7</b>, and <b>17</b> were also tested; only a ∼2- to 10-fold decrease in IC<sub>50</sub> values compared to wild type KGA was observed (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Finally, R387 was mutated into Leu to give KGA R387L, against which compounds <b>5</b>, <b>7</b>, and <b>17</b> were also tested; only a ∼12- to ∼14-fold decrease in IC<sub>50</sub> values compared to wild type KGA was observed (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). These results further validate the hydrophobic bonding interaction hypothesis of R387 with compounds <b>5</b>, <b>7</b>, and <b>17</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Kinetic Studies on the KGA Inhibition by Thiazolidine-2,4-dione Glutaminase Inhibitors</h3><div class="NLM_p">Compound <b>5</b> was found to inhibit KGA in a mixed mode of a competitive and a partial noncompetitive inhibition (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>); in a competitive mode when compound <b>5</b> concentration was increased from 0 to 0.1 μM, the <i>V</i><sub>max</sub> retained almost the same value while the <i>K</i><sub>m</sub> increased; in a partial noncompetitive mode when compound <b>5</b> concentration was increased from 0.1 μM to 0.4 μM the <i>V</i><sub>max</sub> decreased while the <i>K</i><sub>m</sub> increased (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C). This inhibition mode of compound <b>5</b> against KGA was in consistent with the above results from docking and site-directed mutagenesis studies.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition mode of thiazolidine-2,4-dione derived glutaminase inhibitors against KGA. (A) Glutamine saturation profiles for KGA at 0–0.4 μM of compound <b>5</b>. (B) Lineweaver–Burk double-reciprocal for KGA and compound <b>5</b>. (C) Data of <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> at different concentrations of compound <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Combined Treatments of GA Inhibitors at Different Binding Sites or with Doxorubicin Afforded Synergistic Effects in Suppressing Carcinoma Cell Proliferation</h3><div class="NLM_p">Combined treatments of GA inhibitor <b>5</b>, <b>6</b>, or BPTES<a onclick="showRef(event, 'ref7 ref25'); return false;" href="javascript:void(0);" class="ref ref7 ref25">(7, 25)</a> with doxorubicin (a stabilizer of the topoisomerase–DNA complex)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> respectively resulted in a synergistic effect for suppressing AsPC-1 carcinoma cell proliferation (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A) with combination indexes from 0.45 to 0.68 at ED<sub>50</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf" class="ext-link">Supporting Information Table S1</a>). The combined treatment of <b>6</b> and BPTES (both GA inhibitors but with different binding sites) exerted a more profound synergistic effect for suppressing HCC1806 breast carcinoma cell proliferation (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B) with combination indexes from 0.13 to 0.14 at ED<sub>50</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf" class="ext-link">Supporting Information Table S1</a>). These combined treatments should be considered when GA allosteric inhibitors are developed into the therapeutic agents and treatment regimens are sought.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Synergistic effects of combined treatments of GA inhibitors with doxorubicin or GA inhibitors at different binding sites in inhibition of carcinoma cell growth. AsPC-1 (A) and HCC1806 (B) cells were grown and treated with indicated compounds. Cell viabilities were assayed by MTS as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Combination index (CI) values at ED<sub>50</sub>, ED<sub>75</sub>, and ED<sub>90</sub> were calculated using Calcusyn software based on the Chou–Talalay method for drug combination<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf" class="ext-link">Supporting Information Table S1</a>. Combination index (CI) = 1 refers to additive effect, CI < 1 refers to synergism, and CI > 1 means antagonism. ED<sub>50</sub>, ED<sub>75</sub>, and ED<sub>90</sub> represent effective doses of 50%, 75%, and 90% inhibition, respectively. Results shown are representative of three independent experiments. The dashed line, isobologram of ED<sub>50</sub>, is drawn for clarity to define area for the additive effect, synergism, or antagonism. When the combination data point falls on the dashed line (CI = 1), an additive effect is suggested. When data point falls on the lower left area of the dashed line (CI < 1), a synergism is suggested, and if it falls on the upper right area (CI > 1), an antagonism is suggested. Data of two combinations for each experiment all fell on the lower left area in the isobologram indicating a synergism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compared to the highest selectivity of BPTES or <b>1</b> for GLS1, the novel class of thiazolidine-2,4-dione glutaminase inhibitors presented herein can inhibit either cellular GLS1 or GLS2 activity in both in vitro cell-based assays and in vivo tumor growth model as demonstrated in reduction of glutamate production in AsPC-1<sup>WT</sup> and AsPC-1<sup><i>GLS1</i>–/–</sup> (<a class="ref internalNav" href="#fig1" aria-label="Figures 1">Figures 1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The solubility and bioavailability of these compounds are inadequate for their immediate use as therapeutic anticancer drugs, and further development is required. Replacement of the heterocyclic or phenyl rings of these thiazolidine-2,4-dione glutaminase inhibitors with corresponding heterocyclic based isosteres or heteroaromatic rings, which potentially increase solubility, should improve the pharmacokinetic properties.</div><div class="NLM_p">The combination of thiazolidine-2,4-dione glutaminase inhibitors with the existing anticancer agents was also tested. A synergistic effect was observed for BPTES, <b>5</b>, or <b>6</b> with doxorubicin (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). A synergistic effect was also observed when compound <b>6</b> was administered in combination with BPTES (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). This result indicates that glutaminase inhibitors binding at different sites of KGA can work cooperatively, in addition to combination with doxorubicin, a very interesting finding that merits further investigation.</div><div class="NLM_p">Because this thiazolidine-2,4-dione compound class shares a key moiety with the thiazolidinedione peroxisome proliferator-activated receptor agonists (PPARs) used in the treatment of diabetes,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> off-target activities toward PPARs of these thiazolidine-2,4-dione glutaminase inhibitors were also investigated. No significant transactivation of PPARγ, PPARα, or PPARδ was found (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf" class="ext-link">Supporting Information Figure S2</a>). Commercially available glitazone drugs were also tested for KGA inhibitory activity; none was found (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf" class="ext-link">Supporting Information Table S2</a>). Accordingly, the lead thiazolidine-2,4-dione compounds reported herein are concluded to impart glutaminase inhibitory activity without targeting cellular PPARs.</div><div class="NLM_p last">In summary, a novel class of thiazolidine-2,4-dione compounds capable of selectively inhibiting glutaminase activity in vitro and in vivo has been discovered and developed. Tumor cells such as AsPC-1, which expresses both GLS1 and GLS2 in significant amounts, are suitable for treatment with thiazolidine-2,4-dione glutaminase inhibitors in order to reduce tumor size. This finding opens another potential arena for GA allosteric inhibitors which bind KGA at the substrate binding pocket. They are neither substrate analogues (e.g., 6-diazo-5-oxo-<span class="smallcaps smallerCapital">l</span>-norleucin or acivicin) nor intermonomer allosteric inhibitors such as BPTES or <b>1</b> for developing GA inhibitors for cancer therapy.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80730" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80730" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">1 Chemistry</h3></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">1.1 General Remarks</h3><div class="NLM_p">According to the substructures listed by Baell and Holloway,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> the core structure of thiazolidine-2,4-dione moiety is in the category as a PAIN hit. However, compound (<i>Z</i>)-5-((1-(4-bromophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methylene)-4-thioxothiazolidin-2-one, with only one oxygen replaced by sulfur at the thiazolidine-2,4-dione moiety of compound <b>2</b>, is also a PAIN hit<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> but exhibited no inhibitory activity against KGA (IC<sub>50</sub> > 100 μM). Therefore, the KGA inhibitory activity of compound <b>2</b> described herein is highly likely not caused by pan assay interference. Moreover, we have provided firm experimental evidence from in vitro and in vivo assays and demonstrated that the novel glutaminase inhibitors thiazolidine-2,4-dione derivatives reported herein are specifically active and their apparent activity is not an artifact.</div><div class="NLM_p last"><sup>1</sup>H and <sup>13</sup>C NMR spectra were measured with a Varian Mercury 300 or Varian Mercury 400 spectrometer, and purity of the final compounds was determined with a Hitachi 2000 series HPLC system using a C18 column as described.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The purity of all tested compounds is >95% except for compounds <b>9</b> (>94%), <b>10</b> (>94%), and <b>17</b> (>92%). See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf" class="ext-link">Supporting Information Table S3</a> for actual pictures of compounds <b>2</b>–<b>17</b> and intermediates with NMR data shown as follows.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">1.2 General Synthetic Procedures for Thiazolidine-2,4-dione Derivatives</h3><div class="NLM_p">Diketone <b>A</b><sub><b>1</b>–<b>3</b></sub> (1.0 equiv), amine <b>B</b><sub><b>1</b>–<b>3</b></sub> (1.2 equiv), and <i>p</i>-toluenesulfonic acid (TsOH, 0.1 equiv) were dissolved in toluene (0.5 M) and refluxed for 12 h. The solution was cooled to room temperature and concentrated in vacuo. The residue was purified by column chromatography over silica gel (<i>n</i>-Hex/EA = 4:1) to give intermediate product <b>C</b><sub><b>1</b>–<b>7</b></sub>.</div><div class="NLM_p">A solution of DMF containing 182 mg of POCl<sub>3</sub> was stirred for 0.5 h at 0 °C. The reaction mixture was allowed to warm up to room temperature. Subsequently, 100 mg (1.0 equiv) of starting material <b>C</b><sub><b>1</b>–<b>7</b></sub> was added, and the mixture was stirred for 1 h at room temperature. The reaction was cooled to 0 °C and quenched by dropwise addition of aqueous NaOH solution. The resulting mixture was extracted with DCM, and the organic layer was dried over magnesium sulfate and concentrated in vacuo. The crude product obtained was purified by column chromatography over silica gel to provide 76.3 mg of the aldehyde product <b>D</b><sub><b>1</b>–<b>7</b></sub>.</div><div class="NLM_p last">The corresponding arylboronic acid (1.5 equiv), sodium carbonate (2 M, 4 equiv), and bromoarene <b>D</b><sub><b>1</b>–<b>7</b></sub> (1 equiv) were added to a degassed suspension with the catalyst Pd(PPh<sub>3</sub>)<sub>4</sub> (0.1 equiv) in the mixture of aqueous EtOH/H<sub>2</sub>O/DME (1:1:2) under argon atmosphere. This reaction mixture was refluxed under argon for 3 h. The reaction was quenched with 5% aqueous HCl, extracted with ether, and the organic layer was dried by magnesium sulfate. The filtrate was evaporated under reduced pressure and was purified by column chromatography over silica gel. A solution mixture of aldehyde <b>D</b><sub><b>1</b>–<b>7</b></sub> (1.0 equiv) (or <b>E</b><sub><b>1</b>–<b>13</b></sub>), thiazolidine-2,4-dione (2.2 equiv), piperidine (in a catalytic amount), and AcOH was then refluxed for 3 h in toluene. The solution was cooled to room temperature and triturated with 10 mL of methanol and filtered to afford yellow solids <b>2</b>–<b>4</b> or <b>5</b>–<b>17</b> as the corresponding products.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">1.3 1-(4-Bromophenyl)-2,5-dimethyl-1<i>H</i>-pyrrole-3-carbaldehyde (<b>D</b><sub><b>1</b></sub>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.87 (s, 1H), 7.66 (dd, <i>J</i> = 8.6, 2.0 Hz, 2H), 7.09 (dd, <i>J</i> = 8.6, 2.0 Hz, 2H), 6.38 (d, <i>J</i> = 1.3 Hz, 1H), 2.28 (s, 3H), 1.98 (s, 3H).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">1.4 1-(4-Bromo-3-methoxyphenyl)-2,5-dimethyl-1<i>H</i>-pyrrole-3-carbaldehyde (<b>D</b><sub><b>2</b></sub>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.92 (s, 1H), 7.72–7.64 (m, 2H), 6.72–6.64 (m, 2H), 3.90 (s, 3H), 2.32 (s, 3H), 2.01 (s, 3H).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">1.5 1-(4-Bromophenyl)-2,5-diphenyl-1<i>H</i>-pyrrole-3-carbaldehyde (<b>D</b><sub><b>4</b></sub>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.70 (s, 1H), 7.39–7.13 (m, 10H), 7.11–7.03 (m, 2H), 6.96 (d, <i>J</i> = 2.5 Hz, 1H), 6.82 (dd, <i>J</i> = 8.8, 2.5 Hz, 2H).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">1.6 1-(4-Bromo-3-methoxyphenyl)-2,5-diphenyl-1<i>H</i>-pyrrole-3-carbaldehyde (<b>D</b><sub><b>5</b></sub>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.71 (s, 1H), 7.39–7.28 (m, 4H), 7.28–7.16 (m, 5H), 7.16–7.05 (m, 2H), 6.96 (d, <i>J</i> = 2.1 Hz, 1H), 6.47–6.34 (m, 2H), 3.49 (s, 3H).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">1.7 1-(4-Bromophenyl)-2,5-di(thiophen-2-yl)-1<i>H</i>-pyrrole-3-carbaldehyde (<b>D<sub>6</sub></b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 9.84 (s, 1H), 7.52–7.48 (m, 2H), 7.38 (dd, <i>J</i> = 1.2, 5.2 Hz, 1H), 7.18 (dd, <i>J</i> = 1.2, 5.2 Hz, 1H), 7.10–7.07 (m, 2H), 7.03 (s, 1H), 7.01–6.99 (m, 1H), 6.97 (dd, <i>J</i> = 1.2, 3.6 Hz, 1H), 6.88 (dd, <i>J</i> = 3.6, 5.2 Hz, 1H), 6.64 (dd, 1.2, 3.6 Hz, 1H).</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">1.8 1-(4-Bromo-3-methoxyphenyl)-2,5-di(thiophen-2-yl)-1<i>H</i>-pyrrole (<b>D</b><sub><b>7</b></sub>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.57 (dq, <i>J</i> = 7.8, 0.8 Hz, 1H), 7.10 (dt, <i>J</i> = 5.1, 1.3 Hz, 2H), 6.85 (ddd, <i>J</i> = 5.1, 3.7, 1.3 Hz, 2H), 6.80 (t, <i>J</i> = 1.5 Hz, 2H), 6.59 (dt, <i>J</i> = 3.7, 1.3 Hz, 2H), 6.53 (d, <i>J</i> = 1.2 Hz, 2H), 3.75 (s, 3H).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">1.9 1-(3′-Ethyl-4′-formyl-[1,1′-biphenyl]-4-yl)-2,5-dimethyl-1<i>H</i>-pyrrole-3-carbaldehyde (<b>E<sub>3</sub></b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 10.35 (s, 1H), 9.90 (s, 1H), 7.96 (d, <i>J</i> = 8.0 Hz, 1H), 7.79–7.77 (m, 2H), 7.63 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 7.56 (d, <i>J</i> = 1.6 Hz, 1H), 7.34–7.30 (m, 2H), 6.42 (d, <i>J</i> = 1.2 Hz, 1H), 3.16 (q, <i>J</i> = 7.6 Hz, 2H), 2.34 (s, 3H), 2.05 (s, 3H), 1.35 (t, <i>J</i> = 7.6 Hz, 3H).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">1.10 1-(4′-Formyl-2-methoxy-[1,1′-biphenyl]-4-yl)-2,5-dimethyl-1<i>H</i>-pyrrole-3-carbaldehyde (<b>E<sub>4</sub></b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 10.34 (s, 1H), 9.91 (s, 1H), 7.91 (d, <i>J</i> = 8.0 Hz, 1H), 7.58 (dd, <i>J</i> = 1.6, 7.6 Hz, 1H), 7.49 (d, <i>J</i> = 1.2 Hz, 1H), 7.46 (d, <i>J</i> = 7.6 Hz, 1H), 6.91 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 6.81 (d, <i>J</i> = 1.6 Hz, 1H), 6.42 (d, <i>J</i> = 0.8 Hz, 1H), 3.84 (s, 3H), 3.14 (q, <i>J</i> = 7.6 Hz, 2H), 2.37 (s, 3H), 2.08 (s, 3H), 1.33 (t, <i>J</i> = 7.6 Hz, 3H).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">1.11 3′-Ethyl-4′-formyl-4-(3-formyl-2,5-dimethyl-1<i>H</i>-pyrrol-1-yl)-[1,1′-biphenyl]-2-carbonitrile (<b>E<sub>6</sub></b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 10.38 (s, 1H), 9.91 (s, 1H), 8.01 (d, <i>J</i> = 8.0 Hz, 1H), 7.73 (d, <i>J</i> = 8.0 Hz, 1H), 7.68 (d, <i>J</i> = 2.0 Hz, 1H), 7.62 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 7.58 (d, <i>J</i> = 2.0 Hz, 1H), 7.56 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 6.45 (d, <i>J</i> = 1.2 Hz, 1H), 3.19 (q, <i>J</i> = 7.6 Hz, 2H), 2.36 (s, 3H), 2.07 (s, 3H), 1.37 (t, <i>J</i> = 7.6 Hz, 3H).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">1.12 1-(4′-Formyl-2-methoxy-[1,1′-biphenyl]-4-yl)-2,5-di(thiophen-2-yl)-1<i>H</i>-pyrrole-3-carbaldehyde (<b>E<sub>11</sub></b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 10.06 (s, 1H), 9.86 (s, 1H), 7.93 (d, <i>J</i> = 10.8 Hz, 2H), 7.72 (d, <i>J</i> = 11.2 Hz, 2H), 7.39 (dd, <i>J</i> = 2.0, 6.8 Hz, 1H), 7.34 (d, <i>J</i> = 10.4 Hz, 1H), 7.19 (d, <i>J</i> = 7.2 Hz, 1H), 7.07 (s, 1H), 7.05–7.00 (m, 2H), 6.94–6.89 (m, 2H), 6.81 (d, <i>J</i> = 2.8 Hz, 1H), 6.75 (d, <i>J</i> = 3.6 Hz, 1H), 3.66 (s, 3H).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">1.13 (<i>Z</i>)-5-((1-(4-Bromophenyl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methylene)thiazolidine-2,4-dione (<b>2</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): 13.45 (s, 1H), 7.77 (d, <i>J</i> = 8.0 Hz, 2H), 7.51 (s, 1H), 7.35 (d, <i>J</i> = 8.0 Hz, 2H), 6.20 (s, 1H), 2.14(s, 3H), 2.00 (s, 3H). <sup>13</sup>C NMR (400 MHz, DMSO): 168.29, 167.50, 136.16, 135.77, 132.59 (×2), 131.50, 130.12 (×2), 126.08, 121.99, 115.15, 115.00, 105.15, 12.49, 10.72. ESI-MS C<sub>16</sub>H<sub>13</sub>BrN<sub>2</sub>O<sub>2</sub>S, 377.25; found, 377/379 [M ]<sup>+</sup>. HPLC chromatograms: purity >96%.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30">1.14 (<i>Z</i>)-5-((1-(4-Bromophenyl)-2,5-di(thiophen-2-yl)-1<i>H</i>-pyrrol-3-yl)methylene)thiazolidine-2,4-dione (<b>3</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): 12.44 (s, 1H), 7.69 (dd, <i>J</i> = 1.2, 5.2 Hz, 1H), 7.64 (d, <i>J</i> = 8.8 Hz, 2H), 7.26 (s, 1H), 7.47 (dd, <i>J</i> = 1.2, 5,2 Hz, 1H), 7.31, (d, <i>J</i> = 8.8 Hz, 2H), 7.10 (dd, <i>J</i> = 3.6, 5.2 Hz, 1H), 7.48 (dd, <i>J</i> = 1.2, 3.6 Hz, 1H), 6.99 (dd, <i>J</i> = 3.6, 5.2 Hz, 1H), 6.93, (dd, 1.2, 3.6 Hz, 1H), 6.77 (s, 1H). <sup>13</sup>C NMR (400 MHz, DMSO): 167.81, 167.38, 136.04, 133.47, 132.24, 131.89, 131.66, 131.60, 131.26, 129.87, 129.03, 128.89, 128.20, 127.42 (×2), 126.95, 126.79, 125.31, 124.86, 122.87, 119.55, 118.51. ESI-MS C<sub>22</sub>H<sub>13</sub>BrN<sub>2</sub>O<sub>2</sub>S<sub>3</sub>, 513.44; found, 513/515 [M]<sup>+</sup>, 536/538 [M + Na<sup>+</sup>]<sup>+</sup>. HPLC chromatograms: purity >98%.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31">1.15 (<i>Z</i>)-5-((1-(4-Bromophenyl)-2,5-diphenyl-1<i>H</i>-pyrrol-3-yl)methylene)thiazolidine-2,4-dione (<b>4</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>), δ (ppm): 7.46 (dd, <i>J</i> = 6.9, 1.8 Hz, 2H), 7.38–7.14 (m, 12H), 7.08 (dd, <i>J</i> = 6.9, 1.8 Hz, 2H), 6.68 (s, 1H). <sup>13</sup>C NMR (176 MHz, DMSO): 140.95, 137.14, 132.28 (×2), 131.56 (×2), 131.51 (×2), 131.38, 129.99 (×2), 129.08, 129.03 (×3), 128.80, 128.77 (×3), 127.99 (×2), 121.72, 117.83, 107.86. ESI-MS C<sub>26</sub>H<sub>17</sub>BrN<sub>2</sub>O<sub>2</sub>S, 501.39; found, 502 [M + H<sup>+</sup>]<sup>+</sup>, 524 [M + Na<sup>+</sup>]<sup>+</sup>. HPLC chromatograms: purity >98%.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32">1.16 (<i>E</i>)-5-((4′-(3-((<i>Z</i>)-(2,4-Dioxothiazolidin-5-ylidene)methyl)-2,5-dimethyl-1<i>H</i>-pyrrol-1-yl)-[1,1′-biphenyl]-4-yl)methylene)thiazolidine-2,4-dione (<b>5</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO): 13.00–12.00 (brs, 2H), 7.95 (dd, <i>J</i> = 3.3, 8.7 Hz, 4H), 7.86 (s, 1H), 7.74 (d, <i>J</i> = 8.4 Hz, 2H), 7.69 (s, 1H), 7.48 (d, <i>J</i> = 8.4 Hz, 2H), 6.21 (s, 1H), 2.17 (s, 3H), 2.05 (s, 3H). <sup>13</sup>C NMR (400 MHz, DMSO): 168.26, 167.87, 167.55, 167.45, 140.37, 139.05, 136.73, 135.87, 132.59, 131.60, 131.00, 130.74 (×2), 128.50 (×2), 127.87 (×2), 127.57 (×2), 126.15, 123.86, 114.94, 114.92, 105.10, 12.59, 10.80. ESI-MS C<sub>26</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub>, 501.57; found, 502 [M + H<sup>+</sup>]<sup>+</sup>. HPLC chromatograms: purity >95%.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33">1.17 (<i>E</i>)-5-((4′-(3-((<i>Z</i>)-(2,4-Dioxothiazolidin-5-ylidene)methyl)-2,5-di(thiophen-2-yl)-1<i>H</i>-pyrrol-1-yl)-[1,1′-biphenyl]-4-yl)methylene)thiazolidine-2,4-dione (<b>6</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): 12.53 (S, 2H), 7.92 (d, <i>J</i> = 8.8 Hz, 2H), 7.85 (d, <i>J</i> = 8.8 Hz, 2H), 7.82 (s, 1H), 7.70 (d, <i>J</i> = 8.4 Hz, 2H), 7.67 (dd, <i>J</i> = 2.0, 4.8 Hz, 1H), 7.56 (s, 1H), 7.44 (m, 3H), 7.08 (m, 2H), 6.99(m, 2H), 6.79 (s, 1H). <sup>13</sup>C NMR (400 MHz, DMSO): 168.00, 167.86, 167.82, 167.44, 139.79, 139.56, 136.57, 133.61, 132.79, 132.14, 131.74, 131.14, 130.79, 130.70 (×2), 130.22, 129.79, 129.25, 127.46 (×3), 127.39 (×3), 127.32, 126.82, 126.57, 125.00, 124.22, 119.43, 118.47, 107.07. ESI-MS C<sub>32</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S<sub>4</sub>, 637.76; found, 638 [M + H<sup>+</sup>]<sup>+</sup>. HPLC chromatograms: purity >96%.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34">1.18 (<i>E</i>)-5-((4′-(3-((<i>Z</i>)-(2,4-Dioxothiazolidin-5-ylidene)methyl)-2,5-diphenyl-1<i>H</i>-pyrrol-1-yl)-[1,1′-biphenyl]-4-yl)methylene)thiazolidine-2,4-dione (<b>7</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): 13.00–12.00 (brs, 2H), 7.74 (d, <i>J</i> = 7.2 Hz, 2H), 7.66 (d, <i>J</i> = 7.2 Hz, 2H), 7.58 (d, <i>J</i> = 7.2 Hz, 2H), 7.41 (s, 1H), 7.36–7.18 (m, 13H), 6.70 (s, 1H). <sup>13</sup>C NMR (75 MHz, DMSO): 167.98, 167.85, 167.49, 167.41, 140.93, 139.78, 138.03, 137.25, 137.00, 132.53, 131.25, 131.25 (×2), 131.08, 130.99, 130.67, 129.64 (×2), 129.45, 128.89 (×2), 128.59, 128.42 (×2), 128.32 (×2), 127.51 (×2), 127.27 (×2), 126.95, 125.88, 123.80, 118.11, 117.20, 107.44. ESI-MS C<sub>36</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub>, 625.71; found, 626 [M + H]<sup>+</sup>, 648 [M + Na]<sup>+</sup>. HPLC chromatograms: purity >97%.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35">1.19 (<i>E</i>)-5-((4′-(3-((<i>Z</i>)-(2,4-Dioxothiazolidin-5-ylidene)methyl)-2,5-dimethyl-1<i>H</i>-pyrrol-1-yl)-2′-methoxy-[1,1′-biphenyl]-4-yl)methylene)thiazolidine-2,4-dione (<b>8</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO): 13.00–12.00 (brs, 2H), 7.80 (s, 1H), 7.74–7.64 (m, 4H), 7.53 (d, <i>J</i> = 8.4 Hz, 2H), 7.12 (d, <i>J</i> = 1.8 Hz, 1H), 7.02 (dd, <i>J</i> = 7.8, 1.5 Hz, 1H), 6.20 (s, 1H), 3.82 (s, 3H), 2.21 (s, 3H), 2.08 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO): 168.31, 167.50, 159.87, 156.81, 138.94, 137.83, 136.01, 132.39, 132.21, 132.08, 131.71, 130.96, 130.12, 129.84, 129.32, 128.81, 126.20, 124.09, 120.18, 119.10, 116.32, 114.89, 111.84, 104.98, 56.20, 12.66, 10.87. ESI-MS C<sub>27</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub>S<sub>2</sub>, 531.60; found, 532 [M + H]<sup>+</sup>. HPLC chromatograms: purity >95%.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36">1.20 (<i>E</i>)-5-((4′-(3-((<i>Z</i>)-(2,4-Dioxothiazolidin-5-ylidene)methyl)-2,5-di(thiophen-2-yl)-1<i>H</i>-pyrrol-1-yl)-2′-methoxy-[1,1′-biphenyl]-4-yl)methylene)thiazolidine-2,4-dione (<b>9</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): 7.68 (dd, <i>J</i> = 2.4, 4.0 Hz, 1H), 7.60 (m, 5H), 7.52 (s, 1H), 7.50 (s, 1H), 7.47 (dd, <i>J</i> = 1.2, 4.8 Hz, 1H), 7.40 (d, <i>J</i> = 8.0 Hz, 1H), 7.18 (d, <i>J</i> = 1.6 Hz, 1H), 7.11 (d, <i>J</i> = 1.6 Hz, 1H), 7.11 (s, 1H), 7.00–6.95 (m, 4H), 6.77 (s, 1H), 3.66 (s, 3H). <sup>13</sup>C NMR (400 MHz, DMSO): 167.97, 167.88, 167.57, 167.43, 156.44, 138.66, 137.49, 133.59, 132.17, 132.04, 131.70, 131.28, 131.23, 130.57, 130.13 (×2), 129.87 (×2), 129.80, 129.41, 129.30, 127.40 (×2), 126.86, 126.69, 125.06, 123.70, 121.94, 119.39, 118.49, 113.87, 107.04, 56.23. ESI-MS C<sub>33</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub>S<sub>4</sub>, 667.78; found, 668 [M + H]<sup>+</sup>. HPLC chromatograms: purity >94%.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37">1.21 (<i>E</i>)-5-((4′-(3-((<i>Z</i>)-(2,4-Dioxothiazolidin-5-ylidene)methyl)-2,5-diphenyl-1<i>H</i>-pyrrol-1-yl)-2′-methoxy-[1,1′-biphenyl]-4-yl)methylene)thiazolidine-2,4-dione (<b>10</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): 13.00–12.00 (brs, 2H), 7.76 (d, <i>J</i> = 2.0 Hz, 1H), 7.58 (s, 4H), 7.41–7.23 (m, 14H), 6.91 (s, 1H), 3.46 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO): 168.07, 168.01, 167.82, 167.44, 156.00, 140.75, 138.58, 138.02, 136.86, 131.90, 131.37, 131.02, 130.16, 129.94, 129.83, 129.76, 128.89, 128.62, 128.29, 128.19, 127.85, 127.52, 125.84, 123.81, 121.03, 118.20, 117.24, 113.10, 107.41, 55.79, 40.12, 39.91, 39.70, 39.49, 39.29, 39.08, 38.87. ESI-MS C<sub>37</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub>S<sub>2</sub>, 655.74; found, 656 [M + H]<sup>+</sup>, 678 [M + Na]<sup>+</sup>. HPLC chromatograms: purity >94%.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38">1.22 (<i>E</i>)-5-((4′-(3-((<i>Z</i>)-(2,4-Dioxothiazolidin-5-ylidene)methyl)-2,5-dimethyl-1<i>H</i>-pyrrol-1-yl)-3-ethyl-[1,1′-biphenyl]-4-yl)methylene)thiazolidine-2,4-dione (<b>11</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): 13.00–12.00 (brs, 2H), 7.95 (s, 1H), 7.93 (d, <i>J</i> = 8.4 Hz, 2H), 7.77–7.76 (m, 2H), 7.68 (s, 1H), 7.54 (d, <i>J</i> = 8.4 Hz, 1H), 7.46 (d, 2H), 6.20 (s, 1H), 2.84 (q, <i>J</i> = 7.6 Hz, 2H), 2.29 (s, 3H), 2.04 (s, 3H), 1.22 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (400 MHz, DMSO): 168.28, 168.08, 167.46, 167.28, 145.49, 140.57, 139.33, 136.63, 135.89, 131.61, 130.89, 128.54, 128.44 (×2), 128.13, 127.95, 127.87 (×2), 126.17, 125.44, 124.99, 114.95, 114.92, 105.10, 26.10, 15.64, 12.59, 10.81. ESI-MS C<sub>28</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub>, 529.62; found, 530 [M + H<sup>+</sup>]<sup>+</sup>. HPLC chromatograms: purity >95%.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39">1.23 (<i>E</i>)-5-((4′-(3-((<i>Z</i>)-(2,4-Dioxothiazolidin-5-ylidene)methyl)-2,5-di(thiophen-2-yl)-1<i>H</i>-pyrrol-1-yl)-3-ethyl-[1,1′-biphenyl]-4-yl)methylene)thiazolidine-2,4-dione (<b>12</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): 13.00–12.00 (brs, 2H), 7.91 (s, 1H), 7.84 (d, <i>J</i> = 8.8 Hz, 2H), 7.72–7.75 (m, 2H), 7.67 (dd, <i>J</i> = 2.0, 4.8 Hz, 1H), 7.56 (s, 1H), 7.52 (d, <i>J</i> = 8.4 Hz, 1H), 7.45–7.43 (m, 3H), 7.10–7.07 (m, 2H), 6.98–6.93 (m, 2H), 6.79 (s, 1H), 2.82 (q, <i>J</i> = 7.6 Hz, 2H), 1.91 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (400 MHz, DMSO): 168.54, 168.17, 167.94, 167.56, 145.46, 139.82, 139.80, 136.45, 133.60, 132.19, 131.75, 131.21, 131.12, 130.15, 129.74, 129.30, 128.91, 128.22, 128.14, 127.94, 127.76 (×2), 127.40, 127.29, 126.78, 126.53, 126.29, 124.97, 124.90, 119.53, 118.49, 107.07, 26.14, 15.72. ESI-MS C<sub>34</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>S<sub>4</sub>, 665.81; found, 666 [M + H<sup>+</sup>]<sup>+</sup>. HPLC chromatograms: purity >98%.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40">1.24 (<i>E</i>)-5-((4′-(3-((<i>Z</i>)-(2,4-Dioxothiazolidin-5-ylidene)methyl)-2,5-diphenyl-1<i>H</i>-pyrrol-1-yl)-3-ethyl-[1,1′-biphenyl]-4-yl)methylene)thiazolidine-2,4-dione (<b>13</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): 7.90 (s, 1H), 7.71–7.63 (m, 4H), 7.46 (d, <i>J</i> = 8.0 Hz, 1H), 7.40 (s, 1H), 7.37–7.19 (m, 11H), 6.70 (s, 1H), 3.46 (s, 3H), 2.63 (q, <i>J</i> = 8.0 Hz, 2H), 1.16 (t, <i>J</i> = 8.0 Hz, 3H). <sup>13</sup>C NMR (75 MHz, DMSO): 168.14, 168.00 (×2), 167.43, 145.48, 139.87, 138.24, 137.15, 137.02, 131.28, 131.10 (×2), 130.87 (×2), 129.66 (×2), 129.40 (×2), 128.91 (×2), 128.60 (×2), 128.59 (×2), 128.33 (×2), 128.08 (×2), 127.60, 127.52, 126.92, 125.90, 124.73, 118.10, 117.19, 107.42, 26.09, 15.72. ESI-MS C<sub>38</sub>H<sub>27</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub>, 653.77; found, 654 [M + H]<sup>+</sup>, 676 [M + Na]<sup>+</sup>. HPLC chromatograms: purity >95%.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41">1.25 (<i>E</i>)-5-((4′-(3-((<i>Z</i>)-(2,4-Dioxothiazolidin-5-ylidene)methyl)-2,5-dimethyl-1<i>H</i>-pyrrol-1-yl)-3-ethyl-2′-methoxy-[1,1′-biphenyl]-4-yl)methylene)thiazolidine-2,4-dione (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): 13.00–12.00 (brs, 2H), 7.94 (s, 1H), 7.69 (s, 1H), 7.57–7.49 (m, 4H), 7.12 (d, <i>J</i> = 2.0 Hz, 1H), 7.02 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 6.20 (s, 1H), 3.82 (s, 3H), 2.81 (q, <i>J</i> = 7.6 Hz, 2H), 2.21 (s, 3H), 2.09 (s, 3H), 1.19 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (400 MHz, DMSO): 168.58, 168.34, 168.13, 167.53, 156.84, 144.43, 139.03, 137.71, 136.03, 131.73, 130.96, 130.44, 130.34, 129.10, 128.32, 127.58, 127.16, 126.23, 125.86, 120.14, 114.91, 114.89, 111.79, 104.99, 56.19, 26.02, 15.65, 12.66, 10.87. ESI-MS C<sub>29</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub>S<sub>2</sub>, 559.65; found, 560 [M + H<sup>+</sup>]<sup>+</sup>, 582 [M + Na<sup>+</sup>]<sup>+</sup>. HPLC chromatograms: purity >96%.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42">1.26 4′-((<i>E</i>)-(2,4-Dioxothiazolidin-5-ylidene)methyl)-4-(3-((<i>Z</i>)-(2,4-dioxothiazolidin-5-ylidene)methyl)-2,5-dimethyl-1<i>H</i>-pyrrol-1-yl)-3′-ethyl-[1,1′-biphenyl]-2-carbonitrile (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): 13.00–12.00 (brs, 2H), 8.13 (<i>J</i> = 2.0 Hz, 1H), 7.96 (s, 1H), 7.87 (d, <i>J</i> = 8.4 Hz, 1H), 7.83 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 7.69–7.67 (m, 3H), 7.61 (d, <i>J</i> = 8.0 Hz, 1H),, 6.23 (s, 1H), 2.87 (q, <i>J</i> = 7.6 Hz, 2H), 2.20 (s, 3H), 2.08 (s, 3H), 1.23 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (400 MHz, DMSO): 168.26, 168.10, 167.47, 167.33, 144.96, 143.73, 138.37, 136.86, 135.90, 133.24, 133.12, 132.23, 131.69, 131.40, 129.98, 128.26, 127.77, 127.03, 126.59, 125.92, 117.62, 115.55, 115.29, 111.35, 105.47, 25.94, 15.29, 12.56, 10.83. ESI-MS C<sub>29</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>S<sub>2</sub>, 554.63; found, 555 [M + H<sup>+</sup>]<sup>+</sup>, 577 [M + Na<sup>+</sup>]<sup>+</sup>. HPLC chromatograms: purity >98%.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43">1.27 (<i>E</i>)-5-((4′-(3-((<i>Z</i>)-(2,4-Dioxothiazolidin-5-ylidene)methyl)-2,5-dimethyl-1<i>H</i>-pyrrol-1-yl)-2′-hydroxy-[1,1′-biphenyl]-4-yl)methylene)thiazolidine-2,4-dione (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): 13.00–12.00 (brs, 2H), 10.10 (s, 1H), 7.72 (d, <i>J</i> = 8.4 Hz, 3H), 7.65 (s, 1H), 7.60 (d, <i>J</i> = 8.4 Hz, 2H), 7.49 (d, <i>J</i> = 8.4 Hz, 1H), 7.45 (s, 1H), 6.86 (dd, <i>J</i> = 1.6, 8.4 Hz, 1H), 6.82 (d, <i>J</i> = 1.6 Hz, 1H), 2.18 (s, 3H), 2.06 (s, 3H). <sup>13</sup>C NMR (400 MHz, DMSO): 169.20, 168.81, 168.36, 167.56, 155.22, 139.19, 137.25, 135.82, 131.98, 131.52, 131.15, 130.46, 129.89 (×2), 129.81(×2), 127.07, 126.22, 124.70, 118.92, 115.32, 114.92, 114.87, 105.06, 12.63, 10.84. ESI-MS C<sub>26</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S<sub>2</sub>, 517.57; found, 518 [M + H]<sup>+</sup>. HPLC chromatograms: purity >95%.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44">1.28 (<i>Z</i>)-5-((1-(3′-Chloro-4′-((<i>E</i>)-(2,4-dioxothiazolidin-5-ylidene)methyl)-[1,1′-biphenyl]-4-yl)-2,5-dimethyl-1<i>H</i>-pyrrol-3-yl)methylene)thiazolidine-2,4-dione (<b>17</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO): 12.80 (s, 1H), 12.23 (s, 1H), 8.08 (s, 1H), 8.00–7.87 (m, 3H), 7.69 (m, 2H), 7.51–7.43 (m, 3H), 6.21 (s, 1H), 2.17 (s, 3H), 2.04 (s, 3H). <sup>13</sup>C NMR (400 MHz, DMSO): 168.29, 167.55, 167.46, 167.16, 141.89, 137.63, 137.23, 135.80, 135.53, 131.54, 130.14, 129.31, 128.54 (×2), 128.26, 128.06 (×2), 127.06, 126.21, 126.10, 125.98, 115.05, 115.03, 105.21, 12.61, 10.80. ESI-MS C<sub>26</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>4</sub>S<sub>2</sub>, 536.01; found, 536/538 [M]<sup>+</sup>. HPLC chromatograms: purity >92%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45">2 Cell Culture and Reagents</h3><div class="NLM_p last">The human carcinoma cell lines breast MDA-MB-231 [BCRC 60425], pancreatic AsPC-1 [BCRC 60494], breast HCC1806 [(ATCC CRL-2335], and breast MCF7 [BCRC 60436] were used in this study. MCF7 cells were maintained in Dulbecco’s modified Eagle medium (DMEM, Hyclone Laboratory Inc.) and supplemented with 10% fetal bovine serum (FBS, Hyclone Laboratory Inc.). AsPC-1, MDA-MB-231, and HCC1806 cells were cultured in RPMI 1640 medium (GIBCO-Life Technologies) supplemented with 10% FBS.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46">3 Cloning, Expression, and Purification of Glutaminases</h3><div class="NLM_p">The human KGA and GAB were prepared as described.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The human GAC gene was amplified from a cDNA library derived from MCF7 cells. Briefly, total RNAs were isolated from MCF7 cells using TRIzol reagent (Invitrogen, Inc.) and converted into cDNAs using the SuperScript III transcriptor first-strand cDNA synthesis system for RT-PCR (Invitrogen, Inc.) according to the manufacturer. A cDNA fragment of 1428 bp, which encodes a human GAC polypeptide of residues Leu123 to Ser598, was obtained by PCR against the obtained MCF7 cDNAs library with primers of 5′-ATACGC<b>GGATCC</b>CTGGTGGCCTCAGGTGAAAA-3′ (containing a BamHI restriction site) and 5′-GCAAGGAAAAAA<b>GCGGCCGC</b>AGCGTTAGCTTTTCTCTCCCAGACTTTCCA-3′ (containing a Notl restriction site). The GAC gene sequence included in this cDNA fragment of 1428 bp was verified by sequence analysis and found to be the same as that of accession no. <a href="https://www.ncbi.nlm.nih.gov/gquery?Term=AF158555">AF158555</a> except three different nucleotides (underlined as follows) that resulted into the changes of aa 172 Asp(GAT) → Gly(G<u class="uu">G</u>T), aa 268 Ala(GCA) → Val(G<u class="uu">T</u>A), and aa 376 Ala(GCA) → Thr(<u class="uu">A</u>CA). This PCR amplified cDNA fragment and the protein expression vector pET28a(+) (Novagen) were separately digested with BamHI and NotI. The desired DNA fragments were cleaned and purified prior to being ligated into a His-tagged GAC protein expression plasmid.</div><div class="NLM_p last">The resultant His-tagged GAC-expression plasmid, pET28a(+)-GAC, was transformed into <i>Escherichia coli</i> strain C41(DE3)pLysS (Yeastern Biotech Co., Taiwan) and then cultured in Terrific Broth medium in the presence of kanamycin. Once the <i>Escherichia coli</i> culture reached an absorbance at 600 nm of 0.6–0.8, isopropyl β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside (1 mM) was added to induce the His-tagged GAC protein expression for 6 h at 25 °C. The resultant bacteria were collected by rapid centrifugation and then resuspended in a lysis buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O, 300 mM NaCl, 5 mM Tris-HCl, pH 8.5, 5% glycerol, 0.1% Triton X-100, 10 mM β-ME, and 50 mM Imidazole) prior to breaking bacteria by sonication. The supernatants from sonication treatment were collected for further protein purification at cold room with a Ni<sup>2+</sup> charged resin (GE Healthcare) column, and the His-tagged GAC bound resin column was washed with the lysis buffer containing 50 mM and 75 mM imidazole. His-tagged GAC was eluted with the lysis buffer containing 500 mM imidazole, and the buffer was then exchanged to 50 mM NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O, 50 mM Tris-HCl, pH 8.0, 2 mM dithiothreitol, and 50% glycerol by using PD-10 desalting column (GE Healthcare). The concentrations of the purified protein were determined as described.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47">4 Glutaminase Activity Assays and Kinetic Studies</h3><div class="NLM_p last">Human glutaminase activity was measured using a two-step assay as described previously.<a onclick="showRef(event, 'ref9 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref9 ref32 ref33">(9, 32, 33)</a> Kinetic studies were measured as described.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48">5 In Vitro Carcinoma Cell Growth Inhibition and Colony Formation Assays</h3><div class="NLM_p last">MDA-MB-231 breast carcinoma, AsPC-1 pancreatic carcinoma, HCC1806 breast carcinoma cells were seeded at 8500, 4000, and 3000 cells/well, respectively, in 96-well plates, as previously described for cell growth inhibition assay.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> To assess anchorage-dependent colony formation effect, the cells (1000 cells/well) were seeded in a six-well plate, as previously described.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49">6 Determination of Intracellular Glutamate Levels</h3><div class="NLM_p last">AsPC-1 cells were seeded at 30 000 cells/well in 96-well plates and incubated in a CO<sub>2</sub> incubator at 37 °C for 24 h. The cells were treated with either the vehicle control (1% DMSO) or 3.13–100 μM glutaminase inhibitors as indicated for an additional 4 h. After a 4 h treatment, the medium was removed and cells per well were washed twice with 1× PBS, and 50 μL of nonidet-P40 lysis buffer was added per well at 4 °C for 20 min. Aliquots (each 10 μL) of the resultant cell lysates were subjected to Amplex red glutamic acid assay (Invitrogen) followed by manufacturer’s recommendations.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50">7 GLS Gene Knockout</h3><div class="NLM_p last">Knockout of <i>GLS</i> was accomplished by ZEN cleavage using zinc-finger nuclease mRNA (GLS-KO ZFN mRNA) designed to target the exon 1 site of <i>GLS</i> glutaminase gene in the CompoZr knockout ZFN kit (CKOZFN9361, Sigma) by manufacturer’s recommendations. AsPC-1 cells were transfected with <i>GLS</i>-KO ZFN mRNA using TransIT-mRNA transfection reagent (MIR2225, Mirus) and incubated for 5 days. Then, a portion of the transfected cells were harvested to isolate the genomic DNA which was used as the template for further PCR amplification. The sequences of PCR primers used for amplification of the <i>GLS</i> target locus were as follows: forward primer 5′-AGCCCTTGGTCACCCTGT-3′ and reverse primer 5′-GGATAGGAGCCGAGGGTCTA-3′. The obtained PCR product was denatured and reannealed to allow the heteroduplex formation between wild type (402 bp) and modified (401 bp) amplicons. Subsequently, the CEL-I mismatched nuclease assay was performed to identify the heteroduplex formation and ZEN cleavage. Once heteroduplex was found from the CEL-I assay, the corresponding <i>GLS</i>-KO ZFN mRNA transfected cells were subject to single-cell sorting and each single cell was cultured in RPMI 1640 medium without glutamine (catalog number 21870-076, GIBCO Life Technologies) supplemented with 10% FBS. Identification of GLS knockout cell line was analyzed by directly sequencing <i>GLS</i> alleles that were isolated by PCR amplification as described above. The verified sequencing data and Western analysis for verification of <i>GLS</i> gene knocked out were provided in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf" class="ext-link">Supporting Information Figure S1</a>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51">8 Animal Study Protocols</h3><div class="NLM_p last">Animal study protocols were reviewed and approved for the in vivo experiments herein by the Institutional Animal Care and Use Committee (IACUC) of National Health Research Institutes, Taiwan.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52">9 Pharmacokinetic Analysis</h3><div class="NLM_p last">Sprague-Dawley rats used for pharmacokinetic studies were obtained from BioLASCO Taiwan Co. (Ilan, Taiwan) and housed in the animal facility at the NHRI, Taiwan. Male rats (330–380 g, 9–10 weeks old) were quarantined for 1 week before use. The rats were surgically implanted with a jugular-vein cannula 1 day before treatment. Compounds BPTES, <b>5</b>, and <b>6</b> were given to rats (<i>n</i> = 3) by intravenous or oral administration as prepared in a mixture of DMA/PEG400 (20%/80%, v/v) and 1% CMC/0.5% Tween-80 for intravenous and oral administration, respectively. At 0 (immediately before dosing), 2 min, 5 min (intravenous only), 15 min, and 30 min and 1 h, 2 h, 4 h, 6 h, 8 h, and 24 h after compound administration, a blood sample (100 μL) was taken from each animal via the jugular-vein cannula and stored in ice (0–4 °C). The processing of the plasma and subsequent analysis by high performance liquid chromatography–tandem mass spectrometry was performed as described.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The pharmacokinetic parameters were obtained by a standard noncompartmental method.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53">10 In Vivo Antitumor Activity</h3><div class="NLM_p last">Male nude mice (BALB/cAnN.Cg-<i>Foxn1</i><sup><i>nu</i></sup>/CrlNarl, National Laboratory Animal Center, Taipei, Taiwan) were 7–8 weeks old and had a body weight range of 18–22 g. Mice were inoculated subcutaneously at the right flank region with AsPC-1 cells (4.5 × 10<sup>6</sup> cells/mouse) in 0.1 mL of Hank’s balanced salt solution (ThermoFisher Scientific) mixing with equal volume of Matrigel (BD Biosciences) for tumor development. Tumors were monitored twice weekly. The mice were sorted into different groups randomly, and the treatments were started when the mean tumor size reached ∼100 mm<sup>3</sup> (this day was thus designated as day 1). The tumor volume was calculated using the equation <i>V</i> (mm<sup>3</sup>) = <i>a</i><i>b</i><sup>2</sup>/2, where <i>a</i> is the largest diameter and <i>b</i> is the smallest diameter. % TGI was determined for antitumor effects which are expressed as [1 – ((<i>T<sub>t</sub></i> – <i>T</i><sub>0</sub>)/(<i>C<sub>t</sub></i> – <i>C</i><sub>0</sub>))] × 100 where <i>T<sub>t</sub></i> = median tumor volume of treated at time <i>t</i>, <i>T</i><sub>0</sub> = median tumor volume of treated at time 0, <i>C<sub>t</sub></i> = median tumor volume of control at time <i>t</i>, and <i>C</i><sub>0</sub> = median tumor volume of control at time 0. Data were presented as the mean ± SD and analyzed using IBM SPSS Statistics version 20.0 software (IBM Corp., Armonk, NY, USA). The Student’s <i>t</i> test was carried out to calculate the percent of tumor growth inhibition (% TGI) in the treatment group versus the vehicle control at the end point. Statistical significance was established at <i>p</i> < 0.05.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54">11 Site-Directed Mutagenesis and Docking</h3><div class="NLM_p last">Site-directed mutagenesis was performed on the pET28a(+)-KGA<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> plasmids using PfuUltra II fusion HS DNA polymerase (Agilent Technologies) to construct the KGA mutants as described.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The mutated codons in mutants KGA S384A, KGA R387A, KGA S387L, and KGA K507A were verified by sequencing. The GLS1 crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>) was applied to BIOVIA 2017 for the docking analysis which was conducted using the BIOVIA/LigandFit program (BIOVIA, Inc., San Diego, CA) with the CHARMm force field.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The population size of docked poses was set as 100 with default parameters. The best pose was determined according to the result of site-directed mutagenesis.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55">12 Statistical Analysis</h3><div class="NLM_p last">The statistical significance between two groups was evaluated by two-tailed unpaired Student’s <i>t</i> test and ∗, ∗∗, and ∗∗∗ were used to denote the statistical significance for <i>p</i> < 0.05, <i>p</i> < 0.01, and <i>p</i> < 0.001, respectively.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00282">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00282" class="ext-link">10.1021/acs.jmedchem.7b00282</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Glutaminase inhibitory activity of commercial available glitazones, summary of synergistic effects of combined treatments of GA inhibitors, pictures/structures of compounds <b>2</b>–<b>17</b> and intermediates, verification of GLS gene knocked out in AsPC-1<sup>GLS–/–</sup> cells, and effects of PPAR agonists or thiazolidine-2,4-dione compounds on the transactivation activities of PPARα, PPARγ, and PPARδ (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf">jm7b00282_si_001.pdf (962.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_002.csv">jm7b00282_si_002.csv (1.97 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00282" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lun Kelvin Tsou</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1593-5226" title="Orcid link">http://orcid.org/0000-0002-1593-5226</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#abc0cec7ddc2c5dfd8c4deebc5c3d9c285c4d9cc85dfdc"><span class="__cf_email__" data-cfemail="83e8e6eff5eaedf7f0ecf6c3edebf1eaadecf1e4adf7f4">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shiow-Ju Lee</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4012-0149" title="Orcid link">http://orcid.org/0000-0003-4012-0149</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ddaeb1b8b89db3b5afb4f3b2afbaf3a9aa"><span class="__cf_email__" data-cfemail="88fbe4ededc8e6e0fae1a6e7faefa6fcff">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Teng-Kuang Yeh</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ching-Chuan Kuo</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yue-Zhi Lee</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8640-9525" title="Orcid link">http://orcid.org/0000-0001-8640-9525</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi-Yu Ke</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuang-Feng Chu</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hsing-Yu Hsu</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hsin-Yu Chang</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu-Wei Liu</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8495-4941" title="Orcid link">http://orcid.org/0000-0001-8495-4941</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jen-Shin Song</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng-Wei Yang</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3994-475X" title="Orcid link">http://orcid.org/0000-0002-3994-475X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Mei Lin</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manwu Sun</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Szu-Huei Wu</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Po-Chu Kuo</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chuan Shih</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiung-Tong Chen</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical
Research, National Health Research Institutes, Miaoli 35053, Taiwan</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>T.-K.Y., C.-C.K., Y.-Z.L., Y.-Y.K., and K.-F.C. are authors with equal contribution. L.K.T. and S.-J.L. are cocorresponding authors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d119e3988-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Grants 101-EC-17-A-02-04-1099, 102-EC-17-A-02-04-1099, 103-EC-17-A-22-1099, 104-EC-17-A-22-1099, and 105-EC-17-A-22-1099 from Ministry of Economic Affairs, Taiwan R.O.C.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i59" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i59"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i60" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i60"> Abbreviations Used</h2><tr><td class="NLM_term">AsPC-1</td><td class="NLM_def"><p class="first last">human pancreatic carcinoma cells</p></td></tr><tr><td class="NLM_term">CMC</td><td class="NLM_def"><p class="first last">carboxymethylcellulose</p></td></tr><tr><td class="NLM_term">cMyc</td><td class="NLM_def"><p class="first last">v-myc avian myelocytomatosis viral oncogene homolog</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">GAPDH</td><td class="NLM_def"><p class="first last">glyceraldehyde 3-phosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">GA</td><td class="NLM_def"><p class="first last">glutaminase</p></td></tr><tr><td class="NLM_term"><i>GLS</i></td><td class="NLM_def"><p class="first last">glutaminase gene</p></td></tr><tr><td class="NLM_term">GAB</td><td class="NLM_def"><p class="first last">glutaminase isoform B</p></td></tr><tr><td class="NLM_term">KGA</td><td class="NLM_def"><p class="first last">glutaminase kidney isoform</p></td></tr><tr><td class="NLM_term">LGA</td><td class="NLM_def"><p class="first last">glutaminase liver isoform</p></td></tr><tr><td class="NLM_term">miRNA</td><td class="NLM_def"><p class="first last">microRNA</p></td></tr><tr><td class="NLM_term">MDA-MB-231</td><td class="NLM_def"><p class="first last">human breast adenocarcinoma epithelial cells</p></td></tr><tr><td class="NLM_term">p53</td><td class="NLM_def"><p class="first last">tumor protein p53</p></td></tr><tr><td class="NLM_term">p63</td><td class="NLM_def"><p class="first last">tumor protein p63</p></td></tr><tr><td class="NLM_term">PPAR</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor</p></td></tr><tr><td class="NLM_term">rac1</td><td class="NLM_def"><p class="first last">Ras-related C3 botulinum toxin substrate 1</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild type</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86252" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86252" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnihotri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, A.</span><span> </span><span class="NLM_article-title">Targeting metabolic remodeling in glioblastoma multiforme</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span><span class="refDoi"> DOI: 10.18632/oncotarget.190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.18632%2Foncotarget.190" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=552-562&issue=7&author=A.+Wolfauthor=S.+Agnihotriauthor=A.+Guha&title=Targeting+metabolic+remodeling+in+glioblastoma+multiforme&doi=10.18632%2Foncotarget.190"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.190%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DAgnihotri%26aufirst%3DS.%26aulast%3DGuha%26aufirst%3DA.%26atitle%3DTargeting%2520metabolic%2520remodeling%2520in%2520glioblastoma%2520multiforme%26jtitle%3DOncotarget%26date%3D2010%26volume%3D1%26issue%3D7%26spage%3D552%26epage%3D562%26doi%3D10.18632%2Foncotarget.190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Erickson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerione, R. A.</span><span> </span><span class="NLM_article-title">Glutaminase: a hot spot for regulation of cancer cell metabolism?</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">740</span><span class="refDoi"> DOI: 10.18632/oncotarget.208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.18632%2Foncotarget.208" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=734-740&issue=8&author=J.+W.+Ericksonauthor=R.+A.+Cerione&title=Glutaminase%3A+a+hot+spot+for+regulation+of+cancer+cell+metabolism%3F&doi=10.18632%2Foncotarget.208"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.208%26sid%3Dliteratum%253Aachs%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DGlutaminase%253A%2520a%2520hot%2520spot%2520for%2520regulation%2520of%2520cancer%2520cell%2520metabolism%253F%26jtitle%3DOncotarget%26date%3D2010%26volume%3D1%26issue%3D8%26spage%3D734%26epage%3D740%26doi%3D10.18632%2Foncotarget.208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Mates, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segura, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Rufian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos-Sandoval, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, J.</span><span> </span><span class="NLM_article-title">Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer</span> <span class="citation_source-journal">Curr. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">514</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span><span class="refDoi"> DOI: 10.2174/1566524011313040005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.2174%2F1566524011313040005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=22934847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFaht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=514-534&issue=4&author=J.+M.+Matesauthor=J.+A.+Seguraauthor=M.+Martin-Rufianauthor=J.+A.+Campos-Sandovalauthor=F.+J.+Alonsoauthor=J.+Marquez&title=Glutaminase+isoenzymes+as+key+regulators+in+metabolic+and+oxidative+stress+against+cancer&doi=10.2174%2F1566524011313040005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer</span></div><div class="casAuthors">Mates, J. M.; Segura, J. A.; Martin-Rufian, M.; Campos-Sandoval, J. A.; Alonso, F. J.; Marquez, J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">514-534</span>CODEN:
                <span class="NLM_cas:coden">CMMUBP</span>;
        ISSN:<span class="NLM_cas:issn">1566-5240</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer cells require a robust supply of reduced nitrogen to produce nucleotides, non-essential amino acids and a high cellular redox activity.  Glutamine provides a major substrate for respiration as well as nitrogen for the prodn. of proteins, hexosamines, and macromols.  Therefore, glutamine is one of key mols. in cancer metab. during cell proliferation.  The notion of targeting glutamine metab. in cancer, originally rationalized by the no. of pathways fed by this nutrient, has been reinforced by more recent studies demonstrating that its metab. is regulated by oncogenes.  Glutamine can exert its effects by modulating redox homeostasis, bioenergetics, nitrogen balance or other functions, including by being a precursor of glutathione, the major nonenzymic cellular antioxidant.  Glutaminase (GA) is the first enzyme that converts glutamine to glutamate, which is in turn converted to alpha-ketoglutarate for further metab. in the tricarboxylic acid cycle.  Different GA isoforms in mammals are encoded by two genes, Gls and Gls2.  As each enzymic form of GA has distinct kinetic and mol. characteristics, it has been speculated that the differential regulation of GA isoforms may reflect distinct functions or requirements in different tissues or cell states.  GA encoded by Gls gene (GLS) has been demonstrated to be regulated by oncogenes and to support tumor cell growth.  GA encoded by Gls2 gene (GLS2) reduces cellular sensitivity to reactive oxygen species-assocd. apoptosis possibly through glutathione-dependent antioxidant defense, and therefore to behave more like a tumor suppressor.  Thus, modulation of GA function may be a new therapeutic target for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzFF_1QmOq07Vg90H21EOLACvtfcHk0lh7HHT5Cjusww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFaht7o%253D&md5=ea6a31c453e00b30a2fb1a858915e105</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1566524011313040005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1566524011313040005%26sid%3Dliteratum%253Aachs%26aulast%3DMates%26aufirst%3DJ.%2BM.%26aulast%3DSegura%26aufirst%3DJ.%2BA.%26aulast%3DMartin-Rufian%26aufirst%3DM.%26aulast%3DCampos-Sandoval%26aufirst%3DJ.%2BA.%26aulast%3DAlonso%26aufirst%3DF.%2BJ.%26aulast%3DMarquez%26aufirst%3DJ.%26atitle%3DGlutaminase%2520isoenzymes%2520as%2520key%2520regulators%2520in%2520metabolic%2520and%2520oxidative%2520stress%2520against%2520cancer%26jtitle%3DCurr.%2520Mol.%2520Med.%26date%3D2013%26volume%3D13%26issue%3D4%26spage%3D514%26epage%3D534%26doi%3D10.2174%2F1566524011313040005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Le, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamaker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebler, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slebos, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorkiewicz, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1016/j.cmet.2011.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2Fj.cmet.2011.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=22225880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=110-121&issue=1&author=A.+Leauthor=A.+N.+Laneauthor=M.+Hamakerauthor=S.+Boseauthor=A.+Gouwauthor=J.+Barbiauthor=T.+Tsukamotoauthor=C.+J.+Rojasauthor=B.+S.+Slusherauthor=H.+Zhangauthor=L.+J.+Zimmermanauthor=D.+C.+Lieblerauthor=R.+J.+Slebosauthor=P.+K.+Lorkiewiczauthor=R.+M.+Higashiauthor=T.+W.+Fanauthor=C.+V.+Dang&title=Glucose-independent+glutamine+metabolism+via+TCA+cycling+for+proliferation+and+survival+in+B+cells&doi=10.1016%2Fj.cmet.2011.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells</span></div><div class="casAuthors">Le, Anne; Lane, Andrew N.; Hamaker, Max; Bose, Sminu; Gouw, Arvin; Barbi, Joseph; Tsukamoto, Takashi; Rojas, Camilio J.; Slusher, Barbara S.; Zhang, Haixia; Zimmerman, Lisa J.; Liebler, Daniel C.; Slebos, Robbert J. C.; Lorkiewicz, Pawel K.; Higashi, Richard M.; Fan, Teresa W. M.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-121</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Because MYC plays a causal role in many human cancers, including those with hypoxic and nutrient-poor tumor microenvironments, we have detd. the metabolic responses of a MYC-inducible human Burkitt lymphoma model P493 cell line to aerobic and hypoxic conditions, and to glucose deprivation, using stable isotope-resolved metabolomics.  Using [U-13C]-glucose as the tracer, both glucose consumption and lactate prodn. were increased by MYC expression and hypoxia.  Using [U-13C,15N]-glutamine as the tracer, glutamine import and metab. through the TCA cycle persisted under hypoxia, and glutamine contributed significantly to citrate Cs.  Under glucose deprivation, glutamine-derived fumarate, malate, and citrate were significantly increased.  Their 13C-labeling patterns demonstrate an alternative energy-generating glutaminolysis pathway involving a glucose-independent TCA cycle.  The essential role of glutamine metab. in cell survival and proliferation under hypoxia and glucose deficiency makes them susceptible to the glutaminase inhibitor BPTES and hence could be targeted for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxz5K5YyvT6rVg90H21EOLACvtfcHk0lh7HHT5Cjusww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2nsg%253D%253D&md5=0e71d2f1fff5795ba1d22afc8a2fefae</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DA.%2BN.%26aulast%3DHamaker%26aufirst%3DM.%26aulast%3DBose%26aufirst%3DS.%26aulast%3DGouw%26aufirst%3DA.%26aulast%3DBarbi%26aufirst%3DJ.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DRojas%26aufirst%3DC.%2BJ.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZimmerman%26aufirst%3DL.%2BJ.%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26aulast%3DSlebos%26aufirst%3DR.%2BJ.%26aulast%3DLorkiewicz%26aufirst%3DP.%2BK.%26aulast%3DHigashi%26aufirst%3DR.%2BM.%26aulast%3DFan%26aufirst%3DT.%2BW.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DGlucose-independent%2520glutamine%2520metabolism%2520via%2520TCA%2520cycling%2520for%2520proliferation%2520and%2520survival%2520in%2520B%2520cells%26jtitle%3DCell%2520Metab.%26date%3D2012%26volume%3D15%26issue%3D1%26spage%3D110%26epage%3D121%26doi%3D10.1016%2Fj.cmet.2011.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Katt, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerione, R. A.</span><span> </span><span class="NLM_article-title">Glutaminase regulation in cancer cells: a druggable chain of events</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span><span class="refDoi"> DOI: 10.1016/j.drudis.2013.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2Fj.drudis.2013.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=24140288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSls7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=450-457&issue=4&author=W.+P.+Kattauthor=R.+A.+Cerione&title=Glutaminase+regulation+in+cancer+cells%3A+a+druggable+chain+of+events&doi=10.1016%2Fj.drudis.2013.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminase regulation in cancer cells: a druggable chain of events</span></div><div class="casAuthors">Katt, William P.; Cerione, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">450-457</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Metab. is the process by which cells convert relatively simple extracellular nutrients into energy and building blocks necessary for their growth and survival.  In cancer cells, metab. is dramatically altered compared with normal cells.  These alterations are known as the Warburg effect.  One consequence of these changes is cellular addiction to glutamine.  Because of this, in recent years the enzyme glutaminase has become a key target for small mol. therapeutic intervention.  Like many oncotargets, however, glutaminase has a no. of upstream partners that might offer addnl. druggable targets.  This review summarizes the work from the current decade surrounding glutaminase and its regulation, and suggests strategies for therapeutic intervention in relevant cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY9cKMRSje5LVg90H21EOLACvtfcHk0ljjEO8VUAebFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSls7vF&md5=01b37117a2665312031d0cf5af24b7e9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DKatt%26aufirst%3DW.%2BP.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DGlutaminase%2520regulation%2520in%2520cancer%2520cells%253A%2520a%2520druggable%2520chain%2520of%2520events%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26issue%3D4%26spage%3D450%26epage%3D457%26doi%3D10.1016%2Fj.drudis.2013.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wang, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinavahi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrosio, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dias, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerione, R. A.</span><span> </span><span class="NLM_article-title">Targeting mitochondrial glutaminase activity inhibits oncogenic transformation</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1016/j.ccr.2010.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2Fj.ccr.2010.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=20832749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGht7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=207-219&issue=3&author=J.+B.+Wangauthor=J.+W.+Ericksonauthor=R.+Fujiauthor=S.+Ramachandranauthor=P.+Gaoauthor=R.+Dinavahiauthor=K.+F.+Wilsonauthor=A.+L.+Ambrosioauthor=S.+M.+Diasauthor=C.+V.+Dangauthor=R.+A.+Cerione&title=Targeting+mitochondrial+glutaminase+activity+inhibits+oncogenic+transformation&doi=10.1016%2Fj.ccr.2010.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation</span></div><div class="casAuthors">Wang, Jian-Bin; Erickson, Jon W.; Fuji, Reina; Ramachandran, Sekar; Gao, Ping; Dinavahi, Ramani; Wilson, Kristin F.; Ambrosio, Andre L. B.; Dias, Sandra M. G.; Dang, Chi-V.; Cerione, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-219</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Rho GTPases impact a no. of activities important for oncogenesis.  We describe a small mol. inhibitor that blocks oncogenic transformation induced by various Rho GTPases in fibroblasts, and the growth of human breast cancer and B lymphoma cells, without affecting normal cells.  We identify the target of this inhibitor to be the metabolic enzyme glutaminase, which catalyzes the hydrolysis of glutamine to glutamate.  We show that transformed fibroblasts and breast cancer cells exhibit elevated glutaminase activity that is dependent on Rho GTPases and NF-κB activity, and is blocked by the small mol. inhibitor.  These findings highlight a previously unappreciated connection between Rho GTPase activation and cellular metab. and demonstrate that targeting glutaminase activity can inhibit oncogenic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTP6YsyzRd1LVg90H21EOLACvtfcHk0ljjEO8VUAebFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGht7bO&md5=67b64e99c992bbe6636ecfc04b83aac0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BB.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DDinavahi%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DK.%2BF.%26aulast%3DAmbrosio%26aufirst%3DA.%2BL.%26aulast%3DDias%26aufirst%3DS.%2BM.%26aulast%3DDang%26aufirst%3DC.%2BV.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DTargeting%2520mitochondrial%2520glutaminase%2520activity%2520inhibits%2520oncogenic%2520transformation%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26issue%3D3%26spage%3D207%26epage%3D219%26doi%3D10.1016%2Fj.ccr.2010.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Shukla, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraris, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahanty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">10551</span><span class="NLM_x">–</span> <span class="NLM_lpage">10563</span><span class="refDoi"> DOI: 10.1021/jm301191p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301191p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10551-10563&issue=23&author=K.+Shuklaauthor=D.+V.+Ferrarisauthor=A.+G.+Thomasauthor=M.+Stathisauthor=B.+Duvallauthor=G.+Delahantyauthor=J.+Altauthor=R.+Raisauthor=C.+Rojasauthor=P.+Gaoauthor=Y.+Xiangauthor=C.+V.+Dangauthor=B.+S.+Slusherauthor=T.+Tsukamoto&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+bis-2-%285-phenylacetamido-1%2C2%2C4-thiadiazol-2-yl%29ethyl+sulfide+3+%28BPTES%29+analogs+as+glutaminase+inhibitors&doi=10.1021%2Fjm301191p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm301191p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301191p%26sid%3Dliteratum%253Aachs%26aulast%3DShukla%26aufirst%3DK.%26aulast%3DFerraris%26aufirst%3DD.%2BV.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DStathis%26aufirst%3DM.%26aulast%3DDuvall%26aufirst%3DB.%26aulast%3DDelahanty%26aufirst%3DG.%26aulast%3DAlt%26aufirst%3DJ.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DDang%26aufirst%3DC.%2BV.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520bis-2-%25285-phenylacetamido-1%252C2%252C4-thiadiazol-2-yl%2529ethyl%2520sulfide%25203%2520%2528BPTES%2529%2520analogs%2520as%2520glutaminase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D23%26spage%3D10551%26epage%3D10563%26doi%3D10.1021%2Fjm301191p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Gross, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demo, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennison, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chernov-Rogan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goyal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laidig, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackinnon, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shwonek, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjogren, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, M. K.</span><span> </span><span class="NLM_article-title">Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">890</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1158%2F1535-7163.MCT-13-0870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=24523301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1Gjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=890-901&issue=4&author=M.+I.+Grossauthor=S.+D.+Demoauthor=J.+B.+Dennisonauthor=L.+Chenauthor=T.+Chernov-Roganauthor=B.+Goyalauthor=J.+R.+Janesauthor=G.+J.+Laidigauthor=E.+R.+Lewisauthor=J.+Liauthor=A.+L.+Mackinnonauthor=F.+Parlatiauthor=M.+L.+Rodriguezauthor=P.+J.+Shwonekauthor=E.+B.+Sjogrenauthor=T.+F.+Stantonauthor=T.+Wangauthor=J.+Yangauthor=F.+Zhaoauthor=M.+K.+Bennett&title=Antitumor+activity+of+the+glutaminase+inhibitor+CB-839+in+triple-negative+breast+cancer&doi=10.1158%2F1535-7163.MCT-13-0870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer</span></div><div class="casAuthors">Gross, Matt I.; Demo, Susan D.; Dennison, Jennifer B.; Chen, Lijing; Chernov-Rogan, Tania; Goyal, Bindu; Janes, Julie R.; Laidig, Guy J.; Lewis, Evan R.; Li, Jim; MacKinnon, Andrew L.; Parlati, Francesco; Rodriguez, Mirna L. M.; Shwonek, Peter J.; Sjogren, Eric B.; Stanton, Timothy F.; Wang, Taotao; Yang, Jinfu; Zhao, Frances; Bennett, Mark K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">890-901</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Glutamine serves as an important source of energy and building blocks for many tumor cells.  The first step in glutamine utilization is its conversion to glutamate by the mitochondrial enzyme glutaminase.  CB-839 is a potent, selective, and orally bioavailable inhibitor of both splice variants of glutaminase (KGA and GAC).  CB-839 had antiproliferative activity in a triple-neg. breast cancer (TNBC) cell line, HCC-1806, that was assocd. with a marked decrease in glutamine consumption, glutamate prodn., oxygen consumption, and the steady-state levels of glutathione and several tricarboxylic acid cycle intermediates.  In contrast, no antiproliferative activity was obsd. in an estrogen receptor-pos. cell line, T47D, and only modest effects on glutamine consumption and downstream metabolites were obsd.  Across a panel of breast cancer cell lines, GAC protein expression and glutaminase activity were elevated in the majority of TNBC cell lines relative to receptor pos. cells.  Furthermore, the TNBC subtype displayed the greatest sensitivity to CB-839 treatment and this sensitivity was correlated with (i) dependence on extracellular glutamine for growth, (ii) intracellular glutamate and glutamine levels, and (iii) GAC (but not KGA) expression, a potential biomarker for sensitivity.  CB-839 displayed significant antitumor activity in two xenograft models: as a single agent in a patient-derived TNBC model and in a basal like HER2+ cell line model, JIMT-1, both as a single agent and in combination with paclitaxel.  Together, these data provide a strong rationale for the clin. investigation of CB-839 as a targeted therapeutic in patients with TNBC and other glutamine-dependent tumors.  Mol Cancer Ther; 13(4); 890-901.2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfUGWU-VZObVg90H21EOLACvtfcHk0li-q3ixDQEM5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1Gjurg%253D&md5=5b9ddb35c56409b58ce2b889bbbbc33f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0870%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DM.%2BI.%26aulast%3DDemo%26aufirst%3DS.%2BD.%26aulast%3DDennison%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChernov-Rogan%26aufirst%3DT.%26aulast%3DGoyal%26aufirst%3DB.%26aulast%3DJanes%26aufirst%3DJ.%2BR.%26aulast%3DLaidig%26aufirst%3DG.%2BJ.%26aulast%3DLewis%26aufirst%3DE.%2BR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMackinnon%26aufirst%3DA.%2BL.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DRodriguez%26aufirst%3DM.%2BL.%26aulast%3DShwonek%26aufirst%3DP.%2BJ.%26aulast%3DSjogren%26aufirst%3DE.%2BB.%26aulast%3DStanton%26aufirst%3DT.%2BF.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DBennett%26aufirst%3DM.%2BK.%26atitle%3DAntitumor%2520activity%2520of%2520the%2520glutaminase%2520inhibitor%2520CB-839%2520in%2520triple-negative%2520breast%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26issue%3D4%26spage%3D890%26epage%3D901%26doi%3D10.1158%2F1535-7163.MCT-13-0870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Lee, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span> </span><span class="NLM_article-title">Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">6087</span><span class="NLM_x">–</span> <span class="NLM_lpage">6101</span><span class="refDoi"> DOI: 10.18632/oncotarget.2173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.18632%2Foncotarget.2173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=25026281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A280%3ADC%252BC2cbitF2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=6087-6101&issue=15&author=Y.+Z.+Leeauthor=C.+W.+Yangauthor=H.+Y.+Changauthor=H.+Y.+Hsuauthor=I.+S.+Chenauthor=H.+S.+Changauthor=C.+H.+Leeauthor=J.+C.+Leeauthor=C.+R.+Kumarauthor=Y.+Q.+Qiuauthor=Y.+S.+Chaoauthor=S.+J.+Lee&title=Discovery+of+selective+inhibitors+of+Glutaminase-2%2C+which+inhibit+mTORC1%2C+activate+autophagy+and+inhibit+proliferation+in+cancer+cells&doi=10.18632%2Foncotarget.2173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells</span></div><div class="casAuthors">Lee Yue-Zhi; Yang Cheng-Wei; Chang Hsin-Yu; Hsu Hsing-Yu; Chen Ih-Shen; Chang Hsun-Shuo; Lee Chih-Hao; Lee Jinq-chyi; Kumar Chidambaram Ramesh; Chao Yu-Sheng; Lee Shiow-Ju; Qiu Ya-Qi</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6087-101</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glutaminase, which converts glutamine to glutamate, is involved in Warburg effect in cancer cells.  Two human glutaminase genes have been identified, GLS (GLS1) and GLS2.  Two alternative transcripts arise from each glutaminase gene: first, the kidney isoform (KGA) and glutaminase C (GAC) for GLS; and, second, the liver isoform (LGA) and glutaminase B (GAB) for GLS2.  While GLS1 is considered as a cancer therapeutic target, the potential role of GLS2 in cancer remains unclear.  Here, we discovered a series of alkyl benzoquinones that preferentially inhibit glutaminase B isoform (GAB, GLS2) rather than the kidney isoform of glutaminase (KGA, GLS1).  We identified amino acid residues in an allosteric binding pocket responsible for the selectivity.  Treatment with the alkyl benzoquinones decreased intracellular glutaminase activity and glutamate levels.  GLS2 inhibition by either alkyl benzoquinones or GLS2 siRNA reduced carcinoma cell proliferation and anchorage-independent colony formation, and induced autophagy via AMPK mediated mTORC1 inhibition.  Our findings demonstrate amino acid sequences for selective inhibition of glutaminase isozymes and validate GLS2 as a potential anti-cancer target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7ipugdsmO_SjiVMCqkKxVfW6udTcc2eZ09Akafr5B67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbitF2htA%253D%253D&md5=0f0e4f0d6a1960aa8a87d645f55b5f68</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2173%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BZ.%26aulast%3DYang%26aufirst%3DC.%2BW.%26aulast%3DChang%26aufirst%3DH.%2BY.%26aulast%3DHsu%26aufirst%3DH.%2BY.%26aulast%3DChen%26aufirst%3DI.%2BS.%26aulast%3DChang%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DKumar%26aufirst%3DC.%2BR.%26aulast%3DQiu%26aufirst%3DY.%2BQ.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3DDiscovery%2520of%2520selective%2520inhibitors%2520of%2520Glutaminase-2%252C%2520which%2520inhibit%2520mTORC1%252C%2520activate%2520autophagy%2520and%2520inhibit%2520proliferation%2520in%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26issue%3D15%26spage%3D6087%26epage%3D6101%26doi%3D10.18632%2Foncotarget.2173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Xiao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qing, G.</span><span> </span><span class="NLM_article-title">Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">38</span><span class="NLM_x">) </span> <span class="NLM_fpage">40655</span><span class="NLM_x">–</span> <span class="NLM_lpage">40666</span><span class="refDoi"> DOI: 10.18632/oncotarget.5821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.18632%2Foncotarget.5821" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=40655-40666&issue=38&author=D.+Xiaoauthor=P.+Renauthor=H.+Suauthor=M.+Yueauthor=R.+Xiuauthor=Y.+Huauthor=H.+Liuauthor=G.+Qing&title=Myc+promotes+glutaminolysis+in+human+neuroblastoma+through+direct+activation+of+glutaminase+2&doi=10.18632%2Foncotarget.5821"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5821%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DYue%26aufirst%3DM.%26aulast%3DXiu%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DQing%26aufirst%3DG.%26atitle%3DMyc%2520promotes%2520glutaminolysis%2520in%2520human%2520neuroblastoma%2520through%2520direct%2520activation%2520of%2520glutaminase%25202%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26issue%3D38%26spage%3D40655%26epage%3D40666%26doi%3D10.18632%2Foncotarget.5821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhanot, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haffty, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span> </span><span class="NLM_article-title">Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e10727</span><span class="refDoi"> DOI: 10.7554/eLife.10727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.7554%2FeLife.10727" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e10727&author=C.+Zhangauthor=J.+Liuauthor=Y.+Zhaoauthor=X.+Yueauthor=Y.+Zhuauthor=X.+Wangauthor=H.+Wuauthor=F.+Blancoauthor=S.+Liauthor=G.+Bhanotauthor=B.+G.+Hafftyauthor=W.+Huauthor=Z.+Feng&title=Glutaminase+2+is+a+novel+negative+regulator+of+small+GTPase+Rac1+and+mediates+p53+function+in+suppressing+metastasis&doi=10.7554%2FeLife.10727"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.7554%2FeLife.10727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.10727%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYue%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DBlanco%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DBhanot%26aufirst%3DG.%26aulast%3DHaffty%26aufirst%3DB.%2BG.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DZ.%26atitle%3DGlutaminase%25202%2520is%2520a%2520novel%2520negative%2520regulator%2520of%2520small%2520GTPase%2520Rac1%2520and%2520mediates%2520p53%2520function%2520in%2520suppressing%2520metastasis%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26spage%3De10727%26doi%3D10.7554%2FeLife.10727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Giacobbe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bongiorno-Borbone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernassola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrinoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markert, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agostini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zolla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agro, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notterman, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peschiaroli, A.</span><span> </span><span class="NLM_article-title">p63 regulates glutaminase 2 expression</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1395</span><span class="NLM_x">–</span> <span class="NLM_lpage">1405</span><span class="refDoi"> DOI: 10.4161/cc.24478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.4161%2Fcc.24478" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1395-1405&issue=9&author=A.+Giacobbeauthor=L.+Bongiorno-Borboneauthor=F.+Bernassolaauthor=A.+Terrinoniauthor=E.+K.+Markertauthor=A.+J.+Levineauthor=Z.+Fengauthor=M.+Agostiniauthor=L.+Zollaauthor=A.+F.+Agroauthor=D.+A.+Nottermanauthor=G.+Melinoauthor=A.+Peschiaroli&title=p63+regulates+glutaminase+2+expression&doi=10.4161%2Fcc.24478"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4161%2Fcc.24478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.24478%26sid%3Dliteratum%253Aachs%26aulast%3DGiacobbe%26aufirst%3DA.%26aulast%3DBongiorno-Borbone%26aufirst%3DL.%26aulast%3DBernassola%26aufirst%3DF.%26aulast%3DTerrinoni%26aufirst%3DA.%26aulast%3DMarkert%26aufirst%3DE.%2BK.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DAgostini%26aufirst%3DM.%26aulast%3DZolla%26aufirst%3DL.%26aulast%3DAgro%26aufirst%3DA.%2BF.%26aulast%3DNotterman%26aufirst%3DD.%2BA.%26aulast%3DMelino%26aufirst%3DG.%26aulast%3DPeschiaroli%26aufirst%3DA.%26atitle%3Dp63%2520regulates%2520glutaminase%25202%2520expression%26jtitle%3DCell%2520Cycle%26date%3D2013%26volume%3D12%26issue%3D9%26spage%3D1395%26epage%3D1405%26doi%3D10.4161%2Fcc.24478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span> </span><span class="NLM_article-title">Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">7455</span><span class="NLM_x">–</span> <span class="NLM_lpage">7460</span><span class="refDoi"> DOI: 10.1073/pnas.1001006107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1073%2Fpnas.1001006107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=7455-7460&issue=16&author=W.+Huauthor=C.+Zhangauthor=R.+Wuauthor=Y.+Sunauthor=A.+Levineauthor=Z.+Feng&title=Glutaminase+2%2C+a+novel+p53+target+gene+regulating+energy+metabolism+and+antioxidant+function&doi=10.1073%2Fpnas.1001006107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1001006107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1001006107%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLevine%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DZ.%26atitle%3DGlutaminase%25202%252C%2520a%2520novel%2520p53%2520target%2520gene%2520regulating%2520energy%2520metabolism%2520and%2520antioxidant%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26issue%3D16%26spage%3D7455%26epage%3D7460%26doi%3D10.1073%2Fpnas.1001006107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poyurovsky, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokshin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokote, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prives, C.</span><span> </span><span class="NLM_article-title">Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">7461</span><span class="NLM_x">–</span> <span class="NLM_lpage">7466</span><span class="refDoi"> DOI: 10.1073/pnas.1002459107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1073%2Fpnas.1002459107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=7461-7466&issue=16&author=S.+Suzukiauthor=T.+Tanakaauthor=M.+V.+Poyurovskyauthor=H.+Naganoauthor=T.+Mayamaauthor=S.+Ohkuboauthor=M.+Lokshinauthor=H.+Hosokawaauthor=T.+Nakayamaauthor=Y.+Suzukiauthor=S.+Suganoauthor=E.+Satoauthor=T.+Nagaoauthor=K.+Yokoteauthor=I.+Tatsunoauthor=C.+Prives&title=Phosphate-activated+glutaminase+%28GLS2%29%2C+a+p53-inducible+regulator+of+glutamine+metabolism+and+reactive+oxygen+species&doi=10.1073%2Fpnas.1002459107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1002459107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1002459107%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DPoyurovsky%26aufirst%3DM.%2BV.%26aulast%3DNagano%26aufirst%3DH.%26aulast%3DMayama%26aufirst%3DT.%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DLokshin%26aufirst%3DM.%26aulast%3DHosokawa%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DSugano%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DE.%26aulast%3DNagao%26aufirst%3DT.%26aulast%3DYokote%26aufirst%3DK.%26aulast%3DTatsuno%26aufirst%3DI.%26aulast%3DPrives%26aufirst%3DC.%26atitle%3DPhosphate-activated%2520glutaminase%2520%2528GLS2%2529%252C%2520a%2520p53-inducible%2520regulator%2520of%2520glutamine%2520metabolism%2520and%2520reactive%2520oxygen%2520species%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26issue%3D16%26spage%3D7461%26epage%3D7466%26doi%3D10.1073%2Fpnas.1002459107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Turner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGivan, J. D.</span><span> </span><span class="NLM_article-title">Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span><span class="refDoi"> DOI: 10.1042/bj20021360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1042%2Fbj20021360" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2003&pages=403-408&issue=2&author=A.+Turnerauthor=J.+D.+McGivan&title=Glutaminase+isoform+expression+in+cell+lines+derived+from+human+colorectal+adenomas+and+carcinomas&doi=10.1042%2Fbj20021360"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1042%2Fbj20021360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021360%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DA.%26aulast%3DMcGivan%26aufirst%3DJ.%2BD.%26atitle%3DGlutaminase%2520isoform%2520expression%2520in%2520cell%2520lines%2520derived%2520from%2520human%2520colorectal%2520adenomas%2520and%2520carcinomas%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D370%26issue%3D2%26spage%3D403%26epage%3D408%26doi%3D10.1042%2Fbj20021360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Perez-Gomez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos-Sandoval, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segura, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzanares, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz-Sanchez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mates, J. M.</span><span> </span><span class="NLM_article-title">Co-expression of glutaminase K and L isoenzymes in human tumour cells</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">386</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.1042/BJ20040996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1042%2FBJ20040996" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2005&pages=535-542&issue=3&author=C.+Perez-Gomezauthor=J.+A.+Campos-Sandovalauthor=F.+J.+Alonsoauthor=J.+A.+Seguraauthor=E.+Manzanaresauthor=P.+Ruiz-Sanchezauthor=M.+E.+Gonzalezauthor=J.+Marquezauthor=J.+M.+Mates&title=Co-expression+of+glutaminase+K+and+L+isoenzymes+in+human+tumour+cells&doi=10.1042%2FBJ20040996"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1042%2FBJ20040996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20040996%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Gomez%26aufirst%3DC.%26aulast%3DCampos-Sandoval%26aufirst%3DJ.%2BA.%26aulast%3DAlonso%26aufirst%3DF.%2BJ.%26aulast%3DSegura%26aufirst%3DJ.%2BA.%26aulast%3DManzanares%26aufirst%3DE.%26aulast%3DRuiz-Sanchez%26aufirst%3DP.%26aulast%3DGonzalez%26aufirst%3DM.%2BE.%26aulast%3DMarquez%26aufirst%3DJ.%26aulast%3DMates%26aufirst%3DJ.%2BM.%26atitle%3DCo-expression%2520of%2520glutaminase%2520K%2520and%2520L%2520isoenzymes%2520in%2520human%2520tumour%2520cells%26jtitle%3DBiochem.%2520J.%26date%3D2005%26volume%3D386%26issue%3D3%26spage%3D535%26epage%3D542%26doi%3D10.1042%2FBJ20040996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Huang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span> </span><span class="NLM_article-title">Expression of glutaminase is upregulated in colorectal cancer and of clinical significance</span> <span class="citation_source-journal">Int. J. Clin. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=24696726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFynur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=1093-1100&issue=3&author=F.+Huangauthor=Q.+Zhangauthor=H.+Maauthor=Q.+Lvauthor=T.+Zhang&title=Expression+of+glutaminase+is+upregulated+in+colorectal+cancer+and+of+clinical+significance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of glutaminase is upregulated in colorectal cancer and of clinical significance</span></div><div class="casAuthors">Huang, Fang; Zhang, Qiuyue; Ma, Hong; Lv, Qing; Zhang, Tao</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1093-1100, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1936-2625</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Cancer cells remodel their metabolic programs to meet the requirements of rapid proliferation.  Glutaminase (GLS1) is a mitochondrial enzyme that converts glutamine to glutamate.  Our aim was to investigate, for the first time, GLS1 protein expression in colorectal cancer and to evaluate its clin. significance.  Immunohistochem. anal. was performed on tissue microarrays contg. pairs of cancer and adjacent normal tissues from colorectal cancer patients (n = 257).  The expression of GLS1 protein in normal colonic tissues and colorectal cancer was measured by western blotting.  Proliferation and cell death were evaluated in colorectal cancer cell lines after GLS1 inhibitor treatment.  Compared with normal tissues (18.15%), we obsd. that the expression of GLS1 increased significantly in colorectal cancer (80.24%; P < 0.0001) by immunohistochem. anal., and the elevation of GLS1 protein expression levels in fresh colorectal cancer samples vs. normal colonic tissues were also obsd. by western blotting.  Furthermore, GLS1 expression levels were significantly assocd. with deeper tumor infiltration (P = 0.0002), and the pathol. pattern of tubular adenocarcinoma (p = 0.0008).  In addn., treatment with the GLS1 inhibitor suppressed proliferation and induced apoptosis in HT29 and SW480 cell lines.  These results suggest that the expression of GLS1 is upregulated and correlates with clinicopathol. factors in colorectal cancer.  GLS1 exhibits functional importance in colon cancer tumorigenesis.  Moreover, GLS1 may serve as a target for colorectal cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrqIrrXKlo17Vg90H21EOLACvtfcHk0liq-NtHCsqUyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFynur0%253D&md5=b7916e85f4c05090f7cbe76f1b4dd443</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DLv%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DT.%26atitle%3DExpression%2520of%2520glutaminase%2520is%2520upregulated%2520in%2520colorectal%2520cancer%2520and%2520of%2520clinical%2520significance%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2014%26volume%3D7%26issue%3D3%26spage%3D1093%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span> </span><span class="NLM_article-title">Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2635</span><span class="NLM_x">–</span> <span class="NLM_lpage">2647</span><span class="refDoi"> DOI: 10.18632/oncotarget.1862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.18632%2Foncotarget.1862" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2635-2647&issue=9&author=J.+Liuauthor=C.+Zhangauthor=M.+Linauthor=W.+Zhuauthor=Y.+Liangauthor=X.+Hongauthor=Y.+Zhaoauthor=K.+H.+Youngauthor=W.+Huauthor=Z.+Feng&title=Glutaminase+2+negatively+regulates+the+PI3K%2FAKT+signaling+and+shows+tumor+suppression+activity+in+human+hepatocellular+carcinoma&doi=10.18632%2Foncotarget.1862"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1862%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYoung%26aufirst%3DK.%2BH.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DZ.%26atitle%3DGlutaminase%25202%2520negatively%2520regulates%2520the%2520PI3K%252FAKT%2520signaling%2520and%2520shows%2520tumor%2520suppression%2520activity%2520in%2520human%2520hepatocellular%2520carcinoma%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26issue%3D9%26spage%3D2635%26epage%3D2647%26doi%3D10.18632%2Foncotarget.1862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Thangavelu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivaraman, J.</span><span> </span><span class="NLM_article-title">Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA)</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3827</span><span class="refDoi"> DOI: 10.1038/srep03827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1038%2Fsrep03827" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=24451979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVCis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=3827&author=K.+Thangaveluauthor=Q.+Y.+Chongauthor=B.+C.+Lowauthor=J.+Sivaraman&title=Structural+basis+for+the+active+site+inhibition+mechanism+of+human+kidney-type+glutaminase+%28KGA%29&doi=10.1038%2Fsrep03827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA)</span></div><div class="casAuthors">Thangavelu, K.; Chong, Qing Yun; Low, Boon Chuan; Sivaraman, J.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3827</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glutaminase is a metabolic enzyme responsible for glutaminolysis, a process harnessed by cancer cells to feed their accelerated growth and proliferation.  Among the glutaminase isoforms, human kidney-type glutaminase (KGA) is often upregulated in cancer and is thus touted as an attractive drug target.  Here we report the active site inhibition mechanism of KGA through the crystal structure of the catalytic domain of KGA (cKGA) in complex with 6-diazo-5-oxo-L-norleucine (DON), a substrate analog of glutamine.  DON covalently binds with the active site Ser286 and interacts with residues such as Tyr249, Asn335, Glu381, Asn388, Tyr414, Tyr466 and Val484.  The nucleophilic attack of Ser286 sidechain on DON releases the diazo group (N2) from the inhibitor and results in the formation of an enzyme-inhibitor complex.  Mutational studies confirmed the key role of these residues in the activity of KGA.  This study will be important in the development of KGA active site inhibitors for therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhI-NVHs5B9bVg90H21EOLACvtfcHk0liq-NtHCsqUyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVCis7Y%253D&md5=86a5c7ae18f1a95c66d7d13e63ad2b0b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsrep03827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep03827%26sid%3Dliteratum%253Aachs%26aulast%3DThangavelu%26aufirst%3DK.%26aulast%3DChong%26aufirst%3DQ.%2BY.%26aulast%3DLow%26aufirst%3DB.%2BC.%26aulast%3DSivaraman%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520for%2520the%2520active%2520site%2520inhibition%2520mechanism%2520of%2520human%2520kidney-type%2520glutaminase%2520%2528KGA%2529%26jtitle%3DSci.%2520Rep.%26date%3D2014%26volume%3D4%26spage%3D3827%26doi%3D10.1038%2Fsrep03827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Wu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukinius, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langstrom, B.</span><span> </span><span class="NLM_article-title">A mechanism behind the antitumour effect of 6-diazo-5-oxo-L-norleucine (DON): disruption of mitochondria</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1155</span><span class="NLM_x">–</span> <span class="NLM_lpage">1161</span><span class="refDoi"> DOI: 10.1016/S0959-8049(99)00099-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2FS0959-8049%2899%2900099-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1999&pages=1155-1161&issue=7&author=F.+Wuauthor=A.+Lukiniusauthor=M.+Bergstromauthor=B.+Erikssonauthor=Y.+Watanabeauthor=B.+Langstrom&title=A+mechanism+behind+the+antitumour+effect+of+6-diazo-5-oxo-L-norleucine+%28DON%29%3A+disruption+of+mitochondria&doi=10.1016%2FS0959-8049%2899%2900099-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2899%2900099-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252899%252900099-4%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DF.%26aulast%3DLukinius%26aufirst%3DA.%26aulast%3DBergstrom%26aufirst%3DM.%26aulast%3DEriksson%26aufirst%3DB.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DLangstrom%26aufirst%3DB.%26atitle%3DA%2520mechanism%2520behind%2520the%2520antitumour%2520effect%2520of%25206-diazo-5-oxo-L-norleucine%2520%2528DON%2529%253A%2520disruption%2520of%2520mitochondria%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1999%26volume%3D35%26issue%3D7%26spage%3D1155%26epage%3D1161%26doi%3D10.1016%2FS0959-8049%2899%2900099-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Mueller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Batran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bausch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethuraman, N.</span><span> </span><span class="NLM_article-title">A phase IIa study of PEGylated glutaminase (PEG-PGA) plus 6-diazo-5-oxo-L-norleucine (DON) in patients with advanced refractory solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">May 20 Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">2533</span><span class="refDoi"> DOI: 10.1200/jco.2008.26.15_suppl.2533</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1200%2Fjco.2008.26.15_suppl.2533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A280%3ADC%252BC2sjmtlGguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=2533&issue=May+20+Suppl.&author=C.+Muellerauthor=S.+Al-Batranauthor=E.+Jaegerauthor=B.+Schmidtauthor=M.+Bauschauthor=C.+Ungerauthor=N.+Sethuraman&title=A+phase+IIa+study+of+PEGylated+glutaminase+%28PEG-PGA%29+plus+6-diazo-5-oxo-L-norleucine+%28DON%29+in+patients+with+advanced+refractory+solid+tumors&doi=10.1200%2Fjco.2008.26.15_suppl.2533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A phase IIa study of PEGylated glutaminase (PEG-PGA) plus 6-diazo-5-oxo-L-norleucine (DON) in patients with advanced refractory solid tumors</span></div><div class="casAuthors">Mueller C; Al-Batran S; Jaeger E; Schmidt B; Bausch M; Unger C; Sethuraman N</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15_suppl</span>),
    <span class="NLM_cas:pages">2533</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">2533 Background: Our phase IIa study evaluated the safety and clinical activity of the glutamine depleting enzyme PEG-PGA in combination with DON.  DON as a glutamine antagonist irreversibly inhibits key enzymes in the purine and pyrimidine synthesis.  Based on the competitive mechanism, effectiveness of DON is greatly enhanced if plasma glutamine level is significantly depleted by PEG-PGA.  METHODS:  In this multicenter study, patients (pts) with advanced solid tumors refractory to standard treatments were enrolled.  Pts were treated with 120 I.U./m(2) PEG-PGA (once weekly) and 140 mg/m(2) DON (twice weekly) both as 15 min intravenous infusions.  Three weeks were considered one cycle and tumor assessment (RECIST) was performed every two cycles.  The primary endpoint was safety.  RESULTS:  Fifty-five pts (20f/35m) were enrolled.  Median age was 60 years (range 31-84). 30% had an ECOG PS <1.  Pts were heavily pretreated and all had progressive disease at study entry.  Treatment duration ranged from 1 to 379 days.  Glutamine levels were depleted below 10% of baseline after the 2nd infusion of PEG-PGA and remained depleted in >90% of the patients.  The treatment was very well tolerated.  Most frequent (>2%) possibly related NCI-CTC grade 3 or 4 non-hematological toxicities were fatigue in 5 (9.1 %), nausea in 3 (5.5%), vomiting in 2 (3.6%) and diarrhea in 2 (3.6%) pts.  Grade 3 or 4 hematological side effects were also rare, with neutropenia and thrombocytopenia being observed in 1 patient (pt), each.  One pt with metastatic colorectal cancer (mCRC) experienced a confirmed partial response.  One additional pt (mCRC) had a prolonged stable disease lasting > 12 months under treatment despite multiple lung metastases (>30).  Among the pts with mCRC, 9/17 (53%) pts 5/17 (29%) pts were progression-free at 3 and 5 months, respectively.  Signs of activity were also observed in pts with lung cancer.  Five of six (83%) pts with lung cancer were progression-free 3 months after inclusion.  CONCLUSIONS:  PEG-PGA and DON were well tolerated and demonstrated activity in late stage colorectal and lung cancer.  The therapeutic approach warrants further investigations. [Table: see text].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxB5UhTWxOXWHOrQ6qeX-mfW6udTcc2eZLN0lCfiO9Jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sjmtlGguw%253D%253D&md5=d7bba73438ab6dfbec821c1d85115658</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1200%2Fjco.2008.26.15_suppl.2533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252Fjco.2008.26.15_suppl.2533%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DC.%26aulast%3DAl-Batran%26aufirst%3DS.%26aulast%3DJaeger%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DBausch%26aufirst%3DM.%26aulast%3DUnger%26aufirst%3DC.%26aulast%3DSethuraman%26aufirst%3DN.%26atitle%3DA%2520phase%2520IIa%2520study%2520of%2520PEGylated%2520glutaminase%2520%2528PEG-PGA%2529%2520plus%25206-diazo-5-oxo-L-norleucine%2520%2528DON%2529%2520in%2520patients%2520with%2520advanced%2520refractory%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2008%26volume%3D26%26issue%3DMay%252020%2520Suppl%26spage%3D2533%26doi%3D10.1200%2Fjco.2008.26.15_suppl.2533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Allen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yunis, A.</span><span> </span><span class="NLM_article-title">The inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501)</span> <span class="citation_source-journal">Res. Commun. Chem. Pathol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=6102405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADyaL3cXht1WltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1980&pages=175-182&issue=1&author=L.+Allenauthor=R.+Meckauthor=A.+Yunis&title=The+inhibition+of+gamma-glutamyl+transpeptidase+from+human+pancreatic+carcinoma+cells+by+%28alpha+S%2C5S%29-alpha-amino-3-chloro-4%2C5-dihydro-5-isoxazoleacetic+acid+%28AT-125%3B+NSC-163501%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibition of γ-glutamyl transpeptidase from human pancreatic carcinoma cells by (αS,5S)-α-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501)</span></div><div class="casAuthors">Allen, Larry; Meck, Robert; Yunis, Adel</div><div class="citationInfo"><span class="NLM_cas:title">Research Communications in Chemical Pathology and Pharmacology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-82</span>CODEN:
                <span class="NLM_cas:coden">RCOCB8</span>;
        ISSN:<span class="NLM_cas:issn">0034-5164</span>.
    </div><div class="casAbstract">AT-125 (I)  [42228-92-2] at 5 μM inhibited the growth of human pancreatic carcinoma cells by 78% after 72 h in continuous culture.  γ-Glutamyl transpeptidase  [9046-27-9] was irreversibly inactivated by I with an inactivation half-life of 80 min at 450 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAEJ1HIQo3ILVg90H21EOLACvtfcHk0lio7AAAf-WfRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXht1WltLY%253D&md5=024833952b028908a7edc8b199adcbab</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DL.%26aulast%3DMeck%26aufirst%3DR.%26aulast%3DYunis%26aufirst%3DA.%26atitle%3DThe%2520inhibition%2520of%2520gamma-glutamyl%2520transpeptidase%2520from%2520human%2520pancreatic%2520carcinoma%2520cells%2520by%2520%2528alpha%2520S%252C5S%2529-alpha-amino-3-chloro-4%252C5-dihydro-5-isoxazoleacetic%2520acid%2520%2528AT-125%253B%2520NSC-163501%2529%26jtitle%3DRes.%2520Commun.%2520Chem.%2520Pathol.%2520Pharmacol.%26date%3D1980%26volume%3D27%26issue%3D1%26spage%3D175%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGovren, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Hoff, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowinsky, E. K.</span><span> </span><span class="NLM_article-title">A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2763</span><span class="NLM_x">–</span> <span class="NLM_lpage">2770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=9829740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADyaK1cXns1Ogurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=2763-2770&issue=11&author=M.+Hidalgoauthor=G.+Rodriguezauthor=J.+G.+Kuhnauthor=T.+Brownauthor=G.+Weissauthor=J.+P.+MacGovrenauthor=D.+D.+Von+Hoffauthor=E.+K.+Rowinsky&title=A+Phase+I+and+pharmacological+study+of+the+glutamine+antagonist+acivicin+with+the+amino+acid+solution+aminosyn+in+patients+with+advanced+solid+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution Aminosyn in patients with advanced solid malignancies</span></div><div class="casAuthors">Hidalgo, Manuel; Rodriguez, Gladys; Kuhn, John G.; Brown, Thomas; Weiss, Geoffrey; MacGovren, J. Patrick; Von Hoff, Daniel D.; Rowinsky, Eric K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2763-2770</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This study evaluated the feasibility of escalating acivicin doses in cancer patients by administering acivicin with a concomitant 96-h i.v. infusion of a mixt. of 16 amino acids (Aminosyn, 10%).  Twenty-three patients with advanced malignancies were treated with acivicin on a 72-h continuous infusion schedule at doses ranging 25-60 mg/m2/day every 3 wk.  Reversible, dose-limiting central nervous system ( CNS) toxicity, characterized by lethargy, confusion, and decreased mental status, occurred in the 2 patients enrolled at the 60-mg/m2/day dose, precluding further dose escalation.  The max. tolerated dose (MTD) and recommended dose for addnl. evaluation of acivicin on this schedule is 50 mg/m2/day.  Other toxicities obsd. were dose-related neutropenia that was grade 4 in 4 patients (4 courses), complicated with fever in 3 of those patients, and grade 3-4 thrombocytopenia in 3 patients (3 courses).  Pharmacokinetic studies performed in 15 patients revealed that the plasma acivicin steady-state concn. (Css) increased from 0.44 μg/mL (range, 0.28-0.59 μg/mL) at the 25-mg/m2day dose to 1.06 μg/mL (0.64-1.5 μg/mL) at the 50-mg/m2/dose.  Acivicin Css at the MTD was not higher than previously reported values with single-agent acivicin on the same schedule of administration at the MTD of 25 mg/m2/day (0.60 μg/mL; range, 0.43-0.81 μg/mL).  Neurotoxicity did not correlate with acivicin Css, but relationships between exposure to acivicin and the occurrence of both neutropenia and thrombocytopenia were well described by a sigmoidal Emax model.  This trial demonstrated that concomitant infusions of amino acids can prevent acivicin-induced CNS toxicity, which allows the dose of acivicin to be escalated 2-fold above previously tolerable doses; however, this effect did not translate into a significant increment in acivicin Css.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJQxbqC6C-7rVg90H21EOLACvtfcHk0lio7AAAf-WfRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXns1Ogurs%253D&md5=51ad0abc45ce9667526748617e7c7313</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DG.%26aulast%3DKuhn%26aufirst%3DJ.%2BG.%26aulast%3DBrown%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DG.%26aulast%3DMacGovren%26aufirst%3DJ.%2BP.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DRowinsky%26aufirst%3DE.%2BK.%26atitle%3DA%2520Phase%2520I%2520and%2520pharmacological%2520study%2520of%2520the%2520glutamine%2520antagonist%2520acivicin%2520with%2520the%2520amino%2520acid%2520solution%2520aminosyn%2520in%2520patients%2520with%2520advanced%2520solid%2520malignancies%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1998%26volume%3D4%26issue%3D11%26spage%3D2763%26epage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. X.</span><span> </span><span class="NLM_article-title">Physapubescin, a natural withanolide as a kidney-type glutaminase (KGA) inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1243</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.01.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2Fj.bmcl.2017.01.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1243-1246&issue=5&author=L.+Chengauthor=C.+R.+Wuauthor=L.+H.+Zhuauthor=H.+Liauthor=L.+X.+Chen&title=Physapubescin%2C+a+natural+withanolide+as+a+kidney-type+glutaminase+%28KGA%29+inhibitor&doi=10.1016%2Fj.bmcl.2017.01.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.01.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.01.057%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DC.%2BR.%26aulast%3DZhu%26aufirst%3DL.%2BH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DL.%2BX.%26atitle%3DPhysapubescin%252C%2520a%2520natural%2520withanolide%2520as%2520a%2520kidney-type%2520glutaminase%2520%2528KGA%2529%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D5%26spage%3D1243%26epage%3D1246%26doi%3D10.1016%2Fj.bmcl.2017.01.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">DeLaBarre, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurov, J. B.</span><span> </span><span class="NLM_article-title">Full-length human glutaminase in complex with an allosteric inhibitor</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">50</span><span class="NLM_x">) </span> <span class="NLM_fpage">10764</span><span class="NLM_x">–</span> <span class="NLM_lpage">10770</span><span class="refDoi"> DOI: 10.1021/bi201613d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi201613d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=10764-10770&issue=50&author=B.+DeLaBarreauthor=S.+Grossauthor=C.+Fangauthor=Y.+Gaoauthor=A.+Jhaauthor=F.+Jiangauthor=J.+J.+Songauthor=W.+Weiauthor=J.+B.+Hurov&title=Full-length+human+glutaminase+in+complex+with+an+allosteric+inhibitor&doi=10.1021%2Fbi201613d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fbi201613d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201613d%26sid%3Dliteratum%253Aachs%26aulast%3DDeLaBarre%26aufirst%3DB.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DJha%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DJ.%2BJ.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DHurov%26aufirst%3DJ.%2BB.%26atitle%3DFull-length%2520human%2520glutaminase%2520in%2520complex%2520with%2520an%2520allosteric%2520inhibitor%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26issue%3D50%26spage%3D10764%26epage%3D10770%26doi%3D10.1021%2Fbi201613d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Katt, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukey, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerione, R. A.</span><span> </span><span class="NLM_article-title">A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span><span class="refDoi"> DOI: 10.4155/fmc-2016-0190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.4155%2Ffmc-2016-0190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=28111979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=223-243&issue=2&author=W.+P.+Kattauthor=M.+J.+Lukeyauthor=R.+A.+Cerione&title=A+tale+of+two+glutaminases%3A+homologous+enzymes+with+distinct+roles+in+tumorigenesis&doi=10.4155%2Ffmc-2016-0190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis</span></div><div class="casAuthors">Katt, William P.; Lukey, Michael J.; Cerione, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-243</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Many cancer cells exhibit an altered metabolic phenotype, in which glutamine consumption is upregulated relative to healthy cells.  This metabolic reprogramming often depends upon mitochondrial glutaminase activity, which converts glutamine to glutamate, a key precursor for biosynthetic and bioenergetic processes.  Two isoenzymes of glutaminase exist, a kidney-type (GLS) and a liver-type enzyme (GLS2 or LGA).  While a majority of studies have focused on GLS, here we summarize key findings on both glutaminases, describing their structure and function, their roles in cancer and pharmacol. approaches to inhibiting their activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTYjzSACf4q7Vg90H21EOLACvtfcHk0lhVjmYC5AFroA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWnur4%253D&md5=6b4bd6dfe8d18402f41bd420c25974b2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0190%26sid%3Dliteratum%253Aachs%26aulast%3DKatt%26aufirst%3DW.%2BP.%26aulast%3DLukey%26aufirst%3DM.%2BJ.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DA%2520tale%2520of%2520two%2520glutaminases%253A%2520homologous%2520enzymes%2520with%2520distinct%2520roles%2520in%2520tumorigenesis%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26issue%3D2%26spage%3D223%26epage%3D243%26doi%3D10.4155%2Ffmc-2016-0190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Stalnecker, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBerardinis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerione, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. W.</span><span> </span><span class="NLM_article-title">Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">394</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span><span class="refDoi"> DOI: 10.1073/pnas.1414056112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1073%2Fpnas.1414056112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=394-399&issue=2&author=C.+A.+Stalneckerauthor=S.+M.+Ulrichauthor=Y.+Liauthor=S.+Ramachandranauthor=M.+K.+McBrayerauthor=R.+J.+DeBerardinisauthor=R.+A.+Cerioneauthor=J.+W.+Erickson&title=Mechanism+by+which+a+recently+discovered+allosteric+inhibitor+blocks+glutamine+metabolism+in+transformed+cells&doi=10.1073%2Fpnas.1414056112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1414056112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1414056112%26sid%3Dliteratum%253Aachs%26aulast%3DStalnecker%26aufirst%3DC.%2BA.%26aulast%3DUlrich%26aufirst%3DS.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DMcBrayer%26aufirst%3DM.%2BK.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26atitle%3DMechanism%2520by%2520which%2520a%2520recently%2520discovered%2520allosteric%2520inhibitor%2520blocks%2520glutamine%2520metabolism%2520in%2520transformed%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26issue%3D2%26spage%3D394%26epage%3D399%26doi%3D10.1073%2Fpnas.1414056112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Tacar, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriamornsak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dass, C. R.</span><span> </span><span class="NLM_article-title">Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1111/j.2042-7158.2012.01567.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1111%2Fj.2042-7158.2012.01567.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=23278683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslGitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=157-170&issue=2&author=O.+Tacarauthor=P.+Sriamornsakauthor=C.+R.+Dass&title=Doxorubicin%3A+an+update+on+anticancer+molecular+action%2C+toxicity+and+novel+drug+delivery+systems&doi=10.1111%2Fj.2042-7158.2012.01567.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems</span></div><div class="casAuthors">Tacar, Oktay; Sriamornsak, Pornsak; Dass, Crispin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-170</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Objectives The frontline drug doxorubicin has been used for treating cancer for over 30 years.  While providing a cure in select cases, doxorubicin causes toxicity to most major organs, esp. life-threatening cardiotoxicity, which forces the treatment to become dose-limiting.  Key findings Doxorubicin is known to bind to DNA-assocd. enzymes, intercalate with DNA base pairs, and target multiple mol. targets to produce a range of cytotoxic effects.  For instance, it causes the activation of various mol. signals from AMPK (AMP-activated protein kinase inducing apoptosis) to influence the Bcl-2/Bax apoptosis pathway.  By altering the Bcl-2/Bax ratio, downstream activation of different caspases can occur resulting in apoptosis.  Doxorubicin also induces apoptosis and necrosis in healthy tissue causing toxicity in the brain, liver, kidney and heart.  Over the years, many studies have been conducted to devise a drug delivery system that would eliminate these adverse affects including liposomes, hydrogel and nanoparticulate systems, and we highlight the pros and cons of these drug delivery systems.  Summary Overall the future for the continued use of doxorubicin clin. against cancer looks set to be prolonged, provided certain enhancements as listed above are made to its chem., delivery and toxicity.  Increased efficacy depends on these three aims being met satisfactorily as discussed in turn in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ULJ-J2uxgrVg90H21EOLACvtfcHk0lhVjmYC5AFroA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslGitb4%253D&md5=fca40d4f8ee61dcdd6216a694cf44548</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.2012.01567.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.2012.01567.x%26sid%3Dliteratum%253Aachs%26aulast%3DTacar%26aufirst%3DO.%26aulast%3DSriamornsak%26aufirst%3DP.%26aulast%3DDass%26aufirst%3DC.%2BR.%26atitle%3DDoxorubicin%253A%2520an%2520update%2520on%2520anticancer%2520molecular%2520action%252C%2520toxicity%2520and%2520novel%2520drug%2520delivery%2520systems%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D65%26issue%3D2%26spage%3D157%26epage%3D170%26doi%3D10.1111%2Fj.2042-7158.2012.01567.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Wright, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadayyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bopst, M.</span><span> </span><span class="NLM_article-title">Minireview: Challenges and opportunities in development of PPAR agonists</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1756</span><span class="NLM_x">–</span> <span class="NLM_lpage">1768</span><span class="refDoi"> DOI: 10.1210/me.2013-1427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1210%2Fme.2013-1427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=25148456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFamtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1756-1768&issue=11&author=M.+B.+Wrightauthor=M.+Bortoliniauthor=M.+Tadayyonauthor=M.+Bopst&title=Minireview%3A+Challenges+and+opportunities+in+development+of+PPAR+agonists&doi=10.1210%2Fme.2013-1427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Minireview: challenges and opportunities in development of PPAR agonists</span></div><div class="casAuthors">Wright, Matthew B.; Bortolini, Michele; Tadayyon, Moh; Bopst, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1756-1768, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">1944-9917</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  The clin. impact of the fibrate and thiazolidinedione drugs on dyslipidemia and diabetes is driven mainly through activation of two transcription factors, peroxisome proliferator-activated receptors (PPAR)-α and PPAR-γ.  However, substantial differences exist in the therapeutic and side-effect profiles of specific drugs.  This has been attributed primarily to the complexity of drug-target complexes that involve many coregulatory proteins in the context of specific target gene promoters.  Recent data have revealed that some PPAR ligands interact with other non-PPAR targets.  Here we review concepts used to develop new agents that preferentially modulate transcriptional complex assembly, target more than one PPAR receptor simultaneously, or act as partial agonists.  We highlight newly described on-target mechanisms of PPAR regulation including phosphorylation and nongenomic regulation.  We briefly describe the recently discovered non-PPAR protein targets of thiazolidinediones, mitoNEET, and mTOT.  Finally, we summarize the contributions of on- and off-target actions to select therapeutic and side effects of PPAR ligands including insulin sensitivity, cardiovascular actions, inflammation, and carcinogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgR2Bsq_zCDbVg90H21EOLACvtfcHk0lib6cQ4L10tiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFamtbY%253D&md5=9f52aab240185e1adf107feb7aa520a7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1210%2Fme.2013-1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2013-1427%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%2BB.%26aulast%3DBortolini%26aufirst%3DM.%26aulast%3DTadayyon%26aufirst%3DM.%26aulast%3DBopst%26aufirst%3DM.%26atitle%3DMinireview%253A%2520Challenges%2520and%2520opportunities%2520in%2520development%2520of%2520PPAR%2520agonists%26jtitle%3DMol.%2520Endocrinol.%26date%3D2014%26volume%3D28%26issue%3D11%26spage%3D1756%26epage%3D1768%26doi%3D10.1210%2Fme.2013-1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&issue=7&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lib6cQ4L10tiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D7%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Chen, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueng, S. H.</span><span> </span><span class="NLM_article-title">Discovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-Tetrahydro-1-Isoquinolinylmethyl)benzamides as novel opioid receptor agonists</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2Fj.ejmech.2016.09.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&pages=202-217&author=S.+R.+Chenauthor=Y.+Y.+Keauthor=T.+K.+Yehauthor=S.+Y.+Linauthor=L.+C.+Ouauthor=S.+C.+Chenauthor=W.+T.+Changauthor=H.+F.+Changauthor=Z.+H.+Wuauthor=C.+C.+Hsiehauthor=P.+Y.+Lawauthor=H.+H.+Lohauthor=C.+Shihauthor=Y.+K.+Laiauthor=S.+H.+Yehauthor=S.+H.+Ueng&title=Discovery%2C+structure-activity+relationship+studies%2C+and+anti-nociceptive+effects+of+N-%281%2C2%2C3%2C4-Tetrahydro-1-Isoquinolinylmethyl%29benzamides+as+novel+opioid+receptor+agonists&doi=10.1016%2Fj.ejmech.2016.09.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%2BR.%26aulast%3DKe%26aufirst%3DY.%2BY.%26aulast%3DYeh%26aufirst%3DT.%2BK.%26aulast%3DLin%26aufirst%3DS.%2BY.%26aulast%3DOu%26aufirst%3DL.%2BC.%26aulast%3DChen%26aufirst%3DS.%2BC.%26aulast%3DChang%26aufirst%3DW.%2BT.%26aulast%3DChang%26aufirst%3DH.%2BF.%26aulast%3DWu%26aufirst%3DZ.%2BH.%26aulast%3DHsieh%26aufirst%3DC.%2BC.%26aulast%3DLaw%26aufirst%3DP.%2BY.%26aulast%3DLoh%26aufirst%3DH.%2BH.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DLai%26aufirst%3DY.%2BK.%26aulast%3DYeh%26aufirst%3DS.%2BH.%26aulast%3DUeng%26aufirst%3DS.%2BH.%26atitle%3DDiscovery%252C%2520structure-activity%2520relationship%2520studies%252C%2520and%2520anti-nociceptive%2520effects%2520of%2520N-%25281%252C2%252C3%252C4-Tetrahydro-1-Isoquinolinylmethyl%2529benzamides%2520as%2520novel%2520opioid%2520receptor%2520agonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D126%26spage%3D202%26epage%3D217%26doi%3D10.1016%2Fj.ejmech.2016.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kenny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curthoys, N. P.</span><span> </span><span class="NLM_article-title">Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1016/S1046-5928(03)00161-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2FS1046-5928%2803%2900161-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=12963351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=140-148&issue=1&author=J.+Kennyauthor=Y.+Baoauthor=B.+Hammauthor=L.+Taylorauthor=A.+Tothauthor=B.+Wagersauthor=N.+P.+Curthoys&title=Bacterial+expression%2C+purification%2C+and+characterization+of+rat+kidney-type+mitochondrial+glutaminase&doi=10.1016%2FS1046-5928%2803%2900161-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase</span></div><div class="casAuthors">Kenny, John; Bao, Yuhne; Hamm, Brian; Taylor, Lynn; Toth, Ann; Wagers, Brian; Curthoys, Norman P.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The human gene that encodes kidney-type glutaminase (KGA) spans 84-kb, contains 19 exons, and encodes 2 alternatively spliced mRNAs.  Here, various segments of rat KGA cDNA were PCR amplified and cloned into a bacterial expression vector and expressed in Escherichia coli to det. whether the N- and C- terminal ends of the glutaminase protein were essential for activity.  A recombinant glutaminase, lacking the coding sequence contained in exon 1, was found to be fully active.  In contrast, proteins that lacked sequences from exons 1 and 2 and exons 1-3 were inactive.  An addnl. construct that corresponded to the sequence encoded by exons 2-14 also retained full activity.  Both of the fully active, truncated proteins were purified to apparent homogeneity using an incorporated N-terminal His6-tag and Ni2+-affinity chromatog.  The Km values for glutamine of the native and recombinant forms of glutaminase were nearly identical.  However, the 2 truncated forms of glutaminase exhibited the characteristic phosphate activation profile only when dialyzed into a buffer lacking phosphate.  Dialysis vs. 10 mM Tris-phosphate was sufficient to form an active tetramer.  Thus, the deleted N-terminal sequence may contribute to the phosphate-dependent oligomerization and activation of the native glutaminase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDLrJrBVieI7Vg90H21EOLACvtfcHk0lhLwH_HroWdOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGkt7s%253D&md5=f7e79be9442292154cbd86c162af53d3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS1046-5928%2803%2900161-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1046-5928%252803%252900161-X%26sid%3Dliteratum%253Aachs%26aulast%3DKenny%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DY.%26aulast%3DHamm%26aufirst%3DB.%26aulast%3DTaylor%26aufirst%3DL.%26aulast%3DToth%26aufirst%3DA.%26aulast%3DWagers%26aufirst%3DB.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DBacterial%2520expression%252C%2520purification%252C%2520and%2520characterization%2520of%2520rat%2520kidney-type%2520mitochondrial%2520glutaminase%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2003%26volume%3D31%26issue%3D1%26spage%3D140%26epage%3D148%26doi%3D10.1016%2FS1046-5928%2803%2900161-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Robinson, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBryant, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraris, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curthoys, N. P.</span><span> </span><span class="NLM_article-title">Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">406</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span><span class="refDoi"> DOI: 10.1042/BJ20070039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1042%2FBJ20070039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2007&pages=407-414&issue=3&author=M.+M.+Robinsonauthor=S.+J.+McBryantauthor=T.+Tsukamotoauthor=C.+Rojasauthor=D.+V.+Ferrarisauthor=S.+K.+Hamiltonauthor=J.+C.+Hansenauthor=N.+P.+Curthoys&title=Novel+mechanism+of+inhibition+of+rat+kidney-type+glutaminase+by+bis-2-%285-phenylacetamido-1%2C2%2C4-thiadiazol-2-yl%29ethyl+sulfide+%28BPTES%29&doi=10.1042%2FBJ20070039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1042%2FBJ20070039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070039%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DM.%2BM.%26aulast%3DMcBryant%26aufirst%3DS.%2BJ.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DFerraris%26aufirst%3DD.%2BV.%26aulast%3DHamilton%26aufirst%3DS.%2BK.%26aulast%3DHansen%26aufirst%3DJ.%2BC.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DNovel%2520mechanism%2520of%2520inhibition%2520of%2520rat%2520kidney-type%2520glutaminase%2520by%2520bis-2-%25285-phenylacetamido-1%252C2%252C4-thiadiazol-2-yl%2529ethyl%2520sulfide%2520%2528BPTES%2529%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D406%26issue%3D3%26spage%3D407%26epage%3D414%26doi%3D10.1042%2FBJ20070039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Brooks, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, C. L.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackerell, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archontis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartels, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boresch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caves, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinner, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodoscek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuczera, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazaridis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovchinnikov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venable, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodcock, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">York, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karplus, M.</span><span> </span><span class="NLM_article-title">CHARMM: the biomolecular simulation program</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">30</span><span class="NLM_x">) </span> <span class="NLM_fpage">1545</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span><span class="refDoi"> DOI: 10.1002/jcc.21287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1002%2Fjcc.21287" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1545-1564&issue=30&author=B.+R.+Brooksauthor=C.+L.+Brooksauthor=A.+D.+Mackerellauthor=L.+Nilssonauthor=R.+J.+Petrellaauthor=B.+Rouxauthor=Y.+Wonauthor=G.+Archontisauthor=C.+Bartelsauthor=S.+Boreschauthor=A.+Caflischauthor=L.+Cavesauthor=Q.+Cuiauthor=A.+R.+Dinnerauthor=M.+Feigauthor=S.+Fischerauthor=J.+Gaoauthor=M.+Hodoscekauthor=W.+Imauthor=K.+Kuczeraauthor=T.+Lazaridisauthor=J.+Maauthor=V.+Ovchinnikovauthor=E.+Paciauthor=R.+W.+Pastorauthor=C.+B.+Postauthor=J.+Z.+Puauthor=M.+Schaeferauthor=B.+Tidorauthor=R.+M.+Venableauthor=H.+L.+Woodcockauthor=X.+Wuauthor=W.+Yangauthor=D.+M.+Yorkauthor=M.+Karplus&title=CHARMM%3A+the+biomolecular+simulation+program&doi=10.1002%2Fjcc.21287"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21287%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26aulast%3DBrooks%26aufirst%3DC.%2BL.%26aulast%3DMackerell%26aufirst%3DA.%2BD.%26aulast%3DNilsson%26aufirst%3DL.%26aulast%3DPetrella%26aufirst%3DR.%2BJ.%26aulast%3DRoux%26aufirst%3DB.%26aulast%3DWon%26aufirst%3DY.%26aulast%3DArchontis%26aufirst%3DG.%26aulast%3DBartels%26aufirst%3DC.%26aulast%3DBoresch%26aufirst%3DS.%26aulast%3DCaflisch%26aufirst%3DA.%26aulast%3DCaves%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DQ.%26aulast%3DDinner%26aufirst%3DA.%2BR.%26aulast%3DFeig%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHodoscek%26aufirst%3DM.%26aulast%3DIm%26aufirst%3DW.%26aulast%3DKuczera%26aufirst%3DK.%26aulast%3DLazaridis%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DOvchinnikov%26aufirst%3DV.%26aulast%3DPaci%26aufirst%3DE.%26aulast%3DPastor%26aufirst%3DR.%2BW.%26aulast%3DPost%26aufirst%3DC.%2BB.%26aulast%3DPu%26aufirst%3DJ.%2BZ.%26aulast%3DSchaefer%26aufirst%3DM.%26aulast%3DTidor%26aufirst%3DB.%26aulast%3DVenable%26aufirst%3DR.%2BM.%26aulast%3DWoodcock%26aufirst%3DH.%2BL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYork%26aufirst%3DD.%2BM.%26aulast%3DKarplus%26aufirst%3DM.%26atitle%3DCHARMM%253A%2520the%2520biomolecular%2520simulation%2520program%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26issue%3D30%26spage%3D1545%26epage%3D1564%26doi%3D10.1002%2Fjcc.21287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Chou, T. C.</span><span> </span><span class="NLM_article-title">Drug combination studies and their synergy quantification using the Chou-Talalay method</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-1947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1158%2F0008-5472.CAN-09-1947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=20068163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=440-446&issue=2&author=T.+C.+Chou&title=Drug+combination+studies+and+their+synergy+quantification+using+the+Chou-Talalay+method&doi=10.1158%2F0008-5472.CAN-09-1947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method</span></div><div class="casAuthors">Chou, Ting-Chao</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">440-446</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  This brief perspective article focuses on the most common errors and pitfalls, as well as the do's and don'ts in drug combination studies, in terms of exptl. design, data acquisition, data interpretation, and computerized simulation.  The Chou-Talalay method for drug combination is based on the median-effect equation, derived from the mass-action law principle, which is the unified theory that provides the common link between single entity and multiple entities, and first order and higher order dynamics.  This general equation encompasses the Michaelis-Menten, Hill, Henderson-Hasselbalch, and Scatchard equations in biochem. and biophysics.  The resulting combination index (CI) theorem of Chou-Talalay offers quant. definition for additive effect (CI = 1), synergism (CI < 1), and antagonism (CI > 1) in drug combinations.  This theory also provides algorithms for automated computer simulation for synergism and/or antagonism at any effect and dose level, as shown in the CI plot and isobologram, resp.  Cancer Res; 70(2); 440-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpECUlVzkYExbVg90H21EOLACvtfcHk0lhLwH_HroWdOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWksA%253D%253D&md5=d0713e60852fc656bc91719ccb27eb1a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-1947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-1947%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26atitle%3DDrug%2520combination%2520studies%2520and%2520their%2520synergy%2520quantification%2520using%2520the%2520Chou-Talalay%2520method%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D2%26spage%3D440%26epage%3D446%26doi%3D10.1158%2F0008-5472.CAN-09-1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xi Xu, Zijian Kuang, Jie Han, Ying Meng, Lei Li, Hongyu Luan, Pengfei Xu, Jubo Wang, Cheng Luo, Hong Ding, Zhiyu Li, <span class="NLM_string-name hlFld-ContribAuthor">Jinlei Bian</span>. </span><span class="cited-content_cbyCitation_article-title">Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9642-9657. <a href="https://doi.org/10.1021/acs.jmedchem.9b01035" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01035%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252BCharacterization%252Bof%252Ba%252BFluorescent%252BProbe%252Bfor%252BGLS1%252Band%252Bthe%252BApplication%252Bfor%252BHigh-Throughput%252BScreening%252Bof%252BAllosteric%252BInhibitors%26aulast%3DXu%26aufirst%3DXi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D03072019%26date%3D24102019%26date%3D11102019%26volume%3D62%26issue%3D21%26spage%3D9642%26epage%3D9657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xi Xu, Ying Meng, Lei Li, Pengfei Xu, Jubo Wang, Zhiyu Li, <span class="NLM_string-name hlFld-ContribAuthor">Jinlei Bian</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1096-1115. <a href="https://doi.org/10.1021/acs.jmedchem.8b00961" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00961</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00961%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252Bthe%252BDevelopment%252Bof%252BGlutaminase%252BInhibitors%25253A%252BAchievements%252Band%252BFuture%252BDirections%26aulast%3DXu%26aufirst%3DXi%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D15062018%26date%3D07092018%26date%3D27082018%26volume%3D62%26issue%3D3%26spage%3D1096%26epage%3D1115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jennifer Jin Ruan, Yan Yu, Wei Hou, Zhao Chen, Jinzhang Fang, Jingjing Zhang, Muowei Ni, Di Li, Shiying Lu, Jingjing Rui, Rui Wu, Wei Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Benfang Helen Ruan</span>. </span><span class="cited-content_cbyCitation_article-title">Kidney-Type Glutaminase Inhibitor Hexylselen Selectively Kills Cancer Cells via a Three-Pronged Mechanism. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2019,</strong> <em>2 </em>
                                    (1)
                                     , 18-30. <a href="https://doi.org/10.1021/acsptsci.8b00047" title="DOI URL">https://doi.org/10.1021/acsptsci.8b00047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.8b00047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.8b00047%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DKidney-Type%252BGlutaminase%252BInhibitor%252BHexylselen%252BSelectively%252BKills%252BCancer%252BCells%252Bvia%252Ba%252BThree-Pronged%252BMechanism%26aulast%3DRuan%26aufirst%3DJennifer%2BJin%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D05112018%26date%3D23012019%26date%3D11012019%26volume%3D2%26issue%3D1%26spage%3D18%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhao Chen, Di Li, Ning Xu, Jinzhang Fang, Yan Yu, Wei Hou, Haoqiang Ruan, Panpan Zhu, Renchao Ma, Shiying Lu, Danhui Cao, Rui Wu, Mowei Ni, Wei Zhang, Weike Su, <span class="NLM_string-name hlFld-ContribAuthor">Benfang Helen Ruan</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 589-603. <a href="https://doi.org/10.1021/acs.jmedchem.8b01198" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01198%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B1%25252C3%25252C4-Selenadiazole-Containing%252BKidney-Type%252BGlutaminase%252BInhibitors%252BShowed%252BImproved%252BCellular%252BUptake%252Band%252BAntitumor%252BActivity%26aulast%3DChen%26aufirst%3DZhao%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D30072018%26date%3D31122018%26date%3D13122018%26volume%3D62%26issue%3D2%26spage%3D589%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sarah
C. Zimmermann, Bridget Duvall, <span class="NLM_string-name hlFld-ContribAuthor">Takashi Tsukamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 46-59. <a href="https://doi.org/10.1021/acs.jmedchem.8b00327" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00327%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BDiscovery%252Bof%252BAllosteric%252BInhibitors%252Bof%252BKidney-Type%252BGlutaminase%26aulast%3DZimmermann%26aufirst%3DSarah%2BC.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D27022018%26date%3D03072018%26volume%3D62%26issue%3D1%26spage%3D46%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">YoungJun  Ju</span>, <span class="hlFld-ContribAuthor ">Yaacov  Ben-David</span>, <span class="hlFld-ContribAuthor ">Daniela  Rotin</span>, <span class="hlFld-ContribAuthor ">Eldad  Zacksenhaus</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-88816-1" title="DOI URL">https://doi.org/10.1038/s41598-021-88816-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-88816-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-88816-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DInhibition%252Bof%252BeEF2K%252Bsynergizes%252Bwith%252Bglutaminase%252Binhibitors%252Bor%252B4EBP1%252Bdepletion%252Bto%252Bsuppress%252Bgrowth%252Bof%252Btriple-negative%252Bbreast%252Bcancer%252Bcells%26aulast%3DJu%26aufirst%3DYoungJun%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dinesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Vamsi Krishna  Kommalapati</span>, <span class="hlFld-ContribAuthor ">Mahesh Kumar  Jerald</span>, <span class="hlFld-ContribAuthor ">Anjana Devi  Tangutur</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorinated thiazolidinol drives autophagic cell death in pancreatic cancer cells via AMPK activation and perturbation of critical sentinels of oncogenic signaling. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2021,</strong> <em>343 </em>, 109433. <a href="https://doi.org/10.1016/j.cbi.2021.109433" title="DOI URL">https://doi.org/10.1016/j.cbi.2021.109433</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2021.109433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2021.109433%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DFluorinated%252Bthiazolidinol%252Bdrives%252Bautophagic%252Bcell%252Bdeath%252Bin%252Bpancreatic%252Bcancer%252Bcells%252Bvia%252BAMPK%252Bactivation%252Band%252Bperturbation%252Bof%252Bcritical%252Bsentinels%252Bof%252Boncogenic%252Bsignaling%26aulast%3DKumar%26aufirst%3DDinesh%26date%3D2021%26volume%3D343%26spage%3D109433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wu-Xi  Zhou</span>, <span class="hlFld-ContribAuthor ">Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao-Qin  Liu</span>, <span class="hlFld-ContribAuthor ">Ying  Li</span>, <span class="hlFld-ContribAuthor ">Yao-Lan  Lin</span>, <span class="hlFld-ContribAuthor ">Xiu-Tao  Wu</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Jian-Guang  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of withangulatin A derivatives as novel glutaminase 1 inhibitors for the treatment of triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112980. <a href="https://doi.org/10.1016/j.ejmech.2020.112980" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112980</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112980%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bwithangulatin%252BA%252Bderivatives%252Bas%252Bnovel%252Bglutaminase%252B1%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DZhou%26aufirst%3DWu-Xi%26date%3D2021%26volume%3D210%26spage%3D112980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhefang  Wang</span>, <span class="hlFld-ContribAuthor ">Fanyu  Liu</span>, <span class="hlFld-ContribAuthor ">Ningbo  Fan</span>, <span class="hlFld-ContribAuthor ">Chenghui  Zhou</span>, <span class="hlFld-ContribAuthor ">Dai  Li</span>, <span class="hlFld-ContribAuthor ">Thomas  Macvicar</span>, <span class="hlFld-ContribAuthor ">Qiongzhu  Dong</span>, <span class="hlFld-ContribAuthor ">Christiane J.  Bruns</span>, <span class="hlFld-ContribAuthor ">Yue  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.589508" title="DOI URL">https://doi.org/10.3389/fonc.2020.589508</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.589508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.589508%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DTargeting%252BGlutaminolysis%25253A%252BNew%252BPerspectives%252Bto%252BUnderstand%252BCancer%252BDevelopment%252Band%252BNovel%252BStrategies%252Bfor%252BPotential%252BTarget%252BTherapies%26aulast%3DWang%26aufirst%3DZhefang%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José M.  Matés</span>, <span class="hlFld-ContribAuthor ">José A.  Campos-Sandoval</span>, <span class="hlFld-ContribAuthor ">Juan  de los Santos-Jiménez</span>, <span class="hlFld-ContribAuthor ">Juan A.  Segura</span>, <span class="hlFld-ContribAuthor ">Francisco J.  Alonso</span>, <span class="hlFld-ContribAuthor ">Javier  Márquez</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Reprogramming of Cancer by Chemicals that Target Glutaminase Isoenzymes. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (32)
                                     , 5317-5339. <a href="https://doi.org/10.2174/0929867326666190416165004" title="DOI URL">https://doi.org/10.2174/0929867326666190416165004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867326666190416165004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867326666190416165004%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DMetabolic%252BReprogramming%252Bof%252BCancer%252Bby%252BChemicals%252Bthat%252BTarget%252BGlutaminase%252BIsoenzymes%26aulast%3DMat%25C3%25A9s%26aufirst%3DJos%25C3%25A9%2BM.%26date%3D2020%26volume%3D27%26issue%3D32%26spage%3D5317%26epage%3D5339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nusrat  Sahiba</span>, <span class="hlFld-ContribAuthor ">Ayushi  Sethiya</span>, <span class="hlFld-ContribAuthor ">Jay  Soni</span>, <span class="hlFld-ContribAuthor ">Dinesh K.  Agarwal</span>, <span class="hlFld-ContribAuthor ">Shikha  Agarwal</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated Five-Membered Thiazolidines and Their Derivatives: From Synthesis to Biological Applications. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2020,</strong> <em>378 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s41061-020-0298-4" title="DOI URL">https://doi.org/10.1007/s41061-020-0298-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-020-0298-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-020-0298-4%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DSaturated%252BFive-Membered%252BThiazolidines%252Band%252BTheir%252BDerivatives%25253A%252BFrom%252BSynthesis%252Bto%252BBiological%252BApplications%26aulast%3DSahiba%26aufirst%3DNusrat%26date%3D2020%26date%3D2020%26volume%3D378%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vijay Kumar  Sharma</span>, <span class="hlFld-ContribAuthor ">Anup  Barde</span>, <span class="hlFld-ContribAuthor ">Sunita  Rattan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Characterization of Pyrimidine based Thiazolidinedione Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Chemistry</span><span> <strong>2020,</strong> <em>32 </em>
                                    (5)
                                     , 1101-1108. <a href="https://doi.org/10.14233/ajchem.2020.22565" title="DOI URL">https://doi.org/10.14233/ajchem.2020.22565</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14233/ajchem.2020.22565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14233%2Fajchem.2020.22565%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BCharacterization%252Bof%252BPyrimidine%252Bbased%252BThiazolidinedione%252BDerivatives%26aulast%3DSharma%26aufirst%3DVijay%2BKumar%26date%3D2020%26date%3D2020%26volume%3D32%26issue%3D5%26spage%3D1101%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José M.  Matés</span>, <span class="hlFld-ContribAuthor ">José A.  Campos-Sandoval</span>, <span class="hlFld-ContribAuthor ">Juan de los  Santos-Jiménez</span>, <span class="hlFld-ContribAuthor ">Javier  Márquez</span>. </span><span class="cited-content_cbyCitation_article-title">Dysregulation of glutaminase and glutamine synthetase in cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2019,</strong> <em>467 </em>, 29-39. <a href="https://doi.org/10.1016/j.canlet.2019.09.011" title="DOI URL">https://doi.org/10.1016/j.canlet.2019.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2019.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2019.09.011%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DDysregulation%252Bof%252Bglutaminase%252Band%252Bglutamine%252Bsynthetase%252Bin%252Bcancer%26aulast%3DMat%25C3%25A9s%26aufirst%3DJos%25C3%25A9%2BM.%26date%3D2019%26volume%3D467%26spage%3D29%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Hou</span>, <span class="hlFld-ContribAuthor ">Jinzhang  Fang</span>, <span class="hlFld-ContribAuthor ">Lin  Su</span>, <span class="hlFld-ContribAuthor ">Hengyu  Ye</span>, <span class="hlFld-ContribAuthor ">Benfang Helen  Ruan</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of biotinylated Hexylselen as a probe to identify KGA allosteric inhibitors by a convenient biomolecular interaction assay. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (17)
                                     , 2498-2502. <a href="https://doi.org/10.1016/j.bmcl.2019.07.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bbiotinylated%252BHexylselen%252Bas%252Ba%252Bprobe%252Bto%252Bidentify%252BKGA%252Ballosteric%252Binhibitors%252Bby%252Ba%252Bconvenient%252Bbiomolecular%252Binteraction%252Bassay%26aulast%3DHou%26aufirst%3DWei%26date%3D2019%26volume%3D29%26issue%3D17%26spage%3D2498%26epage%3D2502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Meng</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">Wenhao  Dai</span>, <span class="hlFld-ContribAuthor ">Xi  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoling  Bi</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and development of small molecule modulators targeting glutamine metabolism. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 215-242. <a href="https://doi.org/10.1016/j.ejmech.2018.11.066" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.066%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bdevelopment%252Bof%252Bsmall%252Bmolecule%252Bmodulators%252Btargeting%252Bglutamine%252Bmetabolism%26aulast%3DLi%26aufirst%3DLei%26date%3D2019%26volume%3D163%26spage%3D215%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José M.  Matés</span>, <span class="hlFld-ContribAuthor ">José A.  Campos-Sandoval</span>, <span class="hlFld-ContribAuthor ">Javier  Márquez</span>. </span><span class="cited-content_cbyCitation_article-title">Glutaminase isoenzymes in the metabolic therapy of cancer. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2018,</strong> <em>1870 </em>
                                    (2)
                                     , 158-164. <a href="https://doi.org/10.1016/j.bbcan.2018.07.007" title="DOI URL">https://doi.org/10.1016/j.bbcan.2018.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2018.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2018.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DGlutaminase%252Bisoenzymes%252Bin%252Bthe%252Bmetabolic%252Btherapy%252Bof%252Bcancer%26aulast%3DMat%25C3%25A9s%26aufirst%3DJos%25C3%25A9%2BM.%26date%3D2018%26volume%3D1870%26issue%3D2%26spage%3D158%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanaparthi  Satheesh</span>, <span class="hlFld-ContribAuthor ">Sundaravel Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Murugan  Vijay</span>, <span class="hlFld-ContribAuthor ">Debashis  Barik</span>, <span class="hlFld-ContribAuthor ">Tharmalingam  Punniyamurthy</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Free [3+2]-Cycloaddition of Thiiranes with Isothiocyanates, Isoselenocyanates and Carbodiimides: Synthesis of 2-Imino-Dithiolane/Thiaselenolane/Thiazolidines. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>7 </em>
                                    (8)
                                     , 1583-1586. <a href="https://doi.org/10.1002/ajoc.201800274" title="DOI URL">https://doi.org/10.1002/ajoc.201800274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201800274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201800274%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-Free%252B%25255B3%25252B2%25255D-Cycloaddition%252Bof%252BThiiranes%252Bwith%252BIsothiocyanates%25252C%252BIsoselenocyanates%252Band%252BCarbodiimides%25253A%252BSynthesis%252Bof%252B2-Imino-Dithiolane%25252FThiaselenolane%25252FThiazolidines%26aulast%3DSatheesh%26aufirst%3DVanaparthi%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D8%26spage%3D1583%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of a Series of Thiazolidine-2,4-dione Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TsOH<sub>(cat.)</sub>, toluene, reflux; (b) POCl<sub>3</sub>, DMF, rt; (c) thiazolidine-2,4-dione, piperidine<sub>(cat.)</sub>, AcOH<sub>(cat.)</sub>, toluene, reflux; (d) (4-formylphenyl)boronic acid or (3-ethyl-4-formylphenyl)boronic acid or (3-chloro-4-formylphenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4 (cat.)</sub>, Na<sub>2</sub>CO<sub>3(aq)</sub>, DME, EtOH, reflux; (e) BBr<sub>3</sub>, DCM, 0 °C. The percentage (%) following each set of R groups is the percent yield for that reaction.</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effects of glutaminase inhibitors, thiazolidine-2,4-dione derivatives, in inhibiting AsPC-1 cellular glutamate production and clonogenicity. Thiazolidine-2,4-dione derivatives inhibited colony formation of AsPC-1 (A) and diminished the cellular glutamate levels in both of AsPC-1<sup>WT</sup> (B, C) and AsPC-1<sup><i>GLS</i>–/–</sup> cells (C). The highly selective compound BPTES, which completely lost glutaminase inhibition in AsPC-1<sup><i>GLS</i>–/–</sup> cells, was used as reference compound control. The cells treated with thiazolidine-2,4-dione derivatives or the reference compound BPTES were subjected to assays for glutamates levels or clonogenicity as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Shown are the mean ± SD from three independent experiments, each in duplicate for (B) and (C): (∗∗) <i>P</i> < 0.01, (∗∗∗) <i>P</i> < 0.001 versus vehicle treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. In vivo antitumoral efficacy of GA inhibitors in AsPC-1 xenograft tumor model. (A) BPTES and compound <b>5</b>: AsPC-1 bearing mice were sorted into four groups. Group 1 mice received vehicle (2% DMSO/PBS), group 2 mice received BPTES at 25 mg/kg, groups 3 and 4 mice received compound <b>5</b> at 25 and 50 mg/kg through intraperitoneal (ip) injection, respectively, once daily on 5 on/2 off (5 days on and then 2 days off) schedule for the entire period of observation. (B) Compound <b>6</b>: AsPC-1 bearing mice were sorted into 3 groups. Group 1 mice received vehicle (2% DMSO/PBS), and groups 2 and 3 received compound <b>6</b> at 25 and 50 mg/kg through ip injection, respectively, once daily on 5 on/2 off schedule for the entire period of observation. % TGI was determined for antitumor effects which are expressed as [1 – ((<i>T<sub>t</sub></i> – <i>T</i><sub>0</sub>)/(<i>C<sub>t</sub></i> – <i>C</i><sub>0</sub>))] × 100 where <i>T<sub>t</sub></i> = median tumor volume of treated at time <i>t</i>, <i>T</i><sub>0</sub> = median tumor volume of treated at time 0, <i>C<sub>t</sub></i> = median tumor volume of control at time <i>t</i>, and <i>C</i><sub>0</sub> = median tumor volume of control at time 0. “<i>t</i>” is indicated as day 43 for (A) and day 68 for (B) in this study. Statistical significance was established at <i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Assignment of the KGA binding site of thiazolidine-2,4-dione derived glutaminase inhibitors. (A) Docking simulation of the compound <b>5</b> binding site in KGA. Shown were the alkyl to alkyl and alkyl to π hydrophobic bonding interactions (in blue dashed lines) of compound <b>5</b> (highlighted in cyan) with the residue Arg 387, which is located in the substrate binding pocket and highlighted in orange, of KGA in the best docked pose. The best docked pose was determined based on the results from site-directed mutagenesis (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) and the molecular modeling and docking studies, which were conducted using the human GLS1 crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9">3UO9</a>) and the BIOVIA/LigandFit program (BIOVIA, Inc., San Diego, CA) with the CHARMM force field.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The residues (Ser 286, Glu 381, Asn 335, and Tyr 414) involved in substrate glutamine binding site of KGA<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> were highlighted in yellow. Those residues, Ser 384 and Lys 507, which did not show interaction with the thiazolidine-2,4-dione derived glutaminase inhibitors as demonstrated by site-directed mutagenesis (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), were highlighted in magenta and green, respectively. (B) Close look of the hydrophobic interactions between the side chain CH<sub>2</sub> of compound <b>5</b> and Arg 387. (C) Overview of the proposed association of compound <b>5</b> in a GA tetramer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition mode of thiazolidine-2,4-dione derived glutaminase inhibitors against KGA. (A) Glutamine saturation profiles for KGA at 0–0.4 μM of compound <b>5</b>. (B) Lineweaver–Burk double-reciprocal for KGA and compound <b>5</b>. (C) Data of <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> at different concentrations of compound <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/medium/jm-2017-00282t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Synergistic effects of combined treatments of GA inhibitors with doxorubicin or GA inhibitors at different binding sites in inhibition of carcinoma cell growth. AsPC-1 (A) and HCC1806 (B) cells were grown and treated with indicated compounds. Cell viabilities were assayed by MTS as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Combination index (CI) values at ED<sub>50</sub>, ED<sub>75</sub>, and ED<sub>90</sub> were calculated using Calcusyn software based on the Chou–Talalay method for drug combination<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf" class="ext-link">Supporting Information Table S1</a>. Combination index (CI) = 1 refers to additive effect, CI < 1 refers to synergism, and CI > 1 means antagonism. ED<sub>50</sub>, ED<sub>75</sub>, and ED<sub>90</sub> represent effective doses of 50%, 75%, and 90% inhibition, respectively. Results shown are representative of three independent experiments. The dashed line, isobologram of ED<sub>50</sub>, is drawn for clarity to define area for the additive effect, synergism, or antagonism. When the combination data point falls on the dashed line (CI = 1), an additive effect is suggested. When data point falls on the lower left area of the dashed line (CI < 1), a synergism is suggested, and if it falls on the upper right area (CI > 1), an antagonism is suggested. Data of two combinations for each experiment all fell on the lower left area in the isobologram indicating a synergism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00282/20170707/images/large/jm-2017-00282t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00282&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnihotri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, A.</span><span> </span><span class="NLM_article-title">Targeting metabolic remodeling in glioblastoma multiforme</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span><span class="refDoi"> DOI: 10.18632/oncotarget.190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.18632%2Foncotarget.190" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=552-562&issue=7&author=A.+Wolfauthor=S.+Agnihotriauthor=A.+Guha&title=Targeting+metabolic+remodeling+in+glioblastoma+multiforme&doi=10.18632%2Foncotarget.190"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.190%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DAgnihotri%26aufirst%3DS.%26aulast%3DGuha%26aufirst%3DA.%26atitle%3DTargeting%2520metabolic%2520remodeling%2520in%2520glioblastoma%2520multiforme%26jtitle%3DOncotarget%26date%3D2010%26volume%3D1%26issue%3D7%26spage%3D552%26epage%3D562%26doi%3D10.18632%2Foncotarget.190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Erickson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerione, R. A.</span><span> </span><span class="NLM_article-title">Glutaminase: a hot spot for regulation of cancer cell metabolism?</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">740</span><span class="refDoi"> DOI: 10.18632/oncotarget.208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.18632%2Foncotarget.208" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=734-740&issue=8&author=J.+W.+Ericksonauthor=R.+A.+Cerione&title=Glutaminase%3A+a+hot+spot+for+regulation+of+cancer+cell+metabolism%3F&doi=10.18632%2Foncotarget.208"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.208%26sid%3Dliteratum%253Aachs%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DGlutaminase%253A%2520a%2520hot%2520spot%2520for%2520regulation%2520of%2520cancer%2520cell%2520metabolism%253F%26jtitle%3DOncotarget%26date%3D2010%26volume%3D1%26issue%3D8%26spage%3D734%26epage%3D740%26doi%3D10.18632%2Foncotarget.208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Mates, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segura, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Rufian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos-Sandoval, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, J.</span><span> </span><span class="NLM_article-title">Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer</span> <span class="citation_source-journal">Curr. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">514</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span><span class="refDoi"> DOI: 10.2174/1566524011313040005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.2174%2F1566524011313040005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=22934847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFaht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=514-534&issue=4&author=J.+M.+Matesauthor=J.+A.+Seguraauthor=M.+Martin-Rufianauthor=J.+A.+Campos-Sandovalauthor=F.+J.+Alonsoauthor=J.+Marquez&title=Glutaminase+isoenzymes+as+key+regulators+in+metabolic+and+oxidative+stress+against+cancer&doi=10.2174%2F1566524011313040005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer</span></div><div class="casAuthors">Mates, J. M.; Segura, J. A.; Martin-Rufian, M.; Campos-Sandoval, J. A.; Alonso, F. J.; Marquez, J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">514-534</span>CODEN:
                <span class="NLM_cas:coden">CMMUBP</span>;
        ISSN:<span class="NLM_cas:issn">1566-5240</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer cells require a robust supply of reduced nitrogen to produce nucleotides, non-essential amino acids and a high cellular redox activity.  Glutamine provides a major substrate for respiration as well as nitrogen for the prodn. of proteins, hexosamines, and macromols.  Therefore, glutamine is one of key mols. in cancer metab. during cell proliferation.  The notion of targeting glutamine metab. in cancer, originally rationalized by the no. of pathways fed by this nutrient, has been reinforced by more recent studies demonstrating that its metab. is regulated by oncogenes.  Glutamine can exert its effects by modulating redox homeostasis, bioenergetics, nitrogen balance or other functions, including by being a precursor of glutathione, the major nonenzymic cellular antioxidant.  Glutaminase (GA) is the first enzyme that converts glutamine to glutamate, which is in turn converted to alpha-ketoglutarate for further metab. in the tricarboxylic acid cycle.  Different GA isoforms in mammals are encoded by two genes, Gls and Gls2.  As each enzymic form of GA has distinct kinetic and mol. characteristics, it has been speculated that the differential regulation of GA isoforms may reflect distinct functions or requirements in different tissues or cell states.  GA encoded by Gls gene (GLS) has been demonstrated to be regulated by oncogenes and to support tumor cell growth.  GA encoded by Gls2 gene (GLS2) reduces cellular sensitivity to reactive oxygen species-assocd. apoptosis possibly through glutathione-dependent antioxidant defense, and therefore to behave more like a tumor suppressor.  Thus, modulation of GA function may be a new therapeutic target for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzFF_1QmOq07Vg90H21EOLACvtfcHk0liLN2znzqQM-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFaht7o%253D&md5=ea6a31c453e00b30a2fb1a858915e105</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1566524011313040005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1566524011313040005%26sid%3Dliteratum%253Aachs%26aulast%3DMates%26aufirst%3DJ.%2BM.%26aulast%3DSegura%26aufirst%3DJ.%2BA.%26aulast%3DMartin-Rufian%26aufirst%3DM.%26aulast%3DCampos-Sandoval%26aufirst%3DJ.%2BA.%26aulast%3DAlonso%26aufirst%3DF.%2BJ.%26aulast%3DMarquez%26aufirst%3DJ.%26atitle%3DGlutaminase%2520isoenzymes%2520as%2520key%2520regulators%2520in%2520metabolic%2520and%2520oxidative%2520stress%2520against%2520cancer%26jtitle%3DCurr.%2520Mol.%2520Med.%26date%3D2013%26volume%3D13%26issue%3D4%26spage%3D514%26epage%3D534%26doi%3D10.2174%2F1566524011313040005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Le, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamaker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebler, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slebos, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorkiewicz, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1016/j.cmet.2011.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2Fj.cmet.2011.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=22225880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=110-121&issue=1&author=A.+Leauthor=A.+N.+Laneauthor=M.+Hamakerauthor=S.+Boseauthor=A.+Gouwauthor=J.+Barbiauthor=T.+Tsukamotoauthor=C.+J.+Rojasauthor=B.+S.+Slusherauthor=H.+Zhangauthor=L.+J.+Zimmermanauthor=D.+C.+Lieblerauthor=R.+J.+Slebosauthor=P.+K.+Lorkiewiczauthor=R.+M.+Higashiauthor=T.+W.+Fanauthor=C.+V.+Dang&title=Glucose-independent+glutamine+metabolism+via+TCA+cycling+for+proliferation+and+survival+in+B+cells&doi=10.1016%2Fj.cmet.2011.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells</span></div><div class="casAuthors">Le, Anne; Lane, Andrew N.; Hamaker, Max; Bose, Sminu; Gouw, Arvin; Barbi, Joseph; Tsukamoto, Takashi; Rojas, Camilio J.; Slusher, Barbara S.; Zhang, Haixia; Zimmerman, Lisa J.; Liebler, Daniel C.; Slebos, Robbert J. C.; Lorkiewicz, Pawel K.; Higashi, Richard M.; Fan, Teresa W. M.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-121</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Because MYC plays a causal role in many human cancers, including those with hypoxic and nutrient-poor tumor microenvironments, we have detd. the metabolic responses of a MYC-inducible human Burkitt lymphoma model P493 cell line to aerobic and hypoxic conditions, and to glucose deprivation, using stable isotope-resolved metabolomics.  Using [U-13C]-glucose as the tracer, both glucose consumption and lactate prodn. were increased by MYC expression and hypoxia.  Using [U-13C,15N]-glutamine as the tracer, glutamine import and metab. through the TCA cycle persisted under hypoxia, and glutamine contributed significantly to citrate Cs.  Under glucose deprivation, glutamine-derived fumarate, malate, and citrate were significantly increased.  Their 13C-labeling patterns demonstrate an alternative energy-generating glutaminolysis pathway involving a glucose-independent TCA cycle.  The essential role of glutamine metab. in cell survival and proliferation under hypoxia and glucose deficiency makes them susceptible to the glutaminase inhibitor BPTES and hence could be targeted for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxz5K5YyvT6rVg90H21EOLACvtfcHk0lj1NB2eH7cRTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2nsg%253D%253D&md5=0e71d2f1fff5795ba1d22afc8a2fefae</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DA.%2BN.%26aulast%3DHamaker%26aufirst%3DM.%26aulast%3DBose%26aufirst%3DS.%26aulast%3DGouw%26aufirst%3DA.%26aulast%3DBarbi%26aufirst%3DJ.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DRojas%26aufirst%3DC.%2BJ.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZimmerman%26aufirst%3DL.%2BJ.%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26aulast%3DSlebos%26aufirst%3DR.%2BJ.%26aulast%3DLorkiewicz%26aufirst%3DP.%2BK.%26aulast%3DHigashi%26aufirst%3DR.%2BM.%26aulast%3DFan%26aufirst%3DT.%2BW.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DGlucose-independent%2520glutamine%2520metabolism%2520via%2520TCA%2520cycling%2520for%2520proliferation%2520and%2520survival%2520in%2520B%2520cells%26jtitle%3DCell%2520Metab.%26date%3D2012%26volume%3D15%26issue%3D1%26spage%3D110%26epage%3D121%26doi%3D10.1016%2Fj.cmet.2011.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Katt, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerione, R. A.</span><span> </span><span class="NLM_article-title">Glutaminase regulation in cancer cells: a druggable chain of events</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span><span class="refDoi"> DOI: 10.1016/j.drudis.2013.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2Fj.drudis.2013.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=24140288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSls7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=450-457&issue=4&author=W.+P.+Kattauthor=R.+A.+Cerione&title=Glutaminase+regulation+in+cancer+cells%3A+a+druggable+chain+of+events&doi=10.1016%2Fj.drudis.2013.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminase regulation in cancer cells: a druggable chain of events</span></div><div class="casAuthors">Katt, William P.; Cerione, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">450-457</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Metab. is the process by which cells convert relatively simple extracellular nutrients into energy and building blocks necessary for their growth and survival.  In cancer cells, metab. is dramatically altered compared with normal cells.  These alterations are known as the Warburg effect.  One consequence of these changes is cellular addiction to glutamine.  Because of this, in recent years the enzyme glutaminase has become a key target for small mol. therapeutic intervention.  Like many oncotargets, however, glutaminase has a no. of upstream partners that might offer addnl. druggable targets.  This review summarizes the work from the current decade surrounding glutaminase and its regulation, and suggests strategies for therapeutic intervention in relevant cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY9cKMRSje5LVg90H21EOLACvtfcHk0lj1NB2eH7cRTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSls7vF&md5=01b37117a2665312031d0cf5af24b7e9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DKatt%26aufirst%3DW.%2BP.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DGlutaminase%2520regulation%2520in%2520cancer%2520cells%253A%2520a%2520druggable%2520chain%2520of%2520events%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26issue%3D4%26spage%3D450%26epage%3D457%26doi%3D10.1016%2Fj.drudis.2013.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wang, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinavahi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrosio, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dias, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerione, R. A.</span><span> </span><span class="NLM_article-title">Targeting mitochondrial glutaminase activity inhibits oncogenic transformation</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1016/j.ccr.2010.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2Fj.ccr.2010.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=20832749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGht7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=207-219&issue=3&author=J.+B.+Wangauthor=J.+W.+Ericksonauthor=R.+Fujiauthor=S.+Ramachandranauthor=P.+Gaoauthor=R.+Dinavahiauthor=K.+F.+Wilsonauthor=A.+L.+Ambrosioauthor=S.+M.+Diasauthor=C.+V.+Dangauthor=R.+A.+Cerione&title=Targeting+mitochondrial+glutaminase+activity+inhibits+oncogenic+transformation&doi=10.1016%2Fj.ccr.2010.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation</span></div><div class="casAuthors">Wang, Jian-Bin; Erickson, Jon W.; Fuji, Reina; Ramachandran, Sekar; Gao, Ping; Dinavahi, Ramani; Wilson, Kristin F.; Ambrosio, Andre L. B.; Dias, Sandra M. G.; Dang, Chi-V.; Cerione, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-219</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Rho GTPases impact a no. of activities important for oncogenesis.  We describe a small mol. inhibitor that blocks oncogenic transformation induced by various Rho GTPases in fibroblasts, and the growth of human breast cancer and B lymphoma cells, without affecting normal cells.  We identify the target of this inhibitor to be the metabolic enzyme glutaminase, which catalyzes the hydrolysis of glutamine to glutamate.  We show that transformed fibroblasts and breast cancer cells exhibit elevated glutaminase activity that is dependent on Rho GTPases and NF-κB activity, and is blocked by the small mol. inhibitor.  These findings highlight a previously unappreciated connection between Rho GTPase activation and cellular metab. and demonstrate that targeting glutaminase activity can inhibit oncogenic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTP6YsyzRd1LVg90H21EOLACvtfcHk0lj1NB2eH7cRTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGht7bO&md5=67b64e99c992bbe6636ecfc04b83aac0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BB.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DDinavahi%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DK.%2BF.%26aulast%3DAmbrosio%26aufirst%3DA.%2BL.%26aulast%3DDias%26aufirst%3DS.%2BM.%26aulast%3DDang%26aufirst%3DC.%2BV.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DTargeting%2520mitochondrial%2520glutaminase%2520activity%2520inhibits%2520oncogenic%2520transformation%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26issue%3D3%26spage%3D207%26epage%3D219%26doi%3D10.1016%2Fj.ccr.2010.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Shukla, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraris, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahanty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">10551</span><span class="NLM_x">–</span> <span class="NLM_lpage">10563</span><span class="refDoi"> DOI: 10.1021/jm301191p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301191p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10551-10563&issue=23&author=K.+Shuklaauthor=D.+V.+Ferrarisauthor=A.+G.+Thomasauthor=M.+Stathisauthor=B.+Duvallauthor=G.+Delahantyauthor=J.+Altauthor=R.+Raisauthor=C.+Rojasauthor=P.+Gaoauthor=Y.+Xiangauthor=C.+V.+Dangauthor=B.+S.+Slusherauthor=T.+Tsukamoto&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+bis-2-%285-phenylacetamido-1%2C2%2C4-thiadiazol-2-yl%29ethyl+sulfide+3+%28BPTES%29+analogs+as+glutaminase+inhibitors&doi=10.1021%2Fjm301191p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm301191p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301191p%26sid%3Dliteratum%253Aachs%26aulast%3DShukla%26aufirst%3DK.%26aulast%3DFerraris%26aufirst%3DD.%2BV.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DStathis%26aufirst%3DM.%26aulast%3DDuvall%26aufirst%3DB.%26aulast%3DDelahanty%26aufirst%3DG.%26aulast%3DAlt%26aufirst%3DJ.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DDang%26aufirst%3DC.%2BV.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520bis-2-%25285-phenylacetamido-1%252C2%252C4-thiadiazol-2-yl%2529ethyl%2520sulfide%25203%2520%2528BPTES%2529%2520analogs%2520as%2520glutaminase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D23%26spage%3D10551%26epage%3D10563%26doi%3D10.1021%2Fjm301191p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Gross, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demo, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennison, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chernov-Rogan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goyal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laidig, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackinnon, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shwonek, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjogren, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, M. K.</span><span> </span><span class="NLM_article-title">Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">890</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1158%2F1535-7163.MCT-13-0870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=24523301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1Gjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=890-901&issue=4&author=M.+I.+Grossauthor=S.+D.+Demoauthor=J.+B.+Dennisonauthor=L.+Chenauthor=T.+Chernov-Roganauthor=B.+Goyalauthor=J.+R.+Janesauthor=G.+J.+Laidigauthor=E.+R.+Lewisauthor=J.+Liauthor=A.+L.+Mackinnonauthor=F.+Parlatiauthor=M.+L.+Rodriguezauthor=P.+J.+Shwonekauthor=E.+B.+Sjogrenauthor=T.+F.+Stantonauthor=T.+Wangauthor=J.+Yangauthor=F.+Zhaoauthor=M.+K.+Bennett&title=Antitumor+activity+of+the+glutaminase+inhibitor+CB-839+in+triple-negative+breast+cancer&doi=10.1158%2F1535-7163.MCT-13-0870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer</span></div><div class="casAuthors">Gross, Matt I.; Demo, Susan D.; Dennison, Jennifer B.; Chen, Lijing; Chernov-Rogan, Tania; Goyal, Bindu; Janes, Julie R.; Laidig, Guy J.; Lewis, Evan R.; Li, Jim; MacKinnon, Andrew L.; Parlati, Francesco; Rodriguez, Mirna L. M.; Shwonek, Peter J.; Sjogren, Eric B.; Stanton, Timothy F.; Wang, Taotao; Yang, Jinfu; Zhao, Frances; Bennett, Mark K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">890-901</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Glutamine serves as an important source of energy and building blocks for many tumor cells.  The first step in glutamine utilization is its conversion to glutamate by the mitochondrial enzyme glutaminase.  CB-839 is a potent, selective, and orally bioavailable inhibitor of both splice variants of glutaminase (KGA and GAC).  CB-839 had antiproliferative activity in a triple-neg. breast cancer (TNBC) cell line, HCC-1806, that was assocd. with a marked decrease in glutamine consumption, glutamate prodn., oxygen consumption, and the steady-state levels of glutathione and several tricarboxylic acid cycle intermediates.  In contrast, no antiproliferative activity was obsd. in an estrogen receptor-pos. cell line, T47D, and only modest effects on glutamine consumption and downstream metabolites were obsd.  Across a panel of breast cancer cell lines, GAC protein expression and glutaminase activity were elevated in the majority of TNBC cell lines relative to receptor pos. cells.  Furthermore, the TNBC subtype displayed the greatest sensitivity to CB-839 treatment and this sensitivity was correlated with (i) dependence on extracellular glutamine for growth, (ii) intracellular glutamate and glutamine levels, and (iii) GAC (but not KGA) expression, a potential biomarker for sensitivity.  CB-839 displayed significant antitumor activity in two xenograft models: as a single agent in a patient-derived TNBC model and in a basal like HER2+ cell line model, JIMT-1, both as a single agent and in combination with paclitaxel.  Together, these data provide a strong rationale for the clin. investigation of CB-839 as a targeted therapeutic in patients with TNBC and other glutamine-dependent tumors.  Mol Cancer Ther; 13(4); 890-901.2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfUGWU-VZObVg90H21EOLACvtfcHk0lgwnmSXwZKFqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1Gjurg%253D&md5=5b9ddb35c56409b58ce2b889bbbbc33f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0870%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DM.%2BI.%26aulast%3DDemo%26aufirst%3DS.%2BD.%26aulast%3DDennison%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChernov-Rogan%26aufirst%3DT.%26aulast%3DGoyal%26aufirst%3DB.%26aulast%3DJanes%26aufirst%3DJ.%2BR.%26aulast%3DLaidig%26aufirst%3DG.%2BJ.%26aulast%3DLewis%26aufirst%3DE.%2BR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMackinnon%26aufirst%3DA.%2BL.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DRodriguez%26aufirst%3DM.%2BL.%26aulast%3DShwonek%26aufirst%3DP.%2BJ.%26aulast%3DSjogren%26aufirst%3DE.%2BB.%26aulast%3DStanton%26aufirst%3DT.%2BF.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DBennett%26aufirst%3DM.%2BK.%26atitle%3DAntitumor%2520activity%2520of%2520the%2520glutaminase%2520inhibitor%2520CB-839%2520in%2520triple-negative%2520breast%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26issue%3D4%26spage%3D890%26epage%3D901%26doi%3D10.1158%2F1535-7163.MCT-13-0870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Lee, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span> </span><span class="NLM_article-title">Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">6087</span><span class="NLM_x">–</span> <span class="NLM_lpage">6101</span><span class="refDoi"> DOI: 10.18632/oncotarget.2173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.18632%2Foncotarget.2173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=25026281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A280%3ADC%252BC2cbitF2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=6087-6101&issue=15&author=Y.+Z.+Leeauthor=C.+W.+Yangauthor=H.+Y.+Changauthor=H.+Y.+Hsuauthor=I.+S.+Chenauthor=H.+S.+Changauthor=C.+H.+Leeauthor=J.+C.+Leeauthor=C.+R.+Kumarauthor=Y.+Q.+Qiuauthor=Y.+S.+Chaoauthor=S.+J.+Lee&title=Discovery+of+selective+inhibitors+of+Glutaminase-2%2C+which+inhibit+mTORC1%2C+activate+autophagy+and+inhibit+proliferation+in+cancer+cells&doi=10.18632%2Foncotarget.2173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells</span></div><div class="casAuthors">Lee Yue-Zhi; Yang Cheng-Wei; Chang Hsin-Yu; Hsu Hsing-Yu; Chen Ih-Shen; Chang Hsun-Shuo; Lee Chih-Hao; Lee Jinq-chyi; Kumar Chidambaram Ramesh; Chao Yu-Sheng; Lee Shiow-Ju; Qiu Ya-Qi</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6087-101</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glutaminase, which converts glutamine to glutamate, is involved in Warburg effect in cancer cells.  Two human glutaminase genes have been identified, GLS (GLS1) and GLS2.  Two alternative transcripts arise from each glutaminase gene: first, the kidney isoform (KGA) and glutaminase C (GAC) for GLS; and, second, the liver isoform (LGA) and glutaminase B (GAB) for GLS2.  While GLS1 is considered as a cancer therapeutic target, the potential role of GLS2 in cancer remains unclear.  Here, we discovered a series of alkyl benzoquinones that preferentially inhibit glutaminase B isoform (GAB, GLS2) rather than the kidney isoform of glutaminase (KGA, GLS1).  We identified amino acid residues in an allosteric binding pocket responsible for the selectivity.  Treatment with the alkyl benzoquinones decreased intracellular glutaminase activity and glutamate levels.  GLS2 inhibition by either alkyl benzoquinones or GLS2 siRNA reduced carcinoma cell proliferation and anchorage-independent colony formation, and induced autophagy via AMPK mediated mTORC1 inhibition.  Our findings demonstrate amino acid sequences for selective inhibition of glutaminase isozymes and validate GLS2 as a potential anti-cancer target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7ipugdsmO_SjiVMCqkKxVfW6udTcc2eZdWOjf4zgBvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbitF2htA%253D%253D&md5=0f0e4f0d6a1960aa8a87d645f55b5f68</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2173%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BZ.%26aulast%3DYang%26aufirst%3DC.%2BW.%26aulast%3DChang%26aufirst%3DH.%2BY.%26aulast%3DHsu%26aufirst%3DH.%2BY.%26aulast%3DChen%26aufirst%3DI.%2BS.%26aulast%3DChang%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DKumar%26aufirst%3DC.%2BR.%26aulast%3DQiu%26aufirst%3DY.%2BQ.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26atitle%3DDiscovery%2520of%2520selective%2520inhibitors%2520of%2520Glutaminase-2%252C%2520which%2520inhibit%2520mTORC1%252C%2520activate%2520autophagy%2520and%2520inhibit%2520proliferation%2520in%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26issue%3D15%26spage%3D6087%26epage%3D6101%26doi%3D10.18632%2Foncotarget.2173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Xiao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qing, G.</span><span> </span><span class="NLM_article-title">Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">38</span><span class="NLM_x">) </span> <span class="NLM_fpage">40655</span><span class="NLM_x">–</span> <span class="NLM_lpage">40666</span><span class="refDoi"> DOI: 10.18632/oncotarget.5821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.18632%2Foncotarget.5821" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=40655-40666&issue=38&author=D.+Xiaoauthor=P.+Renauthor=H.+Suauthor=M.+Yueauthor=R.+Xiuauthor=Y.+Huauthor=H.+Liuauthor=G.+Qing&title=Myc+promotes+glutaminolysis+in+human+neuroblastoma+through+direct+activation+of+glutaminase+2&doi=10.18632%2Foncotarget.5821"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5821%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DYue%26aufirst%3DM.%26aulast%3DXiu%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DQing%26aufirst%3DG.%26atitle%3DMyc%2520promotes%2520glutaminolysis%2520in%2520human%2520neuroblastoma%2520through%2520direct%2520activation%2520of%2520glutaminase%25202%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26issue%3D38%26spage%3D40655%26epage%3D40666%26doi%3D10.18632%2Foncotarget.5821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhanot, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haffty, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span> </span><span class="NLM_article-title">Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e10727</span><span class="refDoi"> DOI: 10.7554/eLife.10727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.7554%2FeLife.10727" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e10727&author=C.+Zhangauthor=J.+Liuauthor=Y.+Zhaoauthor=X.+Yueauthor=Y.+Zhuauthor=X.+Wangauthor=H.+Wuauthor=F.+Blancoauthor=S.+Liauthor=G.+Bhanotauthor=B.+G.+Hafftyauthor=W.+Huauthor=Z.+Feng&title=Glutaminase+2+is+a+novel+negative+regulator+of+small+GTPase+Rac1+and+mediates+p53+function+in+suppressing+metastasis&doi=10.7554%2FeLife.10727"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.7554%2FeLife.10727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.10727%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYue%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DBlanco%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DBhanot%26aufirst%3DG.%26aulast%3DHaffty%26aufirst%3DB.%2BG.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DZ.%26atitle%3DGlutaminase%25202%2520is%2520a%2520novel%2520negative%2520regulator%2520of%2520small%2520GTPase%2520Rac1%2520and%2520mediates%2520p53%2520function%2520in%2520suppressing%2520metastasis%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26spage%3De10727%26doi%3D10.7554%2FeLife.10727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Giacobbe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bongiorno-Borbone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernassola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrinoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markert, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agostini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zolla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agro, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notterman, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peschiaroli, A.</span><span> </span><span class="NLM_article-title">p63 regulates glutaminase 2 expression</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1395</span><span class="NLM_x">–</span> <span class="NLM_lpage">1405</span><span class="refDoi"> DOI: 10.4161/cc.24478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.4161%2Fcc.24478" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1395-1405&issue=9&author=A.+Giacobbeauthor=L.+Bongiorno-Borboneauthor=F.+Bernassolaauthor=A.+Terrinoniauthor=E.+K.+Markertauthor=A.+J.+Levineauthor=Z.+Fengauthor=M.+Agostiniauthor=L.+Zollaauthor=A.+F.+Agroauthor=D.+A.+Nottermanauthor=G.+Melinoauthor=A.+Peschiaroli&title=p63+regulates+glutaminase+2+expression&doi=10.4161%2Fcc.24478"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4161%2Fcc.24478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.24478%26sid%3Dliteratum%253Aachs%26aulast%3DGiacobbe%26aufirst%3DA.%26aulast%3DBongiorno-Borbone%26aufirst%3DL.%26aulast%3DBernassola%26aufirst%3DF.%26aulast%3DTerrinoni%26aufirst%3DA.%26aulast%3DMarkert%26aufirst%3DE.%2BK.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DAgostini%26aufirst%3DM.%26aulast%3DZolla%26aufirst%3DL.%26aulast%3DAgro%26aufirst%3DA.%2BF.%26aulast%3DNotterman%26aufirst%3DD.%2BA.%26aulast%3DMelino%26aufirst%3DG.%26aulast%3DPeschiaroli%26aufirst%3DA.%26atitle%3Dp63%2520regulates%2520glutaminase%25202%2520expression%26jtitle%3DCell%2520Cycle%26date%3D2013%26volume%3D12%26issue%3D9%26spage%3D1395%26epage%3D1405%26doi%3D10.4161%2Fcc.24478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span> </span><span class="NLM_article-title">Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">7455</span><span class="NLM_x">–</span> <span class="NLM_lpage">7460</span><span class="refDoi"> DOI: 10.1073/pnas.1001006107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1073%2Fpnas.1001006107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=7455-7460&issue=16&author=W.+Huauthor=C.+Zhangauthor=R.+Wuauthor=Y.+Sunauthor=A.+Levineauthor=Z.+Feng&title=Glutaminase+2%2C+a+novel+p53+target+gene+regulating+energy+metabolism+and+antioxidant+function&doi=10.1073%2Fpnas.1001006107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1001006107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1001006107%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLevine%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DZ.%26atitle%3DGlutaminase%25202%252C%2520a%2520novel%2520p53%2520target%2520gene%2520regulating%2520energy%2520metabolism%2520and%2520antioxidant%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26issue%3D16%26spage%3D7455%26epage%3D7460%26doi%3D10.1073%2Fpnas.1001006107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poyurovsky, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokshin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokote, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prives, C.</span><span> </span><span class="NLM_article-title">Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">7461</span><span class="NLM_x">–</span> <span class="NLM_lpage">7466</span><span class="refDoi"> DOI: 10.1073/pnas.1002459107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1073%2Fpnas.1002459107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=7461-7466&issue=16&author=S.+Suzukiauthor=T.+Tanakaauthor=M.+V.+Poyurovskyauthor=H.+Naganoauthor=T.+Mayamaauthor=S.+Ohkuboauthor=M.+Lokshinauthor=H.+Hosokawaauthor=T.+Nakayamaauthor=Y.+Suzukiauthor=S.+Suganoauthor=E.+Satoauthor=T.+Nagaoauthor=K.+Yokoteauthor=I.+Tatsunoauthor=C.+Prives&title=Phosphate-activated+glutaminase+%28GLS2%29%2C+a+p53-inducible+regulator+of+glutamine+metabolism+and+reactive+oxygen+species&doi=10.1073%2Fpnas.1002459107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1002459107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1002459107%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DPoyurovsky%26aufirst%3DM.%2BV.%26aulast%3DNagano%26aufirst%3DH.%26aulast%3DMayama%26aufirst%3DT.%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DLokshin%26aufirst%3DM.%26aulast%3DHosokawa%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DSugano%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DE.%26aulast%3DNagao%26aufirst%3DT.%26aulast%3DYokote%26aufirst%3DK.%26aulast%3DTatsuno%26aufirst%3DI.%26aulast%3DPrives%26aufirst%3DC.%26atitle%3DPhosphate-activated%2520glutaminase%2520%2528GLS2%2529%252C%2520a%2520p53-inducible%2520regulator%2520of%2520glutamine%2520metabolism%2520and%2520reactive%2520oxygen%2520species%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26issue%3D16%26spage%3D7461%26epage%3D7466%26doi%3D10.1073%2Fpnas.1002459107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Turner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGivan, J. D.</span><span> </span><span class="NLM_article-title">Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span><span class="refDoi"> DOI: 10.1042/bj20021360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1042%2Fbj20021360" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2003&pages=403-408&issue=2&author=A.+Turnerauthor=J.+D.+McGivan&title=Glutaminase+isoform+expression+in+cell+lines+derived+from+human+colorectal+adenomas+and+carcinomas&doi=10.1042%2Fbj20021360"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1042%2Fbj20021360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021360%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DA.%26aulast%3DMcGivan%26aufirst%3DJ.%2BD.%26atitle%3DGlutaminase%2520isoform%2520expression%2520in%2520cell%2520lines%2520derived%2520from%2520human%2520colorectal%2520adenomas%2520and%2520carcinomas%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D370%26issue%3D2%26spage%3D403%26epage%3D408%26doi%3D10.1042%2Fbj20021360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Perez-Gomez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos-Sandoval, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segura, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzanares, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz-Sanchez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mates, J. M.</span><span> </span><span class="NLM_article-title">Co-expression of glutaminase K and L isoenzymes in human tumour cells</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">386</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.1042/BJ20040996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1042%2FBJ20040996" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2005&pages=535-542&issue=3&author=C.+Perez-Gomezauthor=J.+A.+Campos-Sandovalauthor=F.+J.+Alonsoauthor=J.+A.+Seguraauthor=E.+Manzanaresauthor=P.+Ruiz-Sanchezauthor=M.+E.+Gonzalezauthor=J.+Marquezauthor=J.+M.+Mates&title=Co-expression+of+glutaminase+K+and+L+isoenzymes+in+human+tumour+cells&doi=10.1042%2FBJ20040996"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1042%2FBJ20040996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20040996%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Gomez%26aufirst%3DC.%26aulast%3DCampos-Sandoval%26aufirst%3DJ.%2BA.%26aulast%3DAlonso%26aufirst%3DF.%2BJ.%26aulast%3DSegura%26aufirst%3DJ.%2BA.%26aulast%3DManzanares%26aufirst%3DE.%26aulast%3DRuiz-Sanchez%26aufirst%3DP.%26aulast%3DGonzalez%26aufirst%3DM.%2BE.%26aulast%3DMarquez%26aufirst%3DJ.%26aulast%3DMates%26aufirst%3DJ.%2BM.%26atitle%3DCo-expression%2520of%2520glutaminase%2520K%2520and%2520L%2520isoenzymes%2520in%2520human%2520tumour%2520cells%26jtitle%3DBiochem.%2520J.%26date%3D2005%26volume%3D386%26issue%3D3%26spage%3D535%26epage%3D542%26doi%3D10.1042%2FBJ20040996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Huang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span> </span><span class="NLM_article-title">Expression of glutaminase is upregulated in colorectal cancer and of clinical significance</span> <span class="citation_source-journal">Int. J. Clin. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=24696726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFynur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=1093-1100&issue=3&author=F.+Huangauthor=Q.+Zhangauthor=H.+Maauthor=Q.+Lvauthor=T.+Zhang&title=Expression+of+glutaminase+is+upregulated+in+colorectal+cancer+and+of+clinical+significance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of glutaminase is upregulated in colorectal cancer and of clinical significance</span></div><div class="casAuthors">Huang, Fang; Zhang, Qiuyue; Ma, Hong; Lv, Qing; Zhang, Tao</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1093-1100, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1936-2625</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Cancer cells remodel their metabolic programs to meet the requirements of rapid proliferation.  Glutaminase (GLS1) is a mitochondrial enzyme that converts glutamine to glutamate.  Our aim was to investigate, for the first time, GLS1 protein expression in colorectal cancer and to evaluate its clin. significance.  Immunohistochem. anal. was performed on tissue microarrays contg. pairs of cancer and adjacent normal tissues from colorectal cancer patients (n = 257).  The expression of GLS1 protein in normal colonic tissues and colorectal cancer was measured by western blotting.  Proliferation and cell death were evaluated in colorectal cancer cell lines after GLS1 inhibitor treatment.  Compared with normal tissues (18.15%), we obsd. that the expression of GLS1 increased significantly in colorectal cancer (80.24%; P < 0.0001) by immunohistochem. anal., and the elevation of GLS1 protein expression levels in fresh colorectal cancer samples vs. normal colonic tissues were also obsd. by western blotting.  Furthermore, GLS1 expression levels were significantly assocd. with deeper tumor infiltration (P = 0.0002), and the pathol. pattern of tubular adenocarcinoma (p = 0.0008).  In addn., treatment with the GLS1 inhibitor suppressed proliferation and induced apoptosis in HT29 and SW480 cell lines.  These results suggest that the expression of GLS1 is upregulated and correlates with clinicopathol. factors in colorectal cancer.  GLS1 exhibits functional importance in colon cancer tumorigenesis.  Moreover, GLS1 may serve as a target for colorectal cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrqIrrXKlo17Vg90H21EOLACvtfcHk0lgl0hiR6H2YgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFynur0%253D&md5=b7916e85f4c05090f7cbe76f1b4dd443</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DLv%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DT.%26atitle%3DExpression%2520of%2520glutaminase%2520is%2520upregulated%2520in%2520colorectal%2520cancer%2520and%2520of%2520clinical%2520significance%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2014%26volume%3D7%26issue%3D3%26spage%3D1093%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span> </span><span class="NLM_article-title">Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2635</span><span class="NLM_x">–</span> <span class="NLM_lpage">2647</span><span class="refDoi"> DOI: 10.18632/oncotarget.1862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.18632%2Foncotarget.1862" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2635-2647&issue=9&author=J.+Liuauthor=C.+Zhangauthor=M.+Linauthor=W.+Zhuauthor=Y.+Liangauthor=X.+Hongauthor=Y.+Zhaoauthor=K.+H.+Youngauthor=W.+Huauthor=Z.+Feng&title=Glutaminase+2+negatively+regulates+the+PI3K%2FAKT+signaling+and+shows+tumor+suppression+activity+in+human+hepatocellular+carcinoma&doi=10.18632%2Foncotarget.1862"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1862%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYoung%26aufirst%3DK.%2BH.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DZ.%26atitle%3DGlutaminase%25202%2520negatively%2520regulates%2520the%2520PI3K%252FAKT%2520signaling%2520and%2520shows%2520tumor%2520suppression%2520activity%2520in%2520human%2520hepatocellular%2520carcinoma%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26issue%3D9%26spage%3D2635%26epage%3D2647%26doi%3D10.18632%2Foncotarget.1862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Thangavelu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivaraman, J.</span><span> </span><span class="NLM_article-title">Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA)</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3827</span><span class="refDoi"> DOI: 10.1038/srep03827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1038%2Fsrep03827" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=24451979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVCis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=3827&author=K.+Thangaveluauthor=Q.+Y.+Chongauthor=B.+C.+Lowauthor=J.+Sivaraman&title=Structural+basis+for+the+active+site+inhibition+mechanism+of+human+kidney-type+glutaminase+%28KGA%29&doi=10.1038%2Fsrep03827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA)</span></div><div class="casAuthors">Thangavelu, K.; Chong, Qing Yun; Low, Boon Chuan; Sivaraman, J.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3827</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glutaminase is a metabolic enzyme responsible for glutaminolysis, a process harnessed by cancer cells to feed their accelerated growth and proliferation.  Among the glutaminase isoforms, human kidney-type glutaminase (KGA) is often upregulated in cancer and is thus touted as an attractive drug target.  Here we report the active site inhibition mechanism of KGA through the crystal structure of the catalytic domain of KGA (cKGA) in complex with 6-diazo-5-oxo-L-norleucine (DON), a substrate analog of glutamine.  DON covalently binds with the active site Ser286 and interacts with residues such as Tyr249, Asn335, Glu381, Asn388, Tyr414, Tyr466 and Val484.  The nucleophilic attack of Ser286 sidechain on DON releases the diazo group (N2) from the inhibitor and results in the formation of an enzyme-inhibitor complex.  Mutational studies confirmed the key role of these residues in the activity of KGA.  This study will be important in the development of KGA active site inhibitors for therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhI-NVHs5B9bVg90H21EOLACvtfcHk0liqAVRTh2ZpxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVCis7Y%253D&md5=86a5c7ae18f1a95c66d7d13e63ad2b0b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsrep03827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep03827%26sid%3Dliteratum%253Aachs%26aulast%3DThangavelu%26aufirst%3DK.%26aulast%3DChong%26aufirst%3DQ.%2BY.%26aulast%3DLow%26aufirst%3DB.%2BC.%26aulast%3DSivaraman%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520for%2520the%2520active%2520site%2520inhibition%2520mechanism%2520of%2520human%2520kidney-type%2520glutaminase%2520%2528KGA%2529%26jtitle%3DSci.%2520Rep.%26date%3D2014%26volume%3D4%26spage%3D3827%26doi%3D10.1038%2Fsrep03827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Wu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukinius, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langstrom, B.</span><span> </span><span class="NLM_article-title">A mechanism behind the antitumour effect of 6-diazo-5-oxo-L-norleucine (DON): disruption of mitochondria</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1155</span><span class="NLM_x">–</span> <span class="NLM_lpage">1161</span><span class="refDoi"> DOI: 10.1016/S0959-8049(99)00099-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2FS0959-8049%2899%2900099-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1999&pages=1155-1161&issue=7&author=F.+Wuauthor=A.+Lukiniusauthor=M.+Bergstromauthor=B.+Erikssonauthor=Y.+Watanabeauthor=B.+Langstrom&title=A+mechanism+behind+the+antitumour+effect+of+6-diazo-5-oxo-L-norleucine+%28DON%29%3A+disruption+of+mitochondria&doi=10.1016%2FS0959-8049%2899%2900099-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2899%2900099-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252899%252900099-4%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DF.%26aulast%3DLukinius%26aufirst%3DA.%26aulast%3DBergstrom%26aufirst%3DM.%26aulast%3DEriksson%26aufirst%3DB.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DLangstrom%26aufirst%3DB.%26atitle%3DA%2520mechanism%2520behind%2520the%2520antitumour%2520effect%2520of%25206-diazo-5-oxo-L-norleucine%2520%2528DON%2529%253A%2520disruption%2520of%2520mitochondria%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1999%26volume%3D35%26issue%3D7%26spage%3D1155%26epage%3D1161%26doi%3D10.1016%2FS0959-8049%2899%2900099-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Mueller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Batran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bausch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethuraman, N.</span><span> </span><span class="NLM_article-title">A phase IIa study of PEGylated glutaminase (PEG-PGA) plus 6-diazo-5-oxo-L-norleucine (DON) in patients with advanced refractory solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">May 20 Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">2533</span><span class="refDoi"> DOI: 10.1200/jco.2008.26.15_suppl.2533</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1200%2Fjco.2008.26.15_suppl.2533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A280%3ADC%252BC2sjmtlGguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=2533&issue=May+20+Suppl.&author=C.+Muellerauthor=S.+Al-Batranauthor=E.+Jaegerauthor=B.+Schmidtauthor=M.+Bauschauthor=C.+Ungerauthor=N.+Sethuraman&title=A+phase+IIa+study+of+PEGylated+glutaminase+%28PEG-PGA%29+plus+6-diazo-5-oxo-L-norleucine+%28DON%29+in+patients+with+advanced+refractory+solid+tumors&doi=10.1200%2Fjco.2008.26.15_suppl.2533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A phase IIa study of PEGylated glutaminase (PEG-PGA) plus 6-diazo-5-oxo-L-norleucine (DON) in patients with advanced refractory solid tumors</span></div><div class="casAuthors">Mueller C; Al-Batran S; Jaeger E; Schmidt B; Bausch M; Unger C; Sethuraman N</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15_suppl</span>),
    <span class="NLM_cas:pages">2533</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">2533 Background: Our phase IIa study evaluated the safety and clinical activity of the glutamine depleting enzyme PEG-PGA in combination with DON.  DON as a glutamine antagonist irreversibly inhibits key enzymes in the purine and pyrimidine synthesis.  Based on the competitive mechanism, effectiveness of DON is greatly enhanced if plasma glutamine level is significantly depleted by PEG-PGA.  METHODS:  In this multicenter study, patients (pts) with advanced solid tumors refractory to standard treatments were enrolled.  Pts were treated with 120 I.U./m(2) PEG-PGA (once weekly) and 140 mg/m(2) DON (twice weekly) both as 15 min intravenous infusions.  Three weeks were considered one cycle and tumor assessment (RECIST) was performed every two cycles.  The primary endpoint was safety.  RESULTS:  Fifty-five pts (20f/35m) were enrolled.  Median age was 60 years (range 31-84). 30% had an ECOG PS <1.  Pts were heavily pretreated and all had progressive disease at study entry.  Treatment duration ranged from 1 to 379 days.  Glutamine levels were depleted below 10% of baseline after the 2nd infusion of PEG-PGA and remained depleted in >90% of the patients.  The treatment was very well tolerated.  Most frequent (>2%) possibly related NCI-CTC grade 3 or 4 non-hematological toxicities were fatigue in 5 (9.1 %), nausea in 3 (5.5%), vomiting in 2 (3.6%) and diarrhea in 2 (3.6%) pts.  Grade 3 or 4 hematological side effects were also rare, with neutropenia and thrombocytopenia being observed in 1 patient (pt), each.  One pt with metastatic colorectal cancer (mCRC) experienced a confirmed partial response.  One additional pt (mCRC) had a prolonged stable disease lasting > 12 months under treatment despite multiple lung metastases (>30).  Among the pts with mCRC, 9/17 (53%) pts 5/17 (29%) pts were progression-free at 3 and 5 months, respectively.  Signs of activity were also observed in pts with lung cancer.  Five of six (83%) pts with lung cancer were progression-free 3 months after inclusion.  CONCLUSIONS:  PEG-PGA and DON were well tolerated and demonstrated activity in late stage colorectal and lung cancer.  The therapeutic approach warrants further investigations. [Table: see text].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxB5UhTWxOXWHOrQ6qeX-mfW6udTcc2eaaeFlrsP650Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sjmtlGguw%253D%253D&md5=d7bba73438ab6dfbec821c1d85115658</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1200%2Fjco.2008.26.15_suppl.2533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252Fjco.2008.26.15_suppl.2533%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DC.%26aulast%3DAl-Batran%26aufirst%3DS.%26aulast%3DJaeger%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DBausch%26aufirst%3DM.%26aulast%3DUnger%26aufirst%3DC.%26aulast%3DSethuraman%26aufirst%3DN.%26atitle%3DA%2520phase%2520IIa%2520study%2520of%2520PEGylated%2520glutaminase%2520%2528PEG-PGA%2529%2520plus%25206-diazo-5-oxo-L-norleucine%2520%2528DON%2529%2520in%2520patients%2520with%2520advanced%2520refractory%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2008%26volume%3D26%26issue%3DMay%252020%2520Suppl%26spage%3D2533%26doi%3D10.1200%2Fjco.2008.26.15_suppl.2533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Allen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yunis, A.</span><span> </span><span class="NLM_article-title">The inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501)</span> <span class="citation_source-journal">Res. Commun. Chem. Pathol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=6102405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADyaL3cXht1WltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1980&pages=175-182&issue=1&author=L.+Allenauthor=R.+Meckauthor=A.+Yunis&title=The+inhibition+of+gamma-glutamyl+transpeptidase+from+human+pancreatic+carcinoma+cells+by+%28alpha+S%2C5S%29-alpha-amino-3-chloro-4%2C5-dihydro-5-isoxazoleacetic+acid+%28AT-125%3B+NSC-163501%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibition of γ-glutamyl transpeptidase from human pancreatic carcinoma cells by (αS,5S)-α-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501)</span></div><div class="casAuthors">Allen, Larry; Meck, Robert; Yunis, Adel</div><div class="citationInfo"><span class="NLM_cas:title">Research Communications in Chemical Pathology and Pharmacology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-82</span>CODEN:
                <span class="NLM_cas:coden">RCOCB8</span>;
        ISSN:<span class="NLM_cas:issn">0034-5164</span>.
    </div><div class="casAbstract">AT-125 (I)  [42228-92-2] at 5 μM inhibited the growth of human pancreatic carcinoma cells by 78% after 72 h in continuous culture.  γ-Glutamyl transpeptidase  [9046-27-9] was irreversibly inactivated by I with an inactivation half-life of 80 min at 450 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAEJ1HIQo3ILVg90H21EOLACvtfcHk0liAk-6O8CnypA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXht1WltLY%253D&md5=024833952b028908a7edc8b199adcbab</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DL.%26aulast%3DMeck%26aufirst%3DR.%26aulast%3DYunis%26aufirst%3DA.%26atitle%3DThe%2520inhibition%2520of%2520gamma-glutamyl%2520transpeptidase%2520from%2520human%2520pancreatic%2520carcinoma%2520cells%2520by%2520%2528alpha%2520S%252C5S%2529-alpha-amino-3-chloro-4%252C5-dihydro-5-isoxazoleacetic%2520acid%2520%2528AT-125%253B%2520NSC-163501%2529%26jtitle%3DRes.%2520Commun.%2520Chem.%2520Pathol.%2520Pharmacol.%26date%3D1980%26volume%3D27%26issue%3D1%26spage%3D175%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGovren, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Hoff, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowinsky, E. K.</span><span> </span><span class="NLM_article-title">A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2763</span><span class="NLM_x">–</span> <span class="NLM_lpage">2770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=9829740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADyaK1cXns1Ogurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=2763-2770&issue=11&author=M.+Hidalgoauthor=G.+Rodriguezauthor=J.+G.+Kuhnauthor=T.+Brownauthor=G.+Weissauthor=J.+P.+MacGovrenauthor=D.+D.+Von+Hoffauthor=E.+K.+Rowinsky&title=A+Phase+I+and+pharmacological+study+of+the+glutamine+antagonist+acivicin+with+the+amino+acid+solution+aminosyn+in+patients+with+advanced+solid+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution Aminosyn in patients with advanced solid malignancies</span></div><div class="casAuthors">Hidalgo, Manuel; Rodriguez, Gladys; Kuhn, John G.; Brown, Thomas; Weiss, Geoffrey; MacGovren, J. Patrick; Von Hoff, Daniel D.; Rowinsky, Eric K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2763-2770</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This study evaluated the feasibility of escalating acivicin doses in cancer patients by administering acivicin with a concomitant 96-h i.v. infusion of a mixt. of 16 amino acids (Aminosyn, 10%).  Twenty-three patients with advanced malignancies were treated with acivicin on a 72-h continuous infusion schedule at doses ranging 25-60 mg/m2/day every 3 wk.  Reversible, dose-limiting central nervous system ( CNS) toxicity, characterized by lethargy, confusion, and decreased mental status, occurred in the 2 patients enrolled at the 60-mg/m2/day dose, precluding further dose escalation.  The max. tolerated dose (MTD) and recommended dose for addnl. evaluation of acivicin on this schedule is 50 mg/m2/day.  Other toxicities obsd. were dose-related neutropenia that was grade 4 in 4 patients (4 courses), complicated with fever in 3 of those patients, and grade 3-4 thrombocytopenia in 3 patients (3 courses).  Pharmacokinetic studies performed in 15 patients revealed that the plasma acivicin steady-state concn. (Css) increased from 0.44 μg/mL (range, 0.28-0.59 μg/mL) at the 25-mg/m2day dose to 1.06 μg/mL (0.64-1.5 μg/mL) at the 50-mg/m2/dose.  Acivicin Css at the MTD was not higher than previously reported values with single-agent acivicin on the same schedule of administration at the MTD of 25 mg/m2/day (0.60 μg/mL; range, 0.43-0.81 μg/mL).  Neurotoxicity did not correlate with acivicin Css, but relationships between exposure to acivicin and the occurrence of both neutropenia and thrombocytopenia were well described by a sigmoidal Emax model.  This trial demonstrated that concomitant infusions of amino acids can prevent acivicin-induced CNS toxicity, which allows the dose of acivicin to be escalated 2-fold above previously tolerable doses; however, this effect did not translate into a significant increment in acivicin Css.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJQxbqC6C-7rVg90H21EOLACvtfcHk0lhYrnpjWiwcpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXns1Ogurs%253D&md5=51ad0abc45ce9667526748617e7c7313</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DG.%26aulast%3DKuhn%26aufirst%3DJ.%2BG.%26aulast%3DBrown%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DG.%26aulast%3DMacGovren%26aufirst%3DJ.%2BP.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DRowinsky%26aufirst%3DE.%2BK.%26atitle%3DA%2520Phase%2520I%2520and%2520pharmacological%2520study%2520of%2520the%2520glutamine%2520antagonist%2520acivicin%2520with%2520the%2520amino%2520acid%2520solution%2520aminosyn%2520in%2520patients%2520with%2520advanced%2520solid%2520malignancies%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1998%26volume%3D4%26issue%3D11%26spage%3D2763%26epage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. X.</span><span> </span><span class="NLM_article-title">Physapubescin, a natural withanolide as a kidney-type glutaminase (KGA) inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1243</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.01.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2Fj.bmcl.2017.01.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1243-1246&issue=5&author=L.+Chengauthor=C.+R.+Wuauthor=L.+H.+Zhuauthor=H.+Liauthor=L.+X.+Chen&title=Physapubescin%2C+a+natural+withanolide+as+a+kidney-type+glutaminase+%28KGA%29+inhibitor&doi=10.1016%2Fj.bmcl.2017.01.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.01.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.01.057%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DC.%2BR.%26aulast%3DZhu%26aufirst%3DL.%2BH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DL.%2BX.%26atitle%3DPhysapubescin%252C%2520a%2520natural%2520withanolide%2520as%2520a%2520kidney-type%2520glutaminase%2520%2528KGA%2529%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D5%26spage%3D1243%26epage%3D1246%26doi%3D10.1016%2Fj.bmcl.2017.01.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">DeLaBarre, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurov, J. B.</span><span> </span><span class="NLM_article-title">Full-length human glutaminase in complex with an allosteric inhibitor</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">50</span><span class="NLM_x">) </span> <span class="NLM_fpage">10764</span><span class="NLM_x">–</span> <span class="NLM_lpage">10770</span><span class="refDoi"> DOI: 10.1021/bi201613d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi201613d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=10764-10770&issue=50&author=B.+DeLaBarreauthor=S.+Grossauthor=C.+Fangauthor=Y.+Gaoauthor=A.+Jhaauthor=F.+Jiangauthor=J.+J.+Songauthor=W.+Weiauthor=J.+B.+Hurov&title=Full-length+human+glutaminase+in+complex+with+an+allosteric+inhibitor&doi=10.1021%2Fbi201613d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fbi201613d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201613d%26sid%3Dliteratum%253Aachs%26aulast%3DDeLaBarre%26aufirst%3DB.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DJha%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DJ.%2BJ.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DHurov%26aufirst%3DJ.%2BB.%26atitle%3DFull-length%2520human%2520glutaminase%2520in%2520complex%2520with%2520an%2520allosteric%2520inhibitor%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26issue%3D50%26spage%3D10764%26epage%3D10770%26doi%3D10.1021%2Fbi201613d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Katt, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukey, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerione, R. A.</span><span> </span><span class="NLM_article-title">A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span><span class="refDoi"> DOI: 10.4155/fmc-2016-0190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.4155%2Ffmc-2016-0190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=28111979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=223-243&issue=2&author=W.+P.+Kattauthor=M.+J.+Lukeyauthor=R.+A.+Cerione&title=A+tale+of+two+glutaminases%3A+homologous+enzymes+with+distinct+roles+in+tumorigenesis&doi=10.4155%2Ffmc-2016-0190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis</span></div><div class="casAuthors">Katt, William P.; Lukey, Michael J.; Cerione, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-243</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Many cancer cells exhibit an altered metabolic phenotype, in which glutamine consumption is upregulated relative to healthy cells.  This metabolic reprogramming often depends upon mitochondrial glutaminase activity, which converts glutamine to glutamate, a key precursor for biosynthetic and bioenergetic processes.  Two isoenzymes of glutaminase exist, a kidney-type (GLS) and a liver-type enzyme (GLS2 or LGA).  While a majority of studies have focused on GLS, here we summarize key findings on both glutaminases, describing their structure and function, their roles in cancer and pharmacol. approaches to inhibiting their activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTYjzSACf4q7Vg90H21EOLACvtfcHk0litn5rBT2SLlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWnur4%253D&md5=6b4bd6dfe8d18402f41bd420c25974b2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0190%26sid%3Dliteratum%253Aachs%26aulast%3DKatt%26aufirst%3DW.%2BP.%26aulast%3DLukey%26aufirst%3DM.%2BJ.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26atitle%3DA%2520tale%2520of%2520two%2520glutaminases%253A%2520homologous%2520enzymes%2520with%2520distinct%2520roles%2520in%2520tumorigenesis%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26issue%3D2%26spage%3D223%26epage%3D243%26doi%3D10.4155%2Ffmc-2016-0190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Stalnecker, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBerardinis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerione, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. W.</span><span> </span><span class="NLM_article-title">Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">394</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span><span class="refDoi"> DOI: 10.1073/pnas.1414056112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1073%2Fpnas.1414056112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=394-399&issue=2&author=C.+A.+Stalneckerauthor=S.+M.+Ulrichauthor=Y.+Liauthor=S.+Ramachandranauthor=M.+K.+McBrayerauthor=R.+J.+DeBerardinisauthor=R.+A.+Cerioneauthor=J.+W.+Erickson&title=Mechanism+by+which+a+recently+discovered+allosteric+inhibitor+blocks+glutamine+metabolism+in+transformed+cells&doi=10.1073%2Fpnas.1414056112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1414056112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1414056112%26sid%3Dliteratum%253Aachs%26aulast%3DStalnecker%26aufirst%3DC.%2BA.%26aulast%3DUlrich%26aufirst%3DS.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DMcBrayer%26aufirst%3DM.%2BK.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26atitle%3DMechanism%2520by%2520which%2520a%2520recently%2520discovered%2520allosteric%2520inhibitor%2520blocks%2520glutamine%2520metabolism%2520in%2520transformed%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26issue%3D2%26spage%3D394%26epage%3D399%26doi%3D10.1073%2Fpnas.1414056112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Tacar, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriamornsak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dass, C. R.</span><span> </span><span class="NLM_article-title">Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1111/j.2042-7158.2012.01567.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1111%2Fj.2042-7158.2012.01567.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=23278683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslGitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=157-170&issue=2&author=O.+Tacarauthor=P.+Sriamornsakauthor=C.+R.+Dass&title=Doxorubicin%3A+an+update+on+anticancer+molecular+action%2C+toxicity+and+novel+drug+delivery+systems&doi=10.1111%2Fj.2042-7158.2012.01567.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems</span></div><div class="casAuthors">Tacar, Oktay; Sriamornsak, Pornsak; Dass, Crispin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-170</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Objectives The frontline drug doxorubicin has been used for treating cancer for over 30 years.  While providing a cure in select cases, doxorubicin causes toxicity to most major organs, esp. life-threatening cardiotoxicity, which forces the treatment to become dose-limiting.  Key findings Doxorubicin is known to bind to DNA-assocd. enzymes, intercalate with DNA base pairs, and target multiple mol. targets to produce a range of cytotoxic effects.  For instance, it causes the activation of various mol. signals from AMPK (AMP-activated protein kinase inducing apoptosis) to influence the Bcl-2/Bax apoptosis pathway.  By altering the Bcl-2/Bax ratio, downstream activation of different caspases can occur resulting in apoptosis.  Doxorubicin also induces apoptosis and necrosis in healthy tissue causing toxicity in the brain, liver, kidney and heart.  Over the years, many studies have been conducted to devise a drug delivery system that would eliminate these adverse affects including liposomes, hydrogel and nanoparticulate systems, and we highlight the pros and cons of these drug delivery systems.  Summary Overall the future for the continued use of doxorubicin clin. against cancer looks set to be prolonged, provided certain enhancements as listed above are made to its chem., delivery and toxicity.  Increased efficacy depends on these three aims being met satisfactorily as discussed in turn in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ULJ-J2uxgrVg90H21EOLACvtfcHk0litn5rBT2SLlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslGitb4%253D&md5=fca40d4f8ee61dcdd6216a694cf44548</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.2012.01567.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.2012.01567.x%26sid%3Dliteratum%253Aachs%26aulast%3DTacar%26aufirst%3DO.%26aulast%3DSriamornsak%26aufirst%3DP.%26aulast%3DDass%26aufirst%3DC.%2BR.%26atitle%3DDoxorubicin%253A%2520an%2520update%2520on%2520anticancer%2520molecular%2520action%252C%2520toxicity%2520and%2520novel%2520drug%2520delivery%2520systems%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D65%26issue%3D2%26spage%3D157%26epage%3D170%26doi%3D10.1111%2Fj.2042-7158.2012.01567.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Wright, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadayyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bopst, M.</span><span> </span><span class="NLM_article-title">Minireview: Challenges and opportunities in development of PPAR agonists</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1756</span><span class="NLM_x">–</span> <span class="NLM_lpage">1768</span><span class="refDoi"> DOI: 10.1210/me.2013-1427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1210%2Fme.2013-1427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=25148456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFamtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1756-1768&issue=11&author=M.+B.+Wrightauthor=M.+Bortoliniauthor=M.+Tadayyonauthor=M.+Bopst&title=Minireview%3A+Challenges+and+opportunities+in+development+of+PPAR+agonists&doi=10.1210%2Fme.2013-1427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Minireview: challenges and opportunities in development of PPAR agonists</span></div><div class="casAuthors">Wright, Matthew B.; Bortolini, Michele; Tadayyon, Moh; Bopst, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1756-1768, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">1944-9917</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  The clin. impact of the fibrate and thiazolidinedione drugs on dyslipidemia and diabetes is driven mainly through activation of two transcription factors, peroxisome proliferator-activated receptors (PPAR)-α and PPAR-γ.  However, substantial differences exist in the therapeutic and side-effect profiles of specific drugs.  This has been attributed primarily to the complexity of drug-target complexes that involve many coregulatory proteins in the context of specific target gene promoters.  Recent data have revealed that some PPAR ligands interact with other non-PPAR targets.  Here we review concepts used to develop new agents that preferentially modulate transcriptional complex assembly, target more than one PPAR receptor simultaneously, or act as partial agonists.  We highlight newly described on-target mechanisms of PPAR regulation including phosphorylation and nongenomic regulation.  We briefly describe the recently discovered non-PPAR protein targets of thiazolidinediones, mitoNEET, and mTOT.  Finally, we summarize the contributions of on- and off-target actions to select therapeutic and side effects of PPAR ligands including insulin sensitivity, cardiovascular actions, inflammation, and carcinogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgR2Bsq_zCDbVg90H21EOLACvtfcHk0ljx7Xjq8KF9Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFamtbY%253D&md5=9f52aab240185e1adf107feb7aa520a7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1210%2Fme.2013-1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2013-1427%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%2BB.%26aulast%3DBortolini%26aufirst%3DM.%26aulast%3DTadayyon%26aufirst%3DM.%26aulast%3DBopst%26aufirst%3DM.%26atitle%3DMinireview%253A%2520Challenges%2520and%2520opportunities%2520in%2520development%2520of%2520PPAR%2520agonists%26jtitle%3DMol.%2520Endocrinol.%26date%3D2014%26volume%3D28%26issue%3D11%26spage%3D1756%26epage%3D1768%26doi%3D10.1210%2Fme.2013-1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&issue=7&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0ljx7Xjq8KF9Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D7%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Chen, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueng, S. H.</span><span> </span><span class="NLM_article-title">Discovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-Tetrahydro-1-Isoquinolinylmethyl)benzamides as novel opioid receptor agonists</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2Fj.ejmech.2016.09.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&pages=202-217&author=S.+R.+Chenauthor=Y.+Y.+Keauthor=T.+K.+Yehauthor=S.+Y.+Linauthor=L.+C.+Ouauthor=S.+C.+Chenauthor=W.+T.+Changauthor=H.+F.+Changauthor=Z.+H.+Wuauthor=C.+C.+Hsiehauthor=P.+Y.+Lawauthor=H.+H.+Lohauthor=C.+Shihauthor=Y.+K.+Laiauthor=S.+H.+Yehauthor=S.+H.+Ueng&title=Discovery%2C+structure-activity+relationship+studies%2C+and+anti-nociceptive+effects+of+N-%281%2C2%2C3%2C4-Tetrahydro-1-Isoquinolinylmethyl%29benzamides+as+novel+opioid+receptor+agonists&doi=10.1016%2Fj.ejmech.2016.09.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%2BR.%26aulast%3DKe%26aufirst%3DY.%2BY.%26aulast%3DYeh%26aufirst%3DT.%2BK.%26aulast%3DLin%26aufirst%3DS.%2BY.%26aulast%3DOu%26aufirst%3DL.%2BC.%26aulast%3DChen%26aufirst%3DS.%2BC.%26aulast%3DChang%26aufirst%3DW.%2BT.%26aulast%3DChang%26aufirst%3DH.%2BF.%26aulast%3DWu%26aufirst%3DZ.%2BH.%26aulast%3DHsieh%26aufirst%3DC.%2BC.%26aulast%3DLaw%26aufirst%3DP.%2BY.%26aulast%3DLoh%26aufirst%3DH.%2BH.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DLai%26aufirst%3DY.%2BK.%26aulast%3DYeh%26aufirst%3DS.%2BH.%26aulast%3DUeng%26aufirst%3DS.%2BH.%26atitle%3DDiscovery%252C%2520structure-activity%2520relationship%2520studies%252C%2520and%2520anti-nociceptive%2520effects%2520of%2520N-%25281%252C2%252C3%252C4-Tetrahydro-1-Isoquinolinylmethyl%2529benzamides%2520as%2520novel%2520opioid%2520receptor%2520agonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D126%26spage%3D202%26epage%3D217%26doi%3D10.1016%2Fj.ejmech.2016.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kenny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curthoys, N. P.</span><span> </span><span class="NLM_article-title">Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1016/S1046-5928(03)00161-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1016%2FS1046-5928%2803%2900161-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=12963351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=140-148&issue=1&author=J.+Kennyauthor=Y.+Baoauthor=B.+Hammauthor=L.+Taylorauthor=A.+Tothauthor=B.+Wagersauthor=N.+P.+Curthoys&title=Bacterial+expression%2C+purification%2C+and+characterization+of+rat+kidney-type+mitochondrial+glutaminase&doi=10.1016%2FS1046-5928%2803%2900161-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase</span></div><div class="casAuthors">Kenny, John; Bao, Yuhne; Hamm, Brian; Taylor, Lynn; Toth, Ann; Wagers, Brian; Curthoys, Norman P.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The human gene that encodes kidney-type glutaminase (KGA) spans 84-kb, contains 19 exons, and encodes 2 alternatively spliced mRNAs.  Here, various segments of rat KGA cDNA were PCR amplified and cloned into a bacterial expression vector and expressed in Escherichia coli to det. whether the N- and C- terminal ends of the glutaminase protein were essential for activity.  A recombinant glutaminase, lacking the coding sequence contained in exon 1, was found to be fully active.  In contrast, proteins that lacked sequences from exons 1 and 2 and exons 1-3 were inactive.  An addnl. construct that corresponded to the sequence encoded by exons 2-14 also retained full activity.  Both of the fully active, truncated proteins were purified to apparent homogeneity using an incorporated N-terminal His6-tag and Ni2+-affinity chromatog.  The Km values for glutamine of the native and recombinant forms of glutaminase were nearly identical.  However, the 2 truncated forms of glutaminase exhibited the characteristic phosphate activation profile only when dialyzed into a buffer lacking phosphate.  Dialysis vs. 10 mM Tris-phosphate was sufficient to form an active tetramer.  Thus, the deleted N-terminal sequence may contribute to the phosphate-dependent oligomerization and activation of the native glutaminase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDLrJrBVieI7Vg90H21EOLACvtfcHk0lgJnbLcKRrtpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGkt7s%253D&md5=f7e79be9442292154cbd86c162af53d3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS1046-5928%2803%2900161-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1046-5928%252803%252900161-X%26sid%3Dliteratum%253Aachs%26aulast%3DKenny%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DY.%26aulast%3DHamm%26aufirst%3DB.%26aulast%3DTaylor%26aufirst%3DL.%26aulast%3DToth%26aufirst%3DA.%26aulast%3DWagers%26aufirst%3DB.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DBacterial%2520expression%252C%2520purification%252C%2520and%2520characterization%2520of%2520rat%2520kidney-type%2520mitochondrial%2520glutaminase%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2003%26volume%3D31%26issue%3D1%26spage%3D140%26epage%3D148%26doi%3D10.1016%2FS1046-5928%2803%2900161-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Robinson, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBryant, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraris, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curthoys, N. P.</span><span> </span><span class="NLM_article-title">Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">406</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span><span class="refDoi"> DOI: 10.1042/BJ20070039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1042%2FBJ20070039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2007&pages=407-414&issue=3&author=M.+M.+Robinsonauthor=S.+J.+McBryantauthor=T.+Tsukamotoauthor=C.+Rojasauthor=D.+V.+Ferrarisauthor=S.+K.+Hamiltonauthor=J.+C.+Hansenauthor=N.+P.+Curthoys&title=Novel+mechanism+of+inhibition+of+rat+kidney-type+glutaminase+by+bis-2-%285-phenylacetamido-1%2C2%2C4-thiadiazol-2-yl%29ethyl+sulfide+%28BPTES%29&doi=10.1042%2FBJ20070039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1042%2FBJ20070039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070039%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DM.%2BM.%26aulast%3DMcBryant%26aufirst%3DS.%2BJ.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DFerraris%26aufirst%3DD.%2BV.%26aulast%3DHamilton%26aufirst%3DS.%2BK.%26aulast%3DHansen%26aufirst%3DJ.%2BC.%26aulast%3DCurthoys%26aufirst%3DN.%2BP.%26atitle%3DNovel%2520mechanism%2520of%2520inhibition%2520of%2520rat%2520kidney-type%2520glutaminase%2520by%2520bis-2-%25285-phenylacetamido-1%252C2%252C4-thiadiazol-2-yl%2529ethyl%2520sulfide%2520%2528BPTES%2529%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D406%26issue%3D3%26spage%3D407%26epage%3D414%26doi%3D10.1042%2FBJ20070039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Brooks, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, C. L.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackerell, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archontis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartels, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boresch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caves, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinner, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodoscek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuczera, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazaridis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovchinnikov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venable, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodcock, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">York, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karplus, M.</span><span> </span><span class="NLM_article-title">CHARMM: the biomolecular simulation program</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">30</span><span class="NLM_x">) </span> <span class="NLM_fpage">1545</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span><span class="refDoi"> DOI: 10.1002/jcc.21287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1002%2Fjcc.21287" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1545-1564&issue=30&author=B.+R.+Brooksauthor=C.+L.+Brooksauthor=A.+D.+Mackerellauthor=L.+Nilssonauthor=R.+J.+Petrellaauthor=B.+Rouxauthor=Y.+Wonauthor=G.+Archontisauthor=C.+Bartelsauthor=S.+Boreschauthor=A.+Caflischauthor=L.+Cavesauthor=Q.+Cuiauthor=A.+R.+Dinnerauthor=M.+Feigauthor=S.+Fischerauthor=J.+Gaoauthor=M.+Hodoscekauthor=W.+Imauthor=K.+Kuczeraauthor=T.+Lazaridisauthor=J.+Maauthor=V.+Ovchinnikovauthor=E.+Paciauthor=R.+W.+Pastorauthor=C.+B.+Postauthor=J.+Z.+Puauthor=M.+Schaeferauthor=B.+Tidorauthor=R.+M.+Venableauthor=H.+L.+Woodcockauthor=X.+Wuauthor=W.+Yangauthor=D.+M.+Yorkauthor=M.+Karplus&title=CHARMM%3A+the+biomolecular+simulation+program&doi=10.1002%2Fjcc.21287"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21287%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26aulast%3DBrooks%26aufirst%3DC.%2BL.%26aulast%3DMackerell%26aufirst%3DA.%2BD.%26aulast%3DNilsson%26aufirst%3DL.%26aulast%3DPetrella%26aufirst%3DR.%2BJ.%26aulast%3DRoux%26aufirst%3DB.%26aulast%3DWon%26aufirst%3DY.%26aulast%3DArchontis%26aufirst%3DG.%26aulast%3DBartels%26aufirst%3DC.%26aulast%3DBoresch%26aufirst%3DS.%26aulast%3DCaflisch%26aufirst%3DA.%26aulast%3DCaves%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DQ.%26aulast%3DDinner%26aufirst%3DA.%2BR.%26aulast%3DFeig%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHodoscek%26aufirst%3DM.%26aulast%3DIm%26aufirst%3DW.%26aulast%3DKuczera%26aufirst%3DK.%26aulast%3DLazaridis%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DOvchinnikov%26aufirst%3DV.%26aulast%3DPaci%26aufirst%3DE.%26aulast%3DPastor%26aufirst%3DR.%2BW.%26aulast%3DPost%26aufirst%3DC.%2BB.%26aulast%3DPu%26aufirst%3DJ.%2BZ.%26aulast%3DSchaefer%26aufirst%3DM.%26aulast%3DTidor%26aufirst%3DB.%26aulast%3DVenable%26aufirst%3DR.%2BM.%26aulast%3DWoodcock%26aufirst%3DH.%2BL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYork%26aufirst%3DD.%2BM.%26aulast%3DKarplus%26aufirst%3DM.%26atitle%3DCHARMM%253A%2520the%2520biomolecular%2520simulation%2520program%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26issue%3D30%26spage%3D1545%26epage%3D1564%26doi%3D10.1002%2Fjcc.21287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Chou, T. C.</span><span> </span><span class="NLM_article-title">Drug combination studies and their synergy quantification using the Chou-Talalay method</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-1947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=10.1158%2F0008-5472.CAN-09-1947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=20068163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=440-446&issue=2&author=T.+C.+Chou&title=Drug+combination+studies+and+their+synergy+quantification+using+the+Chou-Talalay+method&doi=10.1158%2F0008-5472.CAN-09-1947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method</span></div><div class="casAuthors">Chou, Ting-Chao</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">440-446</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  This brief perspective article focuses on the most common errors and pitfalls, as well as the do's and don'ts in drug combination studies, in terms of exptl. design, data acquisition, data interpretation, and computerized simulation.  The Chou-Talalay method for drug combination is based on the median-effect equation, derived from the mass-action law principle, which is the unified theory that provides the common link between single entity and multiple entities, and first order and higher order dynamics.  This general equation encompasses the Michaelis-Menten, Hill, Henderson-Hasselbalch, and Scatchard equations in biochem. and biophysics.  The resulting combination index (CI) theorem of Chou-Talalay offers quant. definition for additive effect (CI = 1), synergism (CI < 1), and antagonism (CI > 1) in drug combinations.  This theory also provides algorithms for automated computer simulation for synergism and/or antagonism at any effect and dose level, as shown in the CI plot and isobologram, resp.  Cancer Res; 70(2); 440-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpECUlVzkYExbVg90H21EOLACvtfcHk0lhZ8HvQebNeCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWksA%253D%253D&md5=d0713e60852fc656bc91719ccb27eb1a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-1947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-1947%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26atitle%3DDrug%2520combination%2520studies%2520and%2520their%2520synergy%2520quantification%2520using%2520the%2520Chou-Talalay%2520method%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D2%26spage%3D440%26epage%3D446%26doi%3D10.1158%2F0008-5472.CAN-09-1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UO9','PDB','3UO9'); return false;">PDB: 3UO9</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=AF158555" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=AF158555','Genbank','AF158555'); return false;">Genbank: AF158555</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i56"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00282">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_88872"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00282">10.1021/acs.jmedchem.7b00282</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Glutaminase inhibitory activity of commercial available glitazones, summary of synergistic effects of combined treatments of GA inhibitors, pictures/structures of compounds <b>2</b>–<b>17</b> and intermediates, verification of GLS gene knocked out in AsPC-1<sup>GLS–/–</sup> cells, and effects of PPAR agonists or thiazolidine-2,4-dione compounds on the transactivation activities of PPARα, PPARγ, and PPARδ (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_001.pdf">jm7b00282_si_001.pdf (962.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00282/suppl_file/jm7b00282_si_002.csv">jm7b00282_si_002.csv (1.97 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00282&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00282%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00282" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b36df094a24eb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
